Party Panel 15.1

Gjalt-Jorn Peters (Greater Good, Open Universiteit & Academy of Behavior Change) & Judith Noijen (Jellinek Preventie)

This report is generated on 14 Aug 2018 at 09:57:04.

Background

Introduction

Party Panel is a Dutch panel study where determinants and beliefs underlying health behaviors in the Dutch nightlife are mapped. This wave started on 28 June 2015. It was developed to explore the use of high doses of ecstasy, in response to the average dose of 3,4-Methylenedioxymethamphetamine (MDMA) in ecstasy pills on the Dutch markets. Specifically, the determinants were measured of three behaviors: using a high dose of MDMA (regardless of whether this was ingested in one highly dosed ecstasy pill, or in multiple lower dosed pills), using highly dosed ecstasy pills (regardless of whether a high dose of MDMA was ingested), and getting one’s ecstasy tested.

This document is the report of the Party Panel results. This is a living document and may be updated.

This document is in English, except the section with prevention recommendations, because it is written specifically for Dutch prevention professionals.

Publication and distribution

Press releases

It is not allowed to publish Party Panel results in a press release. Only the Celebrate Safe project committee has the right to publish press releases containing Party Panel results, and then only after explicit approval from Greater Good. If you think doing a press release about a specific Party Panel result can be helpful as a prevention effort, you can always contact the Celebrate Safe project committee and explain this to them. However, Party Panel is intended as scientific research and to inform prevention efforts: not as a marketing tool.

Confidentiality and embargo

The wave described in this document started on 28 June 2015 and therefore, all resources developed for this Party Panel wave as well as the collected data are available under CC-BY-NC-SA (see http://creativecommons.org/licenses/by-nc-sa/4.0/) and have been since 28 June 2017.

Full disclosure

Party Panel follows the Open Science principle of Full Disclosure. Each Party Panel wave has a component repository in the general Party Panel Open Science Framework repository at https://osf.io/s4fmu/. Note that the general terms and conditions as contained in the Creative Commons license listed above, as well as the restriction pertaining to press releases, remains in effect.

Behavior Change

Party Panel was designed to inform development of effective behavior change interventions in the Dutch nightlife, to support a healthy, safe, fun nightlife where the personal integrity of its visitors is respected.

Reading this report may require expertise regarding behavior change. Interested readers who as yet lack the required knowledge can use the Open Access (freely available) articles about behavior change that are available at https://effectivebehaviorchange.com.

Ethics

Ethical approval for the Party Panel determinant studies was granted by the committee for Ethical Testing of Research (commissie Ethische Toetsing Onderzoek, cETO) of the Open University of the Netherlands, under files numbers U2015/03757/HVM and U2017/03081/FRO. The applications and approval letters are available at the Open Science Framework repository for the shared Party Panel resources at https://osf.io/7bv4w/.

Acknowledgements

Party Panel is the result of the combination of energy, knowledge, skills and enthusiasm of a large group of people. Party Panel is funded by Celebrate Safe, with a subsidy from the Dutch Ministry of Health, Welfare and Sport. It is developed, executed, analysed and managed by Greater Good, with invaluable input from Jellinek Preventie. Without the Unity peers’ unique insights, the questionnaires and collected data would never reach the richness and depth it does. The Celebrate Safe project committee, advisory board, and affiliated expert organisations also provided valuable feedback. Without the festival and event organisers, clubs, and other nightlife organisations, we would never have been able to reach all the participants that we did. For this wave specifically, we would like to thank Ferry Goossens for thinking along with the questionnaire. So thank you all!!! We hope you can benefit from these results as well, and in general, that they contribute to improving our nightlife.

How to use this report

Because this report contains a lot of information, it is organised using tabs, which you see above this section. Click a tab to view the associated contents.

Prevention recommendations

This section contains recommendations for prevention professionals. Because these recommendations are for prevention professionals working with nightlife-related behaviors in the Netherlands, these recommendations will be in Dutch.

Inleiding

Party Panel is een semi-panel studie in het Nederlandse uitgaansleven met als doel de determinanten van verschillende uitgaansleven-gerelateerde gezondheidsgedragingen in kaart te brengen. Het in kaart brengen van die determinanten is nodig voor preventie: je kunt geen effectieve interventie ontwikkelen als je niet weet waar die interventie zich op moet richten.

Preventie betreft altijd een poging om iets te voorkomen (letterlijk per definitie), en bijna altijd een poging om iets onwenselijks te voorkomen. De te voorkomen zaken zijn altijd het gevolg van menselijk gedrag (van bezoekers van een feest of optreden, van clubeigenaren, van politici, en ga maar door), en de oorzaken van menselijk gedrag zijn in te delen in twee categorieën: de omgeving en de menselijke psychologie. Effectieve preventie vereist noodzakelijkerwijs eerst inzicht in die oorzaken. Pas als je dat inzicht hebt kun je bepalen of je probeert om de omgeving te veranderen (bijvoorbeeld gratis condooms, oordopjes, of water verstrekken; dit bereik je door gedrag van beslissers in de omgeving, zoals politici of organisatoren, te veranderen) of om de menselijke psychologie te veranderen (bijvoorbeeld door misverstanden de wereld uit te helpen of door mensen tips te geven om zich aan hun voornemen te houden).

Als je incidenten in het uitgaansleven wil voorkomen, en eigenlijk in het algemeen gewoon een leuk en veilig uitgaansleven wil, dan moet je dus eerst weten waarom mensen doen wat ze doen. Party Panel is een instrument om dit in kaart te brengen.

Verandering van gedrag

Gedragsverandering is eigenlijk gewoon versneld leren. Mensen kunnen ‘van nature’ natuurlijk al goed leren: wezens zonder het vermogen om te leren hebben een veel lagere overlevingskans, waardoor het vermogen te leren in veruit de meeste diersoorten is geëvolueerd. Tegelijkertijd is dat vermogen om te leren natuurlijk nooit ontwikkeld om preventie mogelijk te maken. Kortom: als je mensen wil helpen hun gedrag te veranderen, gebruik je een proces (leren) dat eigenlijk ergens anders voor is ontwikkeld.

Het komt daarom erg nauw wat je doet: het is moeilijk om precies het ‘leerproces’ waar de menselijke psychologie mee is uitgerust na te bootsen om zo de juiste veranderingen in iemands opvattingen te bewerkstelligen. Omdat dit zo lastig is, is er veel onderzoek naar gedaan. Uit dat onderzoek zijn inmiddels een aantal methoden voor gedragsverandering bekend. Deze methoden maken gebruik van verschillende vormen van leren, die soms op verschillende typen geheugen zijn gericht.

Methoden voor gedragsverandering zijn niet zomaar ‘blind’ te gebruiken: het is jammer genoeg niet zo dat je alleen maar het “juiste truckje” hoeft te vinden. Verschillende methoden zijn in staat om verschillende soorten opvattingen te veranderen. Mensen kunnen immers allerlei uiteenlopende redenen hebben voor hun gedrag, en die vereisen allemaal een andere aanpak. Voordat je echt over verandering na kunt denken, moet je dus begrijpen waarom mensen doen wat ze doen.

Verklaring van gedrag

Mensen kunnen allerlei redenen hebben voor wat ze doen. Menselijk gedrag is complex: denk maar eens na over waarom je hier nu bent; waarom je gisteren hebt gegeten wat je hebt gegeten; waarom je vorig weekend hebt besteed zoals je dat deed; en ga maar door. Voor een gegeven gedrag (bijvoorbeeld in een restaurant pizza of pasta bestellen) kunnen, als je maar genoeg mensen vraagt, honderden, soms duizenden redenen zijn. Dat maakt het natuurlijk lastig om in kaart te brengen waarom mensen doen wat ze doen.

Gelukkig wordt er al een dikke honderd jaar onderzoek gedaan in de psychologie, dus inmiddels zijn hier allerlei oplossingen voor gevonden. In de basis zijn die gebaseerd op hetzelfde uitgangspunt: al die verschillende redenen kun je groeperen. Sommige redenen lijken namelijk nogal op elkaar. Mensen voelen bijvoorbeeld sociale druk; of houden rekening met hun lange-termijn doelen; of hebben niet het gevoel dat ze iets goed kunnen. Je kunt die honderden redenen dus ordenen door ze te groeperen, en dit is wat psychologische theorieën doen.

Er zijn inmiddels heel veel theorieën die verklaren waarom mensen doen wat ze doen. Veel gezondheidsgedrag is gedrag waar mensen over nadenken: zogenaamde beredeneerd gedrag. Een van de meest gebruikte theorieën over beredeneerd gedrag heet heel toepasselijk de “Beredeneerd Gedrag Benadering” (ok, hij heet eigenlijk de Reasoned Action Approach, RAA, wat toch wat beter klinkt). De RAA is de derde ‘versie’ van een theorie die hiervoor de Theory van Geplanned Gedrag heette, en daarvoor de Theorie van Beredeneerde Actie.

Deze theorie stelt dat beredeneerd gedrag vooral wordt bepaald door of mensen de intentie hebben om dat betreffende gedrag uit te voeren. Dat is natuurlijk nogal logisch: als je van plan bent om iets te doen, dan doe je het meestal ook, als er tenminste geen obstakels in de omgeving zijn, en als de controle over je gedrag niet afneemt. De kracht van de RAA zit in de voorspellers van die intentie. Dit zijn volgens de RAA drie groepen vergelijkbare redenen: attitude, waargenomen norm, en waargenomen gedragscontrole.

Attitude

Attitude is een soort ‘gewogen gemiddelde’ van alle voor- en nadelen van een gedrag, of accurater uitgedrukt, van de mogelijke gevolgen, hoe waarschijnlijk iemand denkt dat die gevolgen zijn, en hoe wenselijk iemand die gevolgen vindt. Inschatting van de risico’s van een gedrag maakt hier deel van uit, maar er is nog veel meer, bijvoorbeeld de voordelen van het gedrag (middelengebruik is bijvoorbeeld leuk/lekker).

Attitude bestaat dus uit twee onderdelen: de ingeschatte waarschijnlijkheid van de mogelijke gevolgen van gedrag, en de wenselijkheid van elk mogelijke gevolg (hoe wenselijk of onwenselijk iemand die gevolgen vindt).

Waargenomen norm

Waargenomen norm gaat over of je denkt dat de mensen die belangrijk voor je zijn het goed- of afkeuren als jij het betreffende gedrag uitvoert, en over of je denkt dat de mensen om je heen dat gedrag zelf uitvoeren. Of mensen iets goedkeuren of afkeuren, en wat ze zelf doen, hoeft natuurlijk niet hetzelfde te zijn: ouders kunnen best hun kinderen vertellen dat ze nooit moeten gaan roken, maar zelf wel roken.

Waargenomen norm bestaat uit drie onderdelen: je inschatting van goed- of afkeuring door anderen (injunctieve norm), de mate waarin je waarde hecht aan die oordelen (motivation to comply), en je inschatting van het gedrag van anderen (descriptieve norm).

Waargenomen gedragscontrole

Waargenomen gedragscontrole gaat over of je denkt dat je het gedrag uit kunt voeren: is het onder jouw controle, en heb je de nodige vaardigheden wel? Je kunt best van plan zijn om genoeg te rusten als je ecstasy hebt gebruikt, maar als er geen chill out is, wordt dat lastig. En wat als je hebt besloten om geen cocaine te gebruiken, maar de drie mensen waar je mee uit bent doen dat wel – weet je hoe je dan toch niet zwicht voor de verleiding? Waargenomen gedragscontrole bestaat uit twee onderdelen: de hoeveelheid controle die je over gedrag hebt (controle), en hoe goed je denkt dat je in het gedrag bent (capaciteit).

Party Panel en gedragsverandering

De RAA stelt dat als je de redenen in die drie categorieën goed in kaart brengt, dat je dan goed kunt voorspellen wat mensen doen. En als je dat kunt, begrijp je genoeg van het gedrag om te gaan denken aan gedragsverandering: dan kun je op zoek naar methoden die werken om de redenen die belangrijk zijn, te veranderen. In een plaatje ziet die RAA er zo uit:

Naast de RAA zijn er nog talloze andere theorieën om gedrag te verklaren. Deze groeperingen van gelijksoortige redenen heten in de psychologie variabelen, en als het gaat over gedragsverandering worden ze vaak determinanten genoemd.

Gedragsverandering is een subdomein van de psychologie. Naast grondige kennis van de psychologie vereist het constructief kunnen denken over effectieve gedragsveranderingsinterventies daarom specialistische kennis met betrekking tot de theorie van verklaring en verandering van gedrag. In de voorgaande alinea’s is gepoogd om voldoende over te brengen zodat ook leken met betrekking tot gedragsverandering uit de voeten kunnen met dit rapport. Lezers die zich verder willen verdiepen adviseren we om de ‘Open Access’ (gratis toegankelijke) inleidende, en verdiepende, artikelen over gedragsverandering op https://effectivebehaviorchange.com te raadplegen. Verder is het altijd raadzaam om bij de ontwikkeling van alle preventie (of andere campagnes) die zijn gericht op gedragsverandering, of verandering van antecedenten van gedrag zoals bewustwording of kennis, experts in de gedragsverandering te raadplegen.

Interventie suggesties

Deze sectie bevat de suggesties voor preventie op basis van de analyse van de determinanten van hooggedoseerde ecstasy gebruiken, een hoge dosis MDMA gebruiken, en ecstasy laten testen.

Het valt op dat de meest frequent gerapporteerde effecten van het gebruiken van een hoge dosis MDMA over het algemeen niet de meest wenselijke effecten zijn. Deelnemers aan Party Panel realiseerden zich dus ergens wel dat het gebruik van een hoge dosis onwenselijke gevolgen had (met betrekking tot de ervaring; het werd duidelijk dat deelnemers zich al realiseerden dat hoge doses gevolgen voor de gezondheid heeft).

Verder werd er een sterk verband geobserveerd tussen of deelnemers het gebruik van een hoge dosis ecstasy een betere ervaring vonden en hun intentie. Dit biedt een ingang voor preventie: wellicht is het mogelijk bij gebruikers reflectie aan te moedigen, waardoor het besef dat hogere doses niet leiden tot een betere ervaring kan worden gerealiseerd. Hierbij is het belangrijk er rekening mee te houden dat sommige mensen effecten van hoge dosering zoals hallucineren wel prettig vinden.

Voor de meeste mensen geldt dat het gelukkige gevoel, het primaire effect van ecstasy, toeneemt met dosering totdat de maximale dosering is bereikt Hierna neemt de in zichzelf gekeerdheid juist toe, wat als onprettig wordt ervaren. Bij mensen die een sterker gelukkig gevoel verwachten bij een hogere dosis kan het dus handig zijn dit misverstand te ontkrachten.

Sommige deelnemers geloven dat hoger gedoseerde pillen ook zuiverder zijn. Echter, een pil is zoveel groter dan het kleine aandeel MDMA dat er zelfs met hooggedoseerde pillen nog voldoende gelegenheid is voor vervuiling. Het gebruik van hooggedoseerde pillen is dus niet veiliger.

Een idee voor een interventie is deelnemers te laten aangeven hoe ze denken dat de verschillende effecten van ecstasy veranderen naarmate de dosis hoger wordt. Een voorbeeld van zo’n curve staat hieronder:

Bij deze persoon zou de ervaring dus maximaal zijn bij ongeveer 65 milligram. Een dosis van 250 milligram zou ongeveer gelijk staan aan het niet nemen van ecstasy, bijvoorbeeld omdat de negatieve effecten (bijvoorbeeld sociaal isolerend gedrag, hallucinaties, tandenknarsen) zo sterk zijn dat ze de positieve effecten overschaduwen.

Als mensen zelf zo’n ‘ervaringscurve’ tekenen, dan kan die bijvoorbeeld worden vergeleken met hoe dit in werkelijkheid zit. Hiervoor is die informatie natuurlijk wel nodig - het is ons nu niet bekend of dit ooit in kaart is gebracht. Zelfs zonder de ‘echte curves’ kan het natuurlijk een zinvolle exercitie zijn om gebruikers hun inschatting van die curves te laten maken.

Het kan dan handig zijn om gebruikers van te voren te laten nadenken over wat de effecten van echt hoge doseringen zijn, zodat het tekenen van de ‘effect curves’ wordt benaderd vanuit de juiste basis, dus gebaseerd op erkenning van het gegeven dat hoge doses onwenselijke effecten hebben.

De determinant ‘anticipated regret’, oftewel ‘geanticipeerde spijt’, hing ook samen met intentie om hooggedoseerde ecstasy te gebruiken. Dat betekent dat als deelnemers bewogen kunnen worden te reflecteren op de negatieve gevolgen van een hoge dosering, dat kan leiden tot gebruik van lagere doses.

Een middel hiervoor kan zijn dat deelnemers aangaven minder te onthouden als een hoge dosis werd gebruikt (terwijl veel onthouden wenselijker was).

De meeste deelnemers gaven aan dat testen anoniem was (wat klopt), dat ze weten waar ze hun ecstasy kunnen laten testen, en dat ze daar relatief eenvoudig konden komen. Dat werd echter wel als vrij tijdrovend beschouwd. Vrij veel deelnemers gaven aan dat testen altijd minimaal een pil kost, terwijl in 50% van de gevallen (70% tijdens ADE) onmiddelijk kan worden bepaald wat er in een pil zit zonder dat deze naar het lab gestuurd hoeft te worden. Deze informatie (dat testen dus maar in de helft van de gevallen een pil kost) kan helpen om testgedrag te bevorderen. Een andere suggesties is meer testlokaties beschikbaar te maken en de procedures te versnellen zodat testen minder tijdrovend wordt.

Tot slot is het makkelijker om poeder te doseren van ecstasypillen. Dit kan eventueel ook als advies worden gegeven. Dit is een sterk ‘harm reduction’ advies, en het kan zijn dat niet alle overheden en preventie-organisaties vinden dat dat binnen hun beleid past.

Data integrity & cleaning

Data preprocessing

No items specified: extracting all variable names in dataframe. Note: 123 variables were not numeric and will not be checked for exceptional values.

Participants of 0 entries indicated that they were test entries (e.g. for testing the survey, or when participants were not entirely serious about completing the survey).

Furthermore, 29 participants were among the 1% with 10 or more exceptional answers (in the lowest 2.5% or the highest 2.5%), and were therefore removed from the dataset as well (row numbers (and number of exceptional anwers): 7 (10), 149 (22), 236 (18), 418 (19), 582 (10), 614 (18), 798 (14), 870 (11), 873 (11), 1361 (16), 1384 (10), 1419 (10), 1562 (10), 1576 (15), 1669 (10), 1683 (16), 1721 (10), 1890 (21), 1959 (13), 1970 (11), 1987 (15), 2069 (12), 2147 (12), 2449 (25), 2456 (12), 2563 (11), 2608 (11), 2957 (15) & 3231 (11)).

1 participants (rows 1844) had more than 5 answers that fell into the wrong class (e.g. typing letters where numbers were required) and were also removed.

Summary of dataset

Data Frame Summary

dat
N: 3765

No	Variable	Stats / Values	Freqs (% of Valid)	Text Graph	Valid	Missing
1	id [numeric]	mean (sd) : 1985.77 (1099.57) min < med < max : 79 < 1987 < 3883 IQR (CV) : 1905 (0.55)	3765 distinct values		3765 (100%)	0 (0%)
2	submitdate [POSIXct, POSIXt]	min : 2015-06-28 16:37:23 med : 2015-08-29 01:32:08 max : 2016-01-16 22:54:28 range : 6m 19d 6H 17M 5S	374 distinct val.		374 (9.93%)	3391 (90.07%)
3	lastpage [numeric]	mean (sd) : 2.62 (4.33) min < med < max : 0 < 0 < 14 IQR (CV) : 2 (1.65)	15 distinct values		3765 (100%)	0 (0%)
4	startlanguage [character]	1. nl-informal	3765 (100.0%)	IIIIIIIIIIIIIIII	3765 (100%)	0 (0%)
5	startdate [POSIXct, POSIXt]	min : 2015-06-28 15:53:09 med : 2015-09-01 17:17:21 max : 2016-03-04 15:02:00 range : 8m 4d 23H 8M 51S	3744 distinct val.		3765 (100%)	0 (0%)
6	datestamp [character]	1. 2015-06-28 16:34:56 2. 2015-06-28 17:41:17 3. 2015-07-30 12:01:07 4. 2015-08-06 10:00:24 5. 2015-08-16 15:55:24 6. 2015-08-16 16:00:04 7. 2015-08-16 16:26:54 8. 2015-08-16 16:36:23 9. 2015-08-16 17:16:45 10. 2015-08-19 11:08:27 [ 3740 others ]	2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 2 ( 0.0%) 3745 (112.3%)	IIIIIIIIIIIIIIII	3765 (100%)	0 (0%)
7	refurl [character]	1. http://www.partypanel.nl/\ 2. http://partypanel.nl/\ 3. http://www.partypanel.nl/\ 4. http://partypanel.nl/?joi\ 5. http://www.partypanel.nl/\ 6. http://partypanel.nl/ls/i\ 7. http://partypanel.nl\ 8. http://www.partypanel.nl\ 9. https://translate.googleu\ 10. https://www.google.nl/\ [ 23 others ]	2035 (66.9%) 365 (12.0%) 361 (11.9%) 112 ( 3.7%) 52 ( 1.7%) 39 ( 1.3%) 15 ( 0.5%) 10 ( 0.3%) 7 ( 0.2%) 7 ( 0.2%) 37 ( 1.2%)	IIIIIIIIIIIIIIII II II	3040 (80.74%)	725 (19.26%)
8	moreInfo_1 [numeric]	mean (sd) : 0.13 (0.34) min < med < max : 0 < 0 < 1 IQR (CV) : 0 (2.57)	0 : 1683 (86.9%) 1 : 254 (13.1%)	IIIIIIIIIIIIIIII II	1937 (51.45%)	1828 (48.55%)
9	informedConsent [factor]	1. Ja, ik ga akkoord met dee 2. Nee, ik wil toch niet mee	1785 (98.8%) 22 ( 1.2%)	IIIIIIIIIIIIIIII	1807 (47.99%)	1958 (52.01%)
10	randomNumber [numeric]	mean (sd) : 2.02 (0.82) min < med < max : 1 < 2 < 3 IQR (CV) : 2 (0.4)	1 : 1223 (32.5%) 2 : 1247 (33.1%) 3 : 1295 (34.4%)	IIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII	3765 (100%)	0 (0%)
11	randomTestingPrice [numeric]	mean (sd) : 4.99 (3.14) min < med < max : 0 < 5 < 10 IQR (CV) : 6 (0.63)	11 distinct values		3765 (100%)	0 (0%)
12	noConsentReason [character]	1. 20 minuten is te lang 2. duurt te lang	1 (50.0%) 1 (50.0%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIIII	2 (0.05%)	3763 (99.95%)
13	goingOutFreqPeriod_houseparty [numeric]	mean (sd) : 2.93 (3.26) min < med < max : 0 < 2 < 30 IQR (CV) : 2 (1.12)	18 distinct values		875 (23.24%)	2890 (76.76%)
14	goingOutFreqNr_houseparty_nr [numeric]	mean (sd) : 6.85 (8.36) min < med < max : 1 < 6 < 26 IQR (CV) : 5 (1.22)	1 : 378 (42.9%) 6 : 372 (42.2%) 26 : 132 (15.0%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIII	882 (23.43%)	2883 (76.57%)
15	goingOutFreqPeriod_cafe [numeric]	mean (sd) : 3.13 (4.92) min < med < max : 0 < 2 < 50 IQR (CV) : 2 (1.57)	23 distinct values		866 (23%)	2899 (77%)
16	goingOutFreqNr_cafe_nr [numeric]	mean (sd) : 9.44 (10.24) min < med < max : 1 < 6 < 26 IQR (CV) : 25 (1.08)	1 : 332 (38.1%) 6 : 306 (35.1%) 26 : 233 (26.8%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIII	871 (23.13%)	2894 (76.87%)
17	goingOutFreqPeriod_disco [numeric]	mean (sd) : 2.2 (3.34) min < med < max : 0 < 1 < 30 IQR (CV) : 2 (1.52)	18 distinct values		864 (22.95%)	2901 (77.05%)
18	goingOutFreqNr_disco_nr [numeric]	mean (sd) : 4.9 (7.06) min < med < max : 1 < 1 < 26 IQR (CV) : 5 (1.44)	1 : 508 (58.5%) 6 : 282 (32.5%) 26 : 79 ( 9.1%)	IIIIIIIIIIIIIIII IIIIIIII II	869 (23.08%)	2896 (76.92%)
19	goingOutFreqPeriod_band [numeric]	mean (sd) : 1.06 (2.43) min < med < max : 0 < 0 < 33 IQR (CV) : 1 (2.31)	16 distinct values		864 (22.95%)	2901 (77.05%)
20	goingOutFreqNr_band_nr [numeric]	mean (sd) : 1.84 (3.4) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.85)	1 : 778 (89.7%) 6 : 75 ( 8.6%) 26 : 14 ( 1.6%)	IIIIIIIIIIIIIIII I	867 (23.03%)	2898 (76.97%)
21	goingOutFreqPeriod_smallPartyInside [numeric]	mean (sd) : 1.67 (2.38) min < med < max : 0 < 1 < 34 IQR (CV) : 2 (1.43)	15 distinct values		857 (22.76%)	2908 (77.24%)
22	goingOutFreqNr_smallPartyInside_nr [numeric]	mean (sd) : 1.73 (2.57) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.49)	1 : 759 (88.3%) 6 : 95 (11.1%) 26 : 6 ( 0.7%)	IIIIIIIIIIIIIIII II	860 (22.84%)	2905 (77.16%)
23	goingOutFreqPeriod_bigPartyInside [numeric]	mean (sd) : 1.09 (1.5) min < med < max : 0 < 1 < 15 IQR (CV) : 2 (1.38)	12 distinct values		856 (22.74%)	2909 (77.26%)
24	goingOutFreqNr_bigPartyInside_nr [numeric]	mean (sd) : 1.36 (1.68) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.24)	1 : 806 (93.8%) 6 : 51 ( 5.9%) 26 : 2 ( 0.2%)	IIIIIIIIIIIIIIII I	859 (22.82%)	2906 (77.18%)
25	goingOutFreqPeriod_smallPartyOutside [numeric]	mean (sd) : 1.32 (1.64) min < med < max : 0 < 1 < 15 IQR (CV) : 2 (1.25)	13 distinct values		853 (22.66%)	2912 (77.34%)
26	goingOutFreqNr_smallPartyOutside_nr [numeric]	mean (sd) : 1.5 (2.27) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.52)	1 : 790 (92.4%) 6 : 60 ( 7.0%) 26 : 5 ( 0.6%)	IIIIIIIIIIIIIIII I	855 (22.71%)	2910 (77.29%)
27	goingOutFreqPeriod_bigPartyOutside [numeric]	mean (sd) : 2.28 (2.11) min < med < max : 0 < 2 < 20 IQR (CV) : 2 (0.93)	14 distinct values		857 (22.76%)	2908 (77.24%)
28	goingOutFreqNr_bigPartyOutside_nr [numeric]	mean (sd) : 1.51 (2.01) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.33)	1 : 783 (91.3%) 6 : 72 ( 8.4%) 26 : 3 ( 0.4%)	IIIIIIIIIIIIIIII I	858 (22.79%)	2907 (77.21%)
29	musicPrefHome_genre1 [character]	1. Hardstyle 2. Techno 3. House 4. Rock 5. Deephouse 6. Hardcore 7. pop 8. Pop 9. hardstyle 10. top 40 [ 329 others ]	58 ( 6.9%) 40 ( 4.7%) 35 ( 4.1%) 28 ( 3.3%) 26 ( 3.1%) 24 ( 2.8%) 18 ( 2.1%) 18 ( 2.1%) 15 ( 1.8%) 14 ( 1.7%) 569 (67.9%)	I I IIIIIIIIIIIIIIII	845 (22.44%)	2920 (77.56%)
30	musicPrefHome_genre2 [character]	1. Techno 2. Hardstyle 3. House 4. Pop 5. Hardcore 6. house 7. Rock 8. Dance 9. techno 10. hardstyle [ 300 others ]	55 ( 6.7%) 43 ( 5.2%) 37 ( 4.5%) 37 ( 4.5%) 31 ( 3.8%) 19 ( 2.3%) 19 ( 2.3%) 18 ( 2.2%) 17 ( 2.1%) 14 ( 1.7%) 534 (64.4%)	I I I I IIIIIIIIIIIIIIII	824 (21.89%)	2941 (78.11%)
31	musicPrefHome_genre3 [character]	1. Techno 2. Pop 3. techno 4. Rock 5. Hardstyle 6. House 7. Hardcore 8. Klassiek 9. pop 10. house [ 318 others ]	45 ( 5.6%) 31 ( 3.9%) 28 ( 3.5%) 27 ( 3.4%) 26 ( 3.3%) 20 ( 2.5%) 19 ( 2.4%) 18 ( 2.3%) 16 ( 2.0%) 15 ( 1.9%) 552 (70.4%)	I IIIIIIIIIIIIIIII	797 (21.17%)	2968 (78.83%)
32	musicPrefParty_genre1 [character]	1. Techno 2. Hardstyle 3. techno 4. House 5. Hardcore 6. Dance 7. hardstyle 8. house 9. Deephouse 10. Rock [ 237 others ]	131 (15.8%) 65 ( 7.8%) 57 ( 6.8%) 56 ( 6.7%) 34 ( 4.1%) 27 ( 3.2%) 20 ( 2.4%) 20 ( 2.4%) 15 ( 1.8%) 15 ( 1.8%) 392 (47.0%)	IIIII II II II I I IIIIIIIIIIIIIIII	832 (22.1%)	2933 (77.9%)
33	musicPrefParty_genre2 [character]	1. Techno 2. House 3. Hardstyle 4. techno 5. Hardcore 6. Deephouse 7. house 8. Pop 9. Dance 10. deephouse [ 262 others ]	69 ( 8.5%) 59 ( 7.3%) 42 ( 5.2%) 42 ( 5.2%) 37 ( 4.6%) 27 ( 3.3%) 27 ( 3.3%) 19 ( 2.4%) 17 ( 2.1%) 17 ( 2.1%) 453 (55.3%)	II II I I I IIIIIIIIIIIIIIII	809 (21.49%)	2956 (78.51%)
34	musicPrefParty_genre3 [character]	1. Techno 2. House 3. house 4. Hardcore 5. techno 6. Rock 7. Dance 8. Pop 9. Deephouse 10. Hardstyle [ 275 others ]	58 ( 7.8%) 48 ( 6.5%) 27 ( 3.6%) 24 ( 3.2%) 22 ( 3.0%) 20 ( 2.7%) 18 ( 2.4%) 16 ( 2.1%) 15 ( 2.0%) 15 ( 2.0%) 480 (63.7%)	I I IIIIIIIIIIIIIIII	743 (19.73%)	3022 (80.27%)
35	specificPartiesPast_pastParty1 [character]	1. Defqon 2. Decibel 3. Dominator 4. Lowlands 5. Awakenings 6. Defqon 1 7. Defqon.1 8. Intents Festival 9. Awakenings festival 10. Awakenings Festival [ 487 others ]	18 ( 2.3%) 17 ( 2.2%) 16 ( 2.0%) 16 ( 2.0%) 14 ( 1.8%) 13 ( 1.7%) 10 ( 1.3%) 7 ( 0.9%) 6 ( 0.8%) 6 ( 0.8%) 656 (85.1%)	IIIIIIIIIIIIIIII	779 (20.69%)	2986 (79.31%)
36	specificPartiesPast_pastParty2 [character]	1. Decibel 2. - 3. Awakenings 4. Dominator 5. Lowlands 6. Defqon 7. Qapital 8. Awakenings Festival 9. Defqon.1 10. Intents [ 512 others ]	12 ( 1.7%) 11 ( 1.6%) 8 ( 1.1%) 8 ( 1.1%) 8 ( 1.1%) 7 ( 1.0%) 7 ( 1.0%) 6 ( 0.9%) 6 ( 0.9%) 6 ( 0.9%) 617 (87.0%)	IIIIIIIIIIIIIIII	696 (18.49%)	3069 (81.51%)
37	specificPartiesPast_pastParty3 [character]	1. - 2. Dominator 3. Decibel 4. Awakenings 5. Loveland 6. / 7. Free Festival 8. Hard Bass 9. Soenda 10. awakenings [ 465 others ]	16 ( 2.6%) 12 ( 2.0%) 11 ( 1.8%) 7 ( 1.1%) 6 ( 1.0%) 4 ( 0.7%) 4 ( 0.7%) 4 ( 0.7%) 4 ( 0.7%) 3 ( 0.5%) 537 (86.5%)	IIIIIIIIIIIIIIII	608 (16.15%)	3157 (83.85%)
38	specificPartiesFutur_futureParty1 [character]	1. ADE 2. Qlimax 3. - 4. Lowlands 5. Q-base 6. Mysteryland 7. Q-Base 8. Valhalla 9. Decibel 10. Qbase [ 462 others ]	22 ( 3.0%) 20 ( 2.8%) 19 ( 2.6%) 13 ( 1.8%) 12 ( 1.7%) 10 ( 1.4%) 10 ( 1.4%) 10 ( 1.4%) 7 ( 1.0%) 7 ( 1.0%) 594 (82.9%)	IIIIIIIIIIIIIIII	724 (19.23%)	3041 (80.77%)
39	specificPartiesFutur_futureParty2 [character]	1. - 2. ADE 3. Freaqshow 4. Qlimax 5. nvt 6. Valhalla 7. Ground zero 8. Supremacy 9. / 10. Decibel [ 420 others ]	27 ( 4.5%) 13 ( 2.2%) 10 ( 1.7%) 10 ( 1.7%) 8 ( 1.3%) 8 ( 1.3%) 6 ( 1.0%) 6 ( 1.0%) 5 ( 0.8%) 5 ( 0.8%) 500 (84.5%)	IIIIIIIIIIIIIIII	598 (15.88%)	3167 (84.12%)
40	specificPartiesFutur_futureParty3 [character]	1. - 2. Qlimax 3. ADE 4. Freaqshow 5. nvt 6. / 7. Awakenings 8. Supremacy 9. geen 10. Q-base [ 328 others ]	38 ( 8.0%) 13 ( 2.7%) 9 ( 1.9%) 9 ( 1.9%) 8 ( 1.7%) 6 ( 1.3%) 6 ( 1.3%) 6 ( 1.3%) 5 ( 1.0%) 4 ( 0.8%) 372 (78.1%)	I IIIIIIIIIIIIIIII	476 (12.64%)	3289 (87.36%)
41	socialReferents_partner [numeric]	mean (sd) : 0.52 (0.5) min < med < max : 0 < 1 < 1 IQR (CV) : 1 (0.97)	0 : 448 (48.2%) 1 : 481 (51.8%)	IIIIIIIIIIIIII IIIIIIIIIIIIIIII	929 (24.67%)	2836 (75.33%)
42	socialReferents_bestFriends [numeric]	mean (sd) : 0.98 (0.15) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.16)	0 : 22 ( 2.4%) 1 : 907 (97.6%)	IIIIIIIIIIIIIIII	929 (24.67%)	2836 (75.33%)
43	socialReferents_xtcFriends [numeric]	mean (sd) : 0.83 (0.37) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.45)	0 : 155 (16.7%) 1 : 774 (83.3%)	III IIIIIIIIIIIIIIII	929 (24.67%)	2836 (75.33%)
44	socialReferents_otherFriends [numeric]	mean (sd) : 0.94 (0.25) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.26)	0 : 60 ( 6.5%) 1 : 869 (93.5%)	I IIIIIIIIIIIIIIII	929 (24.67%)	2836 (75.33%)
45	socialReferents_parents [numeric]	mean (sd) : 0.87 (0.33) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.38)	0 : 117 (12.6%) 1 : 812 (87.4%)	II IIIIIIIIIIIIIIII	929 (24.67%)	2836 (75.33%)
46	socialReferents_siblings [numeric]	mean (sd) : 0.83 (0.37) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.45)	0 : 156 (16.8%) 1 : 773 (83.2%)	III IIIIIIIIIIIIIIII	929 (24.67%)	2836 (75.33%)
47	usedXtc [numeric]	mean (sd) : 2.15 (2.6) min < med < max : 0 < 2 < 25 IQR (CV) : 2 (1.21)	17 distinct values		735 (19.52%)	3030 (80.48%)
48	substUsePastBehPeriod_alc [numeric]	mean (sd) : 3.55 (5.62) min < med < max : 0 < 2 < 80 IQR (CV) : 2 (1.58)	22 distinct values		745 (19.79%)	3020 (80.21%)
49	substUsePastBehNr_alc_nr [numeric]	mean (sd) : 19.93 (9.92) min < med < max : 1 < 26 < 26 IQR (CV) : 20 (0.5)	1 : 82 (10.9%) 6 : 125 (16.7%) 26 : 543 (72.4%)	II III IIIIIIIIIIIIIIII	750 (19.92%)	3015 (80.08%)
50	substUsePastBehPeriod_tbc [numeric]	mean (sd) : 9.32 (27.88) min < med < max : 0 < 2 < 360 IQR (CV) : 7 (2.99)	37 distinct values		739 (19.63%)	3026 (80.37%)
51	substUsePastBehNr_tbc_nr [numeric]	mean (sd) : 14.04 (12.11) min < med < max : 1 < 26 < 26 IQR (CV) : 25 (0.86)	1 : 301 (40.2%) 6 : 71 ( 9.5%) 26 : 376 (50.3%)	IIIIIIIIIIII III IIIIIIIIIIIIIIII	748 (19.87%)	3017 (80.13%)
52	substUsePastBehPeriod_cnb [numeric]	mean (sd) : 2.41 (6.29) min < med < max : 0 < 1 < 150 IQR (CV) : 3 (2.61)	18 distinct values		743 (19.73%)	3022 (80.27%)
53	substUsePastBehNr_cnb_nr [numeric]	mean (sd) : 7.73 (10.31) min < med < max : 1 < 1 < 26 IQR (CV) : 5 (1.33)	1 : 445 (59.6%) 6 : 126 (16.9%) 26 : 176 (23.6%)	IIIIIIIIIIIIIIII IIII IIIIII	747 (19.84%)	3018 (80.16%)
54	substUsePastBehPeriod_xtc [numeric]	mean (sd) : 2.14 (2.6) min < med < max : 0 < 2 < 25 IQR (CV) : 2 (1.22)	17 distinct values		743 (19.73%)	3022 (80.27%)
55	substUsePastBehNr_xtc_nr [numeric]	mean (sd) : 2.07 (2.98) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.44)	1 : 615 (82.4%) 6 : 124 (16.6%) 26 : 7 ( 0.9%)	IIIIIIIIIIIIIIII III	746 (19.81%)	3019 (80.19%)
56	substUsePastBehPeriod_mdma [numeric]	mean (sd) : 0.69 (1.19) min < med < max : 0 < 0 < 10 IQR (CV) : 1 (1.72)	0 : 463 (62.2%) 1 : 148 (19.9%) 2 : 82 (11.0%) 3 : 26 ( 3.5%) 4 : 13 ( 1.8%) 5 : 7 ( 0.9%) 7 : 2 ( 0.3%) 8 : 2 ( 0.3%) 10 : 1 ( 0.1%)	IIIIIIIIIIIIIIII IIIII II	744 (19.76%)	3021 (80.24%)
57	substUsePastBehNr_mdma_nr [numeric]	mean (sd) : 1.62 (2.96) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.82)	1 : 691 (92.4%) 6 : 48 ( 6.4%) 26 : 9 ( 1.2%)	IIIIIIIIIIIIIIII I	748 (19.87%)	3017 (80.13%)
58	substUsePastBehPeriod_fourfa [numeric]	mean (sd) : 0.82 (1.39) min < med < max : 0 < 0 < 10 IQR (CV) : 1 (1.68)	0 : 439 (59.2%) 1 : 155 (20.9%) 2 : 77 (10.4%) 3 : 32 ( 4.3%) 4 : 14 ( 1.9%) 5 : 11 ( 1.5%) 6 : 8 ( 1.1%) 7 : 2 ( 0.3%) 8 : 3 ( 0.4%) 10 : 1 ( 0.1%)	IIIIIIIIIIIIIIII IIIII II I	742 (19.71%)	3023 (80.29%)
59	substUsePastBehNr_fourfa_nr [numeric]	mean (sd) : 1.64 (2.97) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.81)	1 : 688 (92.1%) 6 : 50 ( 6.7%) 26 : 9 ( 1.2%)	IIIIIIIIIIIIIIII I	747 (19.84%)	3018 (80.16%)
60	substUsePastBehPeriod_coke [numeric]	mean (sd) : 0.95 (1.98) min < med < max : 0 < 0 < 15 IQR (CV) : 1 (2.09)	12 distinct values		740 (19.65%)	3025 (80.35%)
61	substUsePastBehNr_coke_nr [numeric]	mean (sd) : 2.09 (4.36) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (2.09)	1 : 671 (90.0%) 6 : 53 ( 7.1%) 26 : 22 ( 2.9%)	IIIIIIIIIIIIIIII I	746 (19.81%)	3019 (80.19%)
62	substUsePastBehPeriod_spd [numeric]	mean (sd) : 1.59 (6.14) min < med < max : 0 < 0 < 140 IQR (CV) : 2 (3.86)	15 distinct values		741 (19.68%)	3024 (80.32%)
63	substUsePastBehNr_spd_nr [numeric]	mean (sd) : 2.21 (4.4) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.99)	1 : 653 (87.6%) 6 : 70 ( 9.4%) 26 : 22 ( 2.9%)	IIIIIIIIIIIIIIII I	745 (19.79%)	3020 (80.21%)
64	substUsePastBehPeriod_gas [numeric]	mean (sd) : 1.76 (5.55) min < med < max : 0 < 0 < 100 IQR (CV) : 2 (3.16)	18 distinct values		742 (19.71%)	3023 (80.29%)
65	substUsePastBehNr_gas_nr [numeric]	mean (sd) : 1.69 (3) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.78)	1 : 679 (91.0%) 6 : 58 ( 7.8%) 26 : 9 ( 1.2%)	IIIIIIIIIIIIIIII I	746 (19.81%)	3019 (80.19%)
66	substUsePastBehPeriod_ghb [numeric]	mean (sd) : 0.39 (2.16) min < med < max : 0 < 0 < 50 IQR (CV) : 0 (5.6)	11 distinct values		740 (19.65%)	3025 (80.35%)
67	substUsePastBehNr_ghb_nr [numeric]	mean (sd) : 1.57 (3.25) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (2.07)	1 : 709 (95.0%) 6 : 25 ( 3.4%) 26 : 12 ( 1.6%)	IIIIIIIIIIIIIIII	746 (19.81%)	3019 (80.19%)
68	substUsePastBehPeriod_ket [numeric]	mean (sd) : 0.63 (1.65) min < med < max : 0 < 0 < 25 IQR (CV) : 0 (2.62)	11 distinct values		742 (19.71%)	3023 (80.29%)
69	substUsePastBehNr_ket_nr [numeric]	mean (sd) : 1.45 (2.72) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.88)	1 : 712 (95.3%) 6 : 27 ( 3.6%) 26 : 8 ( 1.1%)	IIIIIIIIIIIIIIII	747 (19.84%)	3018 (80.16%)
70	otherSubstances_otherSubstance1 [character]	1. LSD 2. 2CB 3. 2cb 4. Truffels 5. 2C-B 6. truffels 7. lsd 8. MXE 9. Paddo’s 10. AL-LAD [ 90 others ]	39 (13.9%) 31 (11.1%) 29 (10.4%) 20 ( 7.1%) 8 ( 2.9%) 8 ( 2.9%) 6 ( 2.1%) 6 ( 2.1%) 6 ( 2.1%) 4 ( 1.4%) 123 (44.1%)	IIIII IIII III II I I IIIIIIIIIIIIIIII	280 (7.44%)	3485 (92.56%)
71	otherSubstances_otherSubstance2 [character]	1. Truffels 2. 2CB 3. LSD 4. 2cb 5. 2C-B 6. MXE 7. Paddo’s 8. DMT 9. paddo’s 10. ritalin [ 61 others ]	17 (11.8%) 13 ( 9.0%) 10 ( 6.9%) 7 ( 4.9%) 6 ( 4.2%) 5 ( 3.5%) 5 ( 3.5%) 4 ( 2.8%) 4 ( 2.8%) 3 ( 2.1%) 70 (48.4%)	III II II I I I I IIIIIIIIIIIIIIII	144 (3.82%)	3621 (96.18%)
72	otherSubstances_otherSubstance3 [character]	1. 2C-B 2. LSD 3. MXE 4. Paddo’s 5. - 6. Paddos 7. Salvia 8. 2cb 9. Poppers 10. Truffels [ 49 others ]	5 ( 6.1%) 5 ( 6.1%) 4 ( 4.9%) 4 ( 4.9%) 3 ( 3.7%) 3 ( 3.7%) 3 ( 3.7%) 2 ( 2.4%) 2 ( 2.4%) 2 ( 2.4%) 49 (59.8%)	I I I I IIIIIIIIIIIIIIII	82 (2.18%)	3683 (97.82%)
73	otherSubstances_otherSubstance4 [character]	1. 2C-B 2. - 3. 2cb 4. 2CB 5. MXE 6. Truffels 7. 0 8. 2C-i 9. 4-aco-dmt 10. 4-AcO-DMT [ 21 others ]	4 (10.0%) 3 ( 7.5%) 2 ( 5.0%) 2 ( 5.0%) 2 ( 5.0%) 2 ( 5.0%) 1 ( 2.5%) 1 ( 2.5%) 1 ( 2.5%) 1 ( 2.5%) 21 (52.5%)	III II I I I I IIIIIIIIIIIIIIII	40 (1.06%)	3725 (98.94%)
74	otherSubstances_otherSubstance5 [character]	1. - 2. Methylone 3. MXE 4. 0 5. 2cd 6. 2CE 7. 3-MMC 8. Andere RC’s 9. Concerta 10. DMT [ 9 others ]	3 (13.0%) 2 ( 8.7%) 2 ( 8.7%) 1 ( 4.3%) 1 ( 4.3%) 1 ( 4.3%) 1 ( 4.3%) 1 ( 4.3%) 1 ( 4.3%) 1 ( 4.3%) 9 (39.1%)	IIIII III III I I I I I I I IIIIIIIIIIIIIIII	23 (0.61%)	3742 (99.39%)
75	otherSubstancesFreqPeriod_otherSubstance1 [numeric]	mean (sd) : 2.39 (3.56) min < med < max : 0 < 2 < 50 IQR (CV) : 2 (1.49)	14 distinct values		275 (7.3%)	3490 (92.7%)
76	otherSubstancesFreqNr_otherSubstance1_nr [numeric]	mean (sd) : 1.93 (3.6) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.86)	1 : 243 (88.7%) 6 : 26 ( 9.5%) 26 : 5 ( 1.8%)	IIIIIIIIIIIIIIII I	274 (7.28%)	3491 (92.72%)
77	otherSubstancesFreqPeriod_otherSubstance2 [numeric]	mean (sd) : 2.22 (2.93) min < med < max : 1 < 1 < 30 IQR (CV) : 1 (1.32)	1 : 73 (52.9%) 2 : 33 (23.9%) 3 : 16 (11.6%) 4 : 6 ( 4.3%) 5 : 4 ( 2.9%) 7 : 1 ( 0.7%) 8 : 1 ( 0.7%) 10 : 3 ( 2.2%) 30 : 1 ( 0.7%)	IIIIIIIIIIIIIIII IIIIIII III I	138 (3.67%)	3627 (96.33%)
78	otherSubstancesFreqNr_otherSubstance2_nr [numeric]	mean (sd) : 2.15 (4.75) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (2.21)	1 : 127 (91.4%) 6 : 7 ( 5.0%) 26 : 5 ( 3.6%)	IIIIIIIIIIIIIIII	139 (3.69%)	3626 (96.31%)
79	otherSubstancesFreqPeriod_otherSubstance3 [numeric]	mean (sd) : 2.07 (1.6) min < med < max : 0 < 2 < 9 IQR (CV) : 1.25 (0.78)	0 : 1 ( 1.3%) 1 : 36 (47.4%) 2 : 20 (26.3%) 3 : 10 (13.2%) 4 : 2 ( 2.6%) 5 : 4 ( 5.3%) 7 : 2 ( 2.6%) 9 : 1 ( 1.3%)	IIIIIIIIIIIIIIII IIIIIIII IIII I	76 (2.02%)	3689 (97.98%)
80	otherSubstancesFreqNr_otherSubstance3_nr [numeric]	mean (sd) : 2.58 (5.67) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (2.2)	1 : 68 (89.5%) 6 : 4 ( 5.3%) 26 : 4 ( 5.3%)	IIIIIIIIIIIIIIII	76 (2.02%)	3689 (97.98%)
81	otherSubstancesFreqPeriod_otherSubstance4 [numeric]	mean (sd) : 3.09 (8.34) min < med < max : 0 < 1 < 50 IQR (CV) : 1 (2.7)	0 : 1 ( 2.9%) 1 : 21 (60.0%) 2 : 9 (25.7%) 4 : 1 ( 2.9%) 5 : 1 ( 2.9%) 10 : 1 ( 2.9%) 50 : 1 ( 2.9%)	IIIIIIIIIIIIIIII IIIIII	35 (0.93%)	3730 (99.07%)
82	otherSubstancesFreqNr_otherSubstance4_nr [numeric]	mean (sd) : 2.53 (5.83) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (2.31)	1 : 33 (91.7%) 6 : 1 ( 2.8%) 26 : 2 ( 5.6%)	IIIIIIIIIIIIIIII	36 (0.96%)	3729 (99.04%)
83	otherSubstancesFreqPeriod_otherSubstance5 [numeric]	mean (sd) : 3.74 (4.04) min < med < max : 0 < 2 < 15 IQR (CV) : 4 (1.08)	0 : 1 ( 5.3%) 1 : 6 (31.6%) 2 : 5 (26.3%) 3 : 1 ( 5.3%) 5 : 2 (10.5%) 7 : 1 ( 5.3%) 10 : 2 (10.5%) 15 : 1 ( 5.3%)	II IIIIIIIIIIIIIIII IIIIIIIIIIIII II IIIII II IIIII II	19 (0.5%)	3746 (99.5%)
84	otherSubstancesFreqNr_otherSubstance5_nr [numeric]	mean (sd) : 3.11 (5.85) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.88)	1 : 15 (79.0%) 6 : 3 (15.8%) 26 : 1 ( 5.3%)	IIIIIIIIIIIIIIII III I	19 (0.5%)	3746 (99.5%)
85	xtcUseIntention [numeric]	mean (sd) : 0.79 (0.41) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.51)	0 : 155 (20.8%) 1 : 590 (79.2%)	IIII IIIIIIIIIIIIIIII	745 (19.79%)	3020 (80.21%)
86	xtcUser [numeric]	mean (sd) : 0.76 (0.42) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.56)	0 : 195 (23.5%) 1 : 633 (76.4%)	IIII IIIIIIIIIIIIIIII	828 (21.99%)	2937 (78.01%)
87	xtcUserOverride [numeric]	mean (sd) : 0.16 (0.37) min < med < max : 0 < 0 < 1 IQR (CV) : 0 (2.3)	0 : 94 (83.9%) 1 : 18 (16.1%)	IIIIIIIIIIIIIIII III	112 (2.97%)	3653 (97.03%)
88	xtcUseIntentionRAA_intention [numeric]	mean (sd) : 4.89 (1.88) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.39)	1 : 50 ( 8.2%) 2 : 41 ( 6.8%) 3 : 38 ( 6.3%) 4 : 96 (15.8%) 5 : 110 (18.1%) 6 : 115 (18.9%) 7 : 157 (25.9%)	IIIII IIII III IIIIIIIII IIIIIIIIIII IIIIIIIIIII IIIIIIIIIIIIIIII	607 (16.12%)	3158 (83.88%)
89	xtcUseIntentionRAA_want [numeric]	mean (sd) : 4.9 (1.46) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.3)	1 : 13 ( 2.1%) 2 : 34 ( 5.6%) 3 : 37 ( 6.1%) 4 : 145 (23.9%) 5 : 155 (25.5%) 6 : 134 (22.1%) 7 : 89 (14.7%)	I III III IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIII	607 (16.12%)	3158 (83.88%)
90	xtcUseIntentionRAA_expectation [numeric]	mean (sd) : 5.64 (1.66) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.29)	1 : 16 ( 2.6%) 2 : 35 ( 5.8%) 3 : 31 ( 5.1%) 4 : 47 ( 7.7%) 5 : 69 (11.4%) 6 : 154 (25.4%) 7 : 255 (42.0%)	I II I II IIII IIIIIIIII IIIIIIIIIIIIIIII	607 (16.12%)	3158 (83.88%)
91	xtcUseIntentionFreq_freq.0 [factor]	1. 0 2. 1 3. 1-2 4. 1,5 5. 1/2 6. 10 7. 14 8. 15 9. 2 10. 2-3 [ 2 others ]	7 ( 1.7%) 197 (47.5%) 4 ( 1.0%) 1 ( 0.2%) 4 ( 1.0%) 2 ( 0.5%) 1 ( 0.2%) 1 ( 0.2%) 196 (47.2%) 1 ( 0.2%) 1 ( 0.2%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIII	415 (11.02%)	3350 (88.98%)
92	xtcUseIntentionFreq_freq.1 [numeric]	mean (sd) : 1.74 (2.2) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.27)	1 : 510 (86.6%) 6 : 77 (13.1%) 26 : 2 ( 0.3%)	IIIIIIIIIIIIIIII II	589 (15.64%)	3176 (84.36%)
93	strngXTC_Definition [numeric]	mean (sd) : 175.62 (57.49) min < med < max : 0 < 180 < 1130 IQR (CV) : 50 (0.33)	36 distinct values		647 (17.18%)	3118 (82.82%)
94	xtcRegulationType_pills [numeric]	mean (sd) : 0.58 (0.49) min < med < max : 0 < 1 < 1 IQR (CV) : 1 (0.86)	0 : 251 (42.3%) 1 : 343 (57.7%)	IIIIIIIIIII IIIIIIIIIIIIIIII	594 (15.78%)	3171 (84.22%)
95	xtcRegulationType_dose [numeric]	mean (sd) : 0.48 (0.5) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.03)	0 : 306 (51.5%) 1 : 288 (48.5%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIII	594 (15.78%)	3171 (84.22%)
96	xtcRegulationType_none [numeric]	mean (sd) : 0.09 (0.28) min < med < max : 0 < 0 < 1 IQR (CV) : 0 (3.26)	0 : 594 (91.4%) 1 : 56 ( 8.6%)	IIIIIIIIIIIIIIII I	650 (17.26%)	3115 (82.74%)
97	xtcUsePillHigh [numeric]	mean (sd) : 2.37 (1.47) min < med < max : 0.5 < 2 < 15 IQR (CV) : 1.5 (0.62)	20 distinct values		398 (10.57%)	3367 (89.43%)
98	xtcUseDoseHigh [numeric]	mean (sd) : 208.05 (130.26) min < med < max : 25 < 180 < 880 IQR (CV) : 130 (0.63)	41 distinct values		288 (7.65%)	3477 (92.35%)
99	xtcUsePillPref [numeric]	mean (sd) : 1.57 (1.38) min < med < max : 0 < 1.3 < 18 IQR (CV) : 1 (0.88)	20 distinct values		398 (10.57%)	3367 (89.43%)
100	xtcUseDosePref [numeric]	mean (sd) : 165.84 (99.82) min < med < max : 20 < 150 < 600 IQR (CV) : 100 (0.6)	37 distinct values		288 (7.65%)	3477 (92.35%)
101	wantToDoMoreParts_0 [numeric]	mean (sd) : 0.35 (0.48) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.37)	0 : 423 (65.1%) 1 : 227 (34.9%)	IIIIIIIIIIIIIIII IIIIIIII	650 (17.26%)	3115 (82.74%)
102	wantToDoMoreParts_1 [numeric]	mean (sd) : 0.82 (0.39) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.47)	0 : 77 (18.2%) 1 : 346 (81.8%)	III IIIIIIIIIIIIIIII	423 (11.24%)	3342 (88.76%)
103	wantToDoMoreParts_2 [numeric]	mean (sd) : 0.87 (0.34) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.4)	0 : 57 (13.5%) 1 : 366 (86.5%)	II IIIIIIIIIIIIIIII	423 (11.24%)	3342 (88.76%)
104	wantToDoMoreParts_3 [numeric]	mean (sd) : 0.86 (0.34) min < med < max : 0 < 1 < 1 IQR (CV) : 0 (0.4)	0 : 58 (13.7%) 1 : 365 (86.3%)	II IIIIIIIIIIIIIIII	423 (11.24%)	3342 (88.76%)
105	testing_Awareness [character]	1. heard 2. no 3. yes	104 (14.1%) 20 ( 2.7%) 615 (83.2%)	II IIIIIIIIIIIIIIII	739 (19.63%)	3026 (80.37%)
106	testing_Behavior_freq.0 [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 7 9. 8	379 (67.2%) 116 (20.6%) 41 ( 7.3%) 13 ( 2.3%) 9 ( 1.6%) 2 ( 0.4%) 2 ( 0.4%) 1 ( 0.2%) 1 ( 0.2%)	IIIIIIIIIIIIIIII IIII I	564 (14.98%)	3201 (85.02%)
107	testing_Behavior_freq.1 [numeric]	mean (sd) : 1.27 (2.2) min < med < max : 1 < 1 < 26 IQR (CV) : 0 (1.73)	1 : 549 (97.3%) 6 : 11 ( 1.9%) 26 : 4 ( 0.7%)	IIIIIIIIIIIIIIII	564 (14.98%)	3201 (85.02%)
108	testing_Intention [numeric]	mean (sd) : 0.43 (0.5) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.15)	0 : 367 (56.8%) 1 : 279 (43.2%)	IIIIIIIIIIIIIIII IIIIIIIIIIII	646 (17.16%)	3119 (82.84%)
109	testing_IntentionRAA_intention [numeric]	mean (sd) : 5.06 (1.7) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.34)	1 : 4 ( 1.4%) 2 : 24 ( 8.6%) 3 : 24 ( 8.6%) 4 : 54 (19.4%) 5 : 46 (16.6%) 6 : 45 (16.2%) 7 : 81 (29.1%)	IIII IIII IIIIIIIIII IIIIIIIII IIIIIIII IIIIIIIIIIIIIIII	278 (7.38%)	3487 (92.62%)
110	testing_IntentionRAA_want [numeric]	mean (sd) : 5.42 (1.5) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.28)	1 : 3 ( 1.1%) 2 : 11 ( 4.0%) 3 : 15 ( 5.4%) 4 : 46 (16.6%) 5 : 57 (20.5%) 6 : 54 (19.4%) 7 : 92 (33.1%)	I II IIIIIIII IIIIIIIII IIIIIIIII IIIIIIIIIIIIIIII	278 (7.38%)	3487 (92.62%)
111	testing_IntentionRAA_expectation [numeric]	mean (sd) : 4.84 (1.82) min < med < max : 1 < 5 < 7 IQR (CV) : 4 (0.38)	1 : 8 ( 2.9%) 2 : 31 (11.2%) 3 : 34 (12.2%) 4 : 43 (15.5%) 5 : 44 (15.8%) 6 : 45 (16.2%) 7 : 73 (26.3%)	I IIIIII IIIIIII IIIIIIIII IIIIIIIII IIIIIIIII IIIIIIIIIIIIIIII	278 (7.38%)	3487 (92.62%)
112	testing_IntentionFreq_testBehav.0 [factor]	1. 0 2. 0-1 3. 1 4. 1,5 5. 1/2 6. 2 7. 2-3	32 (12.2%) 1 ( 0.4%) 190 (72.5%) 1 ( 0.4%) 1 ( 0.4%) 36 (13.7%) 1 ( 0.4%)	II IIIIIIIIIIIIIIII III	262 (6.96%)	3503 (93.04%)
113	testing_IntentionFreq_testBehav.1 [numeric]	mean (sd) : 1.05 (0.52) min < med < max : 1 < 1 < 6 IQR (CV) : 0 (0.49)	1 : 275 (98.9%) 6 : 3 ( 1.1%)	IIIIIIIIIIIIIIII	278 (7.38%)	3487 (92.62%)
114	strngXTC_IntentionRAA_intention [numeric]	mean (sd) : 4.29 (2.05) min < med < max : 1 < 5 < 7 IQR (CV) : 4 (0.48)	1 : 64 (16.8%) 2 : 36 ( 9.4%) 3 : 20 ( 5.2%) 4 : 58 (15.2%) 5 : 69 (18.1%) 6 : 77 (20.2%) 7 : 57 (15.0%)	IIIIIIIIIIIII IIIIIII IIII IIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII	381 (10.12%)	3384 (89.88%)
115	strngXTC_IntentionRAA_want [numeric]	mean (sd) : 3.75 (1.78) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.47)	1 : 66 (17.3%) 2 : 42 (11.0%) 3 : 35 ( 9.2%) 4 : 97 (25.5%) 5 : 79 (20.7%) 6 : 42 (11.0%) 7 : 20 ( 5.2%)	IIIIIIIIII IIIIII IIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIII III	381 (10.12%)	3384 (89.88%)
116	strngXTC_IntentionRAA_expectation [numeric]	mean (sd) : 4.56 (2.05) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.45)	1 : 55 (14.4%) 2 : 34 ( 8.9%) 3 : 20 ( 5.2%) 4 : 36 ( 9.4%) 5 : 75 (19.7%) 6 : 90 (23.6%) 7 : 71 (18.6%)	IIIIIIIII IIIIII III IIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII	381 (10.12%)	3384 (89.88%)
117	strngXTC_IntentionFrq_freq.0 [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 1/2 9. 0,5 10. 1,5 [ 3 others ]	105 (27.6%) 100 (26.2%) 83 (21.8%) 51 (13.4%) 26 ( 6.8%) 5 ( 1.3%) 4 ( 1.0%) 2 ( 0.5%) 1 ( 0.3%) 1 ( 0.3%) 3 ( 0.8%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIII IIIIIII III	381 (10.12%)	3384 (89.88%)
118	strngXTC_IntentionFrq_freq.1 [numeric]	mean (sd) : 1.42 (1.39) min < med < max : 1 < 1 < 6 IQR (CV) : 0 (0.98)	1 : 349 (91.6%) 6 : 32 ( 8.4%)	IIIIIIIIIIIIIIII I	381 (10.12%)	3384 (89.88%)
119	strngXTC_AttGeneral_good [numeric]	mean (sd) : 4.15 (1.55) min < med < max : 1 < 4 < 7 IQR (CV) : 2 (0.37)	1 : 26 ( 6.9%) 2 : 32 ( 8.4%) 3 : 48 (12.7%) 4 : 134 (35.4%) 5 : 56 (14.8%) 6 : 60 (15.8%) 7 : 23 ( 6.1%)	III III IIIII IIIIIIIIIIIIIIII IIIIII IIIIIII II	379 (10.07%)	3386 (89.93%)
120	strngXTC_AttGeneral_prettig [numeric]	mean (sd) : 4.43 (1.75) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.4)	1 : 30 ( 7.9%) 2 : 36 ( 9.5%) 3 : 41 (10.8%) 4 : 69 (18.2%) 5 : 80 (21.1%) 6 : 82 (21.6%) 7 : 41 (10.8%)	IIIII IIIIIII IIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIII	379 (10.07%)	3386 (89.93%)
121	strngXTC_AttGeneral_slim [numeric]	mean (sd) : 3.5 (1.22) min < med < max : 1 < 4 < 7 IQR (CV) : 1 (0.35)	1 : 34 ( 9.0%) 2 : 39 (10.3%) 3 : 80 (21.1%) 4 : 175 (46.2%) 5 : 32 ( 8.4%) 6 : 17 ( 4.5%) 7 : 2 ( 0.5%)	III III IIIIIII IIIIIIIIIIIIIIII II I	379 (10.07%)	3386 (89.93%)
122	strngXTC_AttGeneral_gezond [numeric]	mean (sd) : 3 (1.27) min < med < max : 1 < 3 < 6 IQR (CV) : 2 (0.42)	1 : 56 (14.8%) 2 : 84 (22.2%) 3 : 83 (21.9%) 4 : 127 (33.5%) 5 : 17 ( 4.5%) 6 : 12 ( 3.2%)	IIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII II I	379 (10.07%)	3386 (89.93%)
123	strngXTC_AttGeneral_spannend [numeric]	mean (sd) : 4.77 (1.22) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.26)	1 : 7 ( 1.8%) 2 : 8 ( 2.1%) 3 : 11 ( 2.9%) 4 : 152 (40.1%) 5 : 93 (24.5%) 6 : 77 (20.3%) 7 : 31 ( 8.2%)	I IIIIIIIIIIIIIIII IIIIIIIII IIIIIIII III	379 (10.07%)	3386 (89.93%)
124	strngXTC_NormGeneral_in1 [numeric]	mean (sd) : 2.02 (1.42) min < med < max : 1 < 1 < 7 IQR (CV) : 2 (0.7)	1 : 222 (58.9%) 2 : 41 (10.9%) 3 : 29 ( 7.7%) 4 : 64 (17.0%) 5 : 14 ( 3.7%) 6 : 6 ( 1.6%) 7 : 1 ( 0.3%)	IIIIIIIIIIIIIIII II II IIII I	377 (10.01%)	3388 (89.99%)
125	strngXTC_NormGeneral_in2 [numeric]	mean (sd) : 3.65 (2.02) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.55)	1 : 87 (23.1%) 2 : 38 (10.1%) 3 : 47 (12.5%) 4 : 80 (21.3%) 5 : 43 (11.4%) 6 : 35 ( 9.3%) 7 : 46 (12.2%)	IIIIIIIIIIIIIIII IIIIII IIIIIIII IIIIIIIIIIIIII IIIIIII IIIIII IIIIIIII	376 (9.99%)	3389 (90.01%)
126	strngXTC_NormGeneral_dn1 [numeric]	mean (sd) : 3.58 (1.87) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.52)	1 : 86 (22.9%) 2 : 36 ( 9.6%) 3 : 32 ( 8.5%) 4 : 103 (27.4%) 5 : 60 (16.0%) 6 : 33 ( 8.8%) 7 : 26 ( 6.9%)	IIIIIIIIIIIII IIIII IIII IIIIIIIIIIIIIIII IIIIIIIII IIIII IIII	376 (9.99%)	3389 (90.01%)
127	strngXTC_NormGeneral_dn2 [numeric]	mean (sd) : 4.54 (1.97) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.43)	1 : 52 (13.8%) 2 : 24 ( 6.4%) 3 : 25 ( 6.6%) 4 : 52 (13.8%) 5 : 75 (20.0%) 6 : 86 (22.9%) 7 : 62 (16.5%)	IIIIIIIII IIII IIII IIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII	376 (9.99%)	3389 (90.01%)
128	strngXTC_PBCgeneral_ifwanted [numeric]	mean (sd) : 6.3 (1.09) min < med < max : 1 < 7 < 7 IQR (CV) : 1 (0.17)	1 : 1 ( 0.3%) 2 : 5 ( 1.3%) 3 : 4 ( 1.1%) 4 : 20 ( 5.3%) 5 : 36 ( 9.6%) 6 : 85 (22.6%) 7 : 225 (59.8%)	I II IIIIII IIIIIIIIIIIIIIII	376 (9.99%)	3389 (90.01%)
129	strngXTC_PBCgeneral_easy [numeric]	mean (sd) : 5.34 (1.49) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.28)	1 : 3 ( 0.8%) 2 : 14 ( 3.7%) 3 : 26 ( 6.9%) 4 : 73 (19.4%) 5 : 65 (17.3%) 6 : 85 (22.6%) 7 : 110 (29.3%)	II III IIIIIIIIII IIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII	376 (9.99%)	3389 (90.01%)
130	strngXTC_PBCgeneral_control [numeric]	mean (sd) : 5.8 (1.53) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.26)	1 : 4 ( 1.1%) 2 : 11 ( 2.9%) 3 : 27 ( 7.2%) 4 : 35 ( 9.3%) 5 : 47 (12.5%) 6 : 67 (17.8%) 7 : 185 (49.2%)	II III IIII IIIII IIIIIIIIIIIIIIII	376 (9.99%)	3389 (90.01%)
131	strngXTC_PBCgeneral_externalFactors [numeric]	mean (sd) : 3.25 (1.92) min < med < max : 1 < 3 < 7 IQR (CV) : 4 (0.59)	1 : 99 (26.4%) 2 : 66 (17.6%) 3 : 46 (12.3%) 4 : 49 (13.1%) 5 : 56 (14.9%) 6 : 39 (10.4%) 7 : 20 ( 5.3%)	IIIIIIIIIIIIIIII IIIIIIIIII IIIIIII IIIIIII IIIIIIIII IIIIII III	375 (9.96%)	3390 (90.04%)
132	strngXTC_PBCgeneral_notOnlyMe [numeric]	mean (sd) : 5.7 (1.57) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.28)	1 : 5 ( 1.3%) 2 : 13 ( 3.5%) 3 : 26 ( 7.0%) 4 : 45 (12.0%) 5 : 35 ( 9.4%) 6 : 81 (21.7%) 7 : 169 (45.2%)	I II IIII III IIIIIII IIIIIIIIIIIIIIII	374 (9.93%)	3391 (90.07%)
133	strngXtcOpenWhy [character]	1. - Gebrek aan kennis - Des 2. - Mensen denken dat een X 3. -Makkelijker verkrijgbaar 4. De reden waarom mensen h 5. ik houd zelf niet van he 6. 1 pil is gedoogd, men hee 7. 85-90% zal maar gewoon wa 8. Aanbod van de leverancier 9. Alle MDMA tabletten die i 10. Als 1 pil een gebruikersd [ 319 others ]	1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 319 (95.7%)	IIIIIIIIIIIIIIII	329 (8.74%)	3436 (91.26%)
134	strngXtcOpenWhyNot [character]	1. moeilijker te doseren 2. - 3. Gevaarlijk 4. Gevaarlijk. 5. Moeilijker doseren 6. - Op de hoogte zijn van d 7. - Schadelijker - Bang om 8. -gevaarlijk -lagere hoeve 9. -Te hoge dosissen bij inn 10. Als “normale” of “lage” d [ 274 others ]	3 ( 1.0%) 2 ( 0.7%) 2 ( 0.7%) 2 ( 0.7%) 2 ( 0.7%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 1 ( 0.3%) 274 (93.2%)	IIIIIIIIIIIIIIII	290 (7.7%)	3475 (92.3%)
135	strngXTC_AttBeliefs_long [numeric]	mean (sd) : 0.77 (1.12) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (1.46)	-3 : 3 ( 0.9%) -2 : 3 ( 0.9%) -1 : 8 ( 2.4%) 0 : 153 (46.5%) 1 : 78 (23.7%) 2 : 55 (16.7%) 3 : 29 ( 8.8%)	IIIIIIIIIIIIIIII IIIIIIII IIIII III	329 (8.74%)	3436 (91.26%)
136	strngXTC_AttBeliefs_intensity [numeric]	mean (sd) : 1.61 (1.14) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (0.7)	-3 : 1 ( 0.3%) -1 : 1 ( 0.3%) 0 : 70 (21.3%) 1 : 69 (21.0%) 2 : 98 (29.8%) 3 : 90 (27.4%)	IIIIIIIIIII IIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII	329 (8.74%)	3436 (91.26%)
137	strngXTC_AttBeliefs_intoxicated [numeric]	mean (sd) : 1.6 (1.13) min < med < max : -2 < 2 < 3 IQR (CV) : 2 (0.71)	-2 : 1 ( 0.3%) -1 : 2 ( 0.6%) 0 : 71 (21.6%) 1 : 66 (20.1%) 2 : 101 (30.7%) 3 : 88 (26.8%)	IIIIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII	329 (8.74%)	3436 (91.26%)
138	strngXTC_AttBeliefs_energy [numeric]	mean (sd) : 0.58 (1.33) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (2.3)	-3 : 5 ( 1.5%) -2 : 17 ( 5.2%) -1 : 30 ( 9.1%) 0 : 121 (36.8%) 1 : 69 (21.0%) 2 : 60 (18.2%) 3 : 27 ( 8.2%)	II III IIIIIIIIIIIIIIII IIIIIIIII IIIIIII III	329 (8.74%)	3436 (91.26%)
139	strngXTC_AttBeliefs_euphoria [numeric]	mean (sd) : 0.68 (1.35) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (2)	-3 : 6 ( 1.8%) -2 : 14 ( 4.3%) -1 : 25 ( 7.6%) 0 : 117 (35.7%) 1 : 73 (22.3%) 2 : 59 (18.0%) 3 : 34 (10.4%)	I III IIIIIIIIIIIIIIII IIIIIIIII IIIIIIII IIII	328 (8.71%)	3437 (91.29%)
140	strngXTC_AttBeliefs_insight [numeric]	mean (sd) : 0.02 (1.08) min < med < max : -3 < 0 < 3 IQR (CV) : 0 (50.44)	-3 : 9 ( 2.7%) -2 : 21 ( 6.4%) -1 : 22 ( 6.7%) 0 : 216 (65.8%) 1 : 31 ( 9.4%) 2 : 20 ( 6.1%) 3 : 9 ( 2.7%)	I I IIIIIIIIIIIIIIII II I	328 (8.71%)	3437 (91.29%)
141	strngXTC_AttBeliefs_connection [numeric]	mean (sd) : 0.52 (1.33) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (2.55)	-3 : 5 ( 1.5%) -2 : 14 ( 4.3%) -1 : 40 (12.2%) 0 : 122 (37.2%) 1 : 70 (21.3%) 2 : 47 (14.3%) 3 : 30 ( 9.2%)	I IIIII IIIIIIIIIIIIIIII IIIIIIIII IIIIII III	328 (8.71%)	3437 (91.29%)
142	strngXTC_AttBeliefs_contact [numeric]	mean (sd) : 0.44 (1.31) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (2.97)	-3 : 3 ( 0.9%) -2 : 16 ( 4.9%) -1 : 43 (13.1%) 0 : 139 (42.4%) 1 : 56 (17.1%) 2 : 40 (12.2%) 3 : 31 ( 9.4%)	I IIII IIIIIIIIIIIIIIII IIIIII IIII III	328 (8.71%)	3437 (91.29%)
143	strngXTC_AttBeliefs_sex [numeric]	mean (sd) : -0.01 (1.46) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (-119.46)	-3 : 24 ( 7.3%) -2 : 26 ( 7.9%) -1 : 37 (11.3%) 0 : 154 (46.9%) 1 : 37 (11.3%) 2 : 30 ( 9.2%) 3 : 20 ( 6.1%)	II II III IIIIIIIIIIIIIIII III III II	328 (8.71%)	3437 (91.29%)
144	strngXTC_AttBeliefs_coping [numeric]	mean (sd) : 0.65 (1.14) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (1.75)	-3 : 2 ( 0.6%) -2 : 3 ( 0.9%) -1 : 15 ( 4.6%) 0 : 175 (53.3%) 1 : 58 (17.7%) 2 : 42 (12.8%) 3 : 33 (10.1%)	I IIIIIIIIIIIIIIII IIIII III III	328 (8.71%)	3437 (91.29%)
145	strngXTC_AttBeliefs_risk [numeric]	mean (sd) : -0.02 (1.17) min < med < max : -3 < 0 < 3 IQR (CV) : 0 (-76.69)	-3 : 17 ( 5.2%) -2 : 16 ( 4.9%) -1 : 12 ( 3.7%) 0 : 240 (73.2%) 1 : 13 ( 4.0%) 2 : 13 ( 4.0%) 3 : 17 ( 5.2%)	I I IIIIIIIIIIIIIIII I	328 (8.71%)	3437 (91.29%)
146	strngXTC_AttBeliefs_isolated [numeric]	mean (sd) : 0.23 (1.36) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (6.04)	-3 : 14 ( 4.3%) -2 : 19 ( 5.8%) -1 : 36 (11.0%) 0 : 148 (45.1%) 1 : 51 (15.6%) 2 : 41 (12.5%) 3 : 19 ( 5.8%)	I II III IIIIIIIIIIIIIIII IIIII IIII II	328 (8.71%)	3437 (91.29%)
147	strngXTC_AttBeliefs_boundaries [numeric]	mean (sd) : 0.09 (1.18) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (13.36)	-3 : 13 ( 4.0%) -2 : 12 ( 3.7%) -1 : 43 (13.1%) 0 : 173 (52.7%) 1 : 49 (14.9%) 2 : 28 ( 8.5%) 3 : 10 ( 3.0%)	I I III IIIIIIIIIIIIIIII IIII II	328 (8.71%)	3437 (91.29%)
148	strngXTC_AttBeliefs_purity [numeric]	mean (sd) : 0.22 (1.07) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (4.86)	-3 : 9 ( 2.7%) -2 : 11 ( 3.4%) -1 : 15 ( 4.6%) 0 : 204 (62.2%) 1 : 51 (15.6%) 2 : 29 ( 8.8%) 3 : 9 ( 2.7%)	I IIIIIIIIIIIIIIII IIII II	328 (8.71%)	3437 (91.29%)
149	strngXTC_AttBeliefs_music [numeric]	mean (sd) : 0.75 (1.08) min < med < max : -2 < 0 < 3 IQR (CV) : 2 (1.45)	-2 : 5 ( 1.5%) -1 : 5 ( 1.5%) 0 : 170 (51.8%) 1 : 65 (19.8%) 2 : 54 (16.5%) 3 : 29 ( 8.8%)	IIIIIIIIIIIIIIII IIIIII IIIII II	328 (8.71%)	3437 (91.29%)
150	strngXTC_AttBeliefs_hallucinate [numeric]	mean (sd) : 1.05 (1.21) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.15)	-3 : 4 ( 1.2%) -2 : 1 ( 0.3%) -1 : 2 ( 0.6%) 0 : 133 (40.6%) 1 : 62 (18.9%) 2 : 80 (24.4%) 3 : 46 (14.0%)	IIIIIIIIIIIIIIII IIIIIII IIIIIIIII IIIII	328 (8.71%)	3437 (91.29%)
151	strngXTC_AttBeliefs_timeAwareness [numeric]	mean (sd) : 1.12 (1.23) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.1)	-3 : 1 ( 0.3%) -2 : 2 ( 0.6%) -1 : 10 ( 3.1%) 0 : 123 (37.6%) 1 : 56 (17.1%) 2 : 79 (24.2%) 3 : 56 (17.1%)	I IIIIIIIIIIIIIIII IIIIIII IIIIIIIIII IIIIIII	327 (8.69%)	3438 (91.31%)
152	strngXTC_AttBeliefs_memory [numeric]	mean (sd) : -0.7 (1.17) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (-1.67)	-3 : 34 (10.4%) -2 : 47 (14.4%) -1 : 59 (18.0%) 0 : 170 (52.0%) 1 : 8 ( 2.4%) 2 : 8 ( 2.4%) 3 : 1 ( 0.3%)	III IIII IIIII IIIIIIIIIIIIIIII	327 (8.69%)	3438 (91.31%)
153	strngXTC_AttBeliefs_health [numeric]	mean (sd) : -1.35 (1.24) min < med < max : -3 < -1 < 1 IQR (CV) : 3 (-0.92)	-3 : 87 (26.6%) -2 : 60 (18.4%) -1 : 68 (20.8%) 0 : 104 (31.8%) 1 : 8 ( 2.4%)	IIIIIIIIIIIII IIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII I	327 (8.69%)	3438 (91.31%)
154	strngXTC_AttBeliefs_priceQuality [numeric]	mean (sd) : 1.11 (1.26) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.14)	-3 : 3 ( 0.9%) -2 : 2 ( 0.6%) -1 : 12 ( 3.7%) 0 : 111 (33.9%) 1 : 64 (19.6%) 2 : 80 (24.5%) 3 : 55 (16.8%)	I IIIIIIIIIIIIIIII IIIIIIIII IIIIIIIIIII IIIIIII	327 (8.69%)	3438 (91.31%)
155	strngXTC_AttBeliefs_better [numeric]	mean (sd) : 0.28 (1.4) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (5.08)	-3 : 15 ( 4.6%) -2 : 17 ( 5.2%) -1 : 36 (11.0%) 0 : 145 (44.3%) 1 : 41 (12.5%) 2 : 55 (16.8%) 3 : 18 ( 5.5%)	I I III IIIIIIIIIIIIIIII IIII IIIIII I	327 (8.69%)	3438 (91.31%)
156	strngXTC_AttBeliefs_physicalSideEffects [numeric]	mean (sd) : 0.67 (1) min < med < max : -2 < 0 < 3 IQR (CV) : 1 (1.48)	-2 : 4 ( 1.2%) -1 : 8 ( 2.4%) 0 : 167 (51.2%) 1 : 76 (23.3%) 2 : 53 (16.3%) 3 : 18 ( 5.5%)	IIIIIIIIIIIIIIII IIIIIII IIIII I	326 (8.66%)	3439 (91.34%)
157	strngXTC_AttBeliefs_psychicSideEffects [numeric]	mean (sd) : 0.71 (1.06) min < med < max : -2 < 0 < 3 IQR (CV) : 1 (1.48)	-2 : 1 ( 0.3%) -1 : 11 ( 3.4%) 0 : 172 (52.8%) 1 : 69 (21.2%) 2 : 42 (12.9%) 3 : 31 ( 9.5%)	I IIIIIIIIIIIIIIII IIIIII III II	326 (8.66%)	3439 (91.34%)
158	strngXTC_AttBeliefs_regret [numeric]	mean (sd) : 0.26 (0.93) min < med < max : -3 < 0 < 3 IQR (CV) : 0 (3.62)	-3 : 4 ( 1.2%) -2 : 5 ( 1.5%) -1 : 12 ( 3.7%) 0 : 234 (71.8%) 1 : 36 (11.0%) 2 : 23 ( 7.1%) 3 : 12 ( 3.7%)	IIIIIIIIIIIIIIII II I	326 (8.66%)	3439 (91.34%)
159	strngXTC_AttDesirable_long [numeric]	mean (sd) : 1.93 (1.14) min < med < max : -2 < 2 < 3 IQR (CV) : 2 (0.59)	-2 : 1 ( 0.3%) -1 : 15 ( 4.6%) 0 : 26 ( 8.0%) 1 : 47 (14.4%) 2 : 112 (34.4%) 3 : 125 (38.3%)	I III IIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII	326 (8.66%)	3439 (91.34%)
160	strngXTC_AttDesirable_intens [numeric]	mean (sd) : 1.3 (1.42) min < med < max : -3 < 1 < 3 IQR (CV) : 1 (1.1)	-3 : 3 ( 0.9%) -2 : 10 ( 3.1%) -1 : 32 ( 9.8%) 0 : 30 ( 9.2%) 1 : 96 (29.4%) 2 : 77 (23.6%) 3 : 78 (23.9%)	I IIIII IIII IIIIIIIIIIIIIIII IIIIIIIIIIII IIIIIIIIIIIII	326 (8.66%)	3439 (91.34%)
161	strngXTC_AttDesirable_intoxicated [numeric]	mean (sd) : 0.58 (1.45) min < med < max : -3 < 1 < 3 IQR (CV) : 3 (2.51)	-3 : 5 ( 1.5%) -2 : 20 ( 6.1%) -1 : 60 (18.4%) 0 : 56 (17.2%) 1 : 101 (31.0%) 2 : 49 (15.0%) 3 : 35 (10.7%)	III IIIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIII IIIII	326 (8.66%)	3439 (91.34%)
162	strngXTC_AttDesirable_energy [numeric]	mean (sd) : 1.94 (1) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (0.51)	-3 : 1 ( 0.3%) -1 : 3 ( 0.9%) 0 : 20 ( 6.1%) 1 : 78 (23.9%) 2 : 111 (34.1%) 3 : 113 (34.7%)	II IIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII	326 (8.66%)	3439 (91.34%)
163	strngXTC_AttDesirable_euphoria [numeric]	mean (sd) : 2.41 (0.77) min < med < max : -2 < 3 < 3 IQR (CV) : 1 (0.32)	-2 : 1 ( 0.3%) 0 : 4 ( 1.2%) 1 : 35 (10.7%) 2 : 105 (32.2%) 3 : 181 (55.5%)	III IIIIIIIII IIIIIIIIIIIIIIII	326 (8.66%)	3439 (91.34%)
164	strngXTC_AttDesirable_insight [numeric]	mean (sd) : 1.1 (1.27) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.15)	-3 : 3 ( 0.9%) -2 : 4 ( 1.2%) -1 : 4 ( 1.2%) 0 : 120 (36.8%) 1 : 72 (22.1%) 2 : 61 (18.7%) 3 : 62 (19.0%)	IIIIIIIIIIIIIIII IIIIIIIII IIIIIIII IIIIIIII	326 (8.66%)	3439 (91.34%)
165	strngXTC_AttDesirable_connection [numeric]	mean (sd) : 2.11 (0.89) min < med < max : 0 < 2 < 3 IQR (CV) : 1 (0.42)	0 : 21 ( 6.4%) 1 : 50 (15.3%) 2 : 127 (39.0%) 3 : 128 (39.3%)	II IIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII	326 (8.66%)	3439 (91.34%)
166	strngXTC_AttDesirable_contact [numeric]	mean (sd) : 2.01 (1.02) min < med < max : -1 < 2 < 3 IQR (CV) : 2 (0.51)	-1 : 1 ( 0.3%) 0 : 39 (12.0%) 1 : 45 (13.9%) 2 : 110 (33.9%) 3 : 130 (40.0%)	IIII IIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII	325 (8.63%)	3440 (91.37%)
167	strngXTC_AttDesirable_sex [numeric]	mean (sd) : 0.78 (1.33) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (1.71)	-3 : 7 ( 2.1%) -2 : 5 ( 1.5%) -1 : 12 ( 3.7%) 0 : 147 (45.2%) 1 : 60 (18.5%) 2 : 47 (14.5%) 3 : 47 (14.5%)	I IIIIIIIIIIIIIIII IIIIII IIIII IIIII	325 (8.63%)	3440 (91.37%)
168	strngXTC_AttDesirable_coping [numeric]	mean (sd) : 0.54 (1.42) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (2.64)	-3 : 12 ( 3.7%) -2 : 13 ( 4.0%) -1 : 16 ( 4.9%) 0 : 152 (46.8%) 1 : 50 (15.4%) 2 : 43 (13.2%) 3 : 39 (12.0%)	I I I IIIIIIIIIIIIIIII IIIII IIII IIII	325 (8.63%)	3440 (91.37%)
169	strngXTC_AttDesirable_risk [numeric]	mean (sd) : -2.1 (1.26) min < med < max : -3 < -3 < 1 IQR (CV) : 2 (-0.6)	-3 : 200 (61.5%) -2 : 31 ( 9.5%) -1 : 22 ( 6.8%) 0 : 70 (21.5%) 1 : 2 ( 0.6%)	IIIIIIIIIIIIIIII II I IIIII	325 (8.63%)	3440 (91.37%)
170	strngXTC_AttDesirable_isolated [numeric]	mean (sd) : -1.31 (1.38) min < med < max : -3 < -1 < 3 IQR (CV) : 3 (-1.05)	-3 : 89 (27.4%) -2 : 65 (20.0%) -1 : 59 (18.1%) 0 : 93 (28.6%) 1 : 12 ( 3.7%) 2 : 4 ( 1.2%) 3 : 3 ( 0.9%)	IIIIIIIIIIIIIII IIIIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII II	325 (8.63%)	3440 (91.37%)
171	strngXTC_AttDesirable_boundaries [numeric]	mean (sd) : -0.24 (1.63) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (-6.8)	-3 : 42 (12.9%) -2 : 37 (11.4%) -1 : 47 (14.5%) 0 : 87 (26.8%) 1 : 68 (20.9%) 2 : 31 ( 9.5%) 3 : 13 ( 4.0%)	IIIIIII IIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII IIIII II	325 (8.63%)	3440 (91.37%)
172	strngXTC_AttDesirable_purity [numeric]	mean (sd) : 2.57 (0.82) min < med < max : 0 < 3 < 3 IQR (CV) : 1 (0.32)	0 : 18 ( 5.5%) 1 : 14 ( 4.3%) 2 : 57 (17.5%) 3 : 236 (72.6%)	I III IIIIIIIIIIIIIIII	325 (8.63%)	3440 (91.37%)
173	strngXTC_AttDesirable_music [numeric]	mean (sd) : 2.5 (0.85) min < med < max : 0 < 3 < 3 IQR (CV) : 1 (0.34)	0 : 17 ( 5.2%) 1 : 26 ( 8.0%) 2 : 59 (18.1%) 3 : 223 (68.6%)	I I IIII IIIIIIIIIIIIIIII	325 (8.63%)	3440 (91.37%)
174	strngXTC_AttDesirable_hallucinate [numeric]	mean (sd) : -0.45 (1.79) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-3.98)	-3 : 66 (20.3%) -2 : 36 (11.1%) -1 : 45 (13.9%) 0 : 68 (20.9%) 1 : 67 (20.6%) 2 : 27 ( 8.3%) 3 : 16 ( 4.9%)	IIIIIIIIIIIIIII IIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIII III	325 (8.63%)	3440 (91.37%)
175	strngXTC_AttDesirable_timeAwareness [numeric]	mean (sd) : -1.18 (1.53) min < med < max : -3 < -1 < 3 IQR (CV) : 3 (-1.31)	-3 : 94 (28.9%) -2 : 49 (15.1%) -1 : 62 (19.1%) 0 : 81 (24.9%) 1 : 21 ( 6.5%) 2 : 15 ( 4.6%) 3 : 3 ( 0.9%)	IIIIIIIIIIIIIIII IIIIIIII IIIIIIIIII IIIIIIIIIIIII III II	325 (8.63%)	3440 (91.37%)
176	strngXTC_AttDesirable_memory [numeric]	mean (sd) : 2.19 (1.07) min < med < max : -2 < 3 < 3 IQR (CV) : 1 (0.49)	-2 : 1 ( 0.3%) -1 : 2 ( 0.6%) 0 : 32 ( 9.8%) 1 : 44 (13.5%) 2 : 66 (20.3%) 3 : 180 (55.4%)	II III IIIII IIIIIIIIIIIIIIII	325 (8.63%)	3440 (91.37%)
177	strngXTC_NormBeliefs_partner [numeric]	mean (sd) : 4.93 (1.69) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.34)	1 : 8 ( 5.5%) 2 : 9 ( 6.2%) 3 : 9 ( 6.2%) 4 : 26 (17.8%) 5 : 26 (17.8%) 6 : 43 (29.4%) 7 : 25 (17.1%)	II III III IIIIIIIII IIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII	146 (3.88%)	3619 (96.12%)
178	strngXTC_NormBeliefs_bestFriends [numeric]	mean (sd) : 4.98 (1.43) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.29)	1 : 5 ( 1.6%) 2 : 17 ( 5.3%) 3 : 26 ( 8.1%) 4 : 58 (18.0%) 5 : 83 (25.8%) 6 : 90 (28.0%) 7 : 43 (13.4%)	III IIII IIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIII	322 (8.55%)	3443 (91.45%)
179	strngXTC_NormBeliefs_xtcFriends [numeric]	mean (sd) : 5.86 (1.09) min < med < max : 2 < 6 < 7 IQR (CV) : 2 (0.19)	2 : 4 ( 1.3%) 3 : 5 ( 1.6%) 4 : 27 ( 8.8%) 5 : 54 (17.5%) 6 : 121 (39.3%) 7 : 97 (31.5%)	III IIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII	308 (8.18%)	3457 (91.82%)
180	strngXTC_NormBeliefs_otherFriends [numeric]	mean (sd) : 4.18 (1.34) min < med < max : 1 < 4 < 7 IQR (CV) : 2 (0.32)	1 : 13 ( 4.2%) 2 : 21 ( 6.7%) 3 : 48 (15.4%) 4 : 104 (33.3%) 5 : 76 (24.4%) 6 : 41 (13.1%) 7 : 9 ( 2.9%)	II III IIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIII I	312 (8.29%)	3453 (91.71%)
181	strngXTC_NormBeliefs_partyPeople [numeric]	mean (sd) : 5.62 (1.17) min < med < max : 2 < 6 < 7 IQR (CV) : 2 (0.21)	2 : 2 ( 0.6%) 3 : 13 ( 4.0%) 4 : 48 (14.8%) 5 : 63 (19.4%) 6 : 116 (35.7%) 7 : 83 (25.5%)	I IIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII	325 (8.63%)	3440 (91.37%)
182	strngXTC_NormBeliefs_parents [numeric]	mean (sd) : 2.44 (1.4) min < med < max : 1 < 2 < 6 IQR (CV) : 3 (0.57)	1 : 105 (36.5%) 2 : 56 (19.4%) 3 : 51 (17.7%) 4 : 49 (17.0%) 5 : 24 ( 8.3%) 6 : 3 ( 1.0%)	IIIIIIIIIIIIIIII IIIIIIII IIIIIII IIIIIII III	288 (7.65%)	3477 (92.35%)
183	strngXTC_NormBeliefs_siblings [numeric]	mean (sd) : 3.71 (1.69) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.45)	1 : 43 (15.9%) 2 : 30 (11.1%) 3 : 28 (10.3%) 4 : 82 (30.3%) 5 : 45 (16.6%) 6 : 35 (12.9%) 7 : 8 ( 2.9%)	IIIIIIII IIIII IIIII IIIIIIIIIIIIIIII IIIIIIII IIIIII I	271 (7.2%)	3494 (92.8%)
184	strngXTC_NormMTC_partner [numeric]	mean (sd) : 1.61 (1.63) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (1.01)	-3 : 9 ( 6.2%) -1 : 3 ( 2.0%) 0 : 20 (13.7%) 1 : 20 (13.7%) 2 : 37 (25.3%) 3 : 57 (39.0%)	II IIIII IIIII IIIIIIIIII IIIIIIIIIIIIIIII	146 (3.88%)	3619 (96.12%)
185	strngXTC_NormMTC_bestFriends [numeric]	mean (sd) : 0.88 (1.72) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.95)	-3 : 28 ( 8.7%) -2 : 11 ( 3.4%) -1 : 15 ( 4.7%) 0 : 55 (17.1%) 1 : 73 (22.7%) 2 : 88 (27.3%) 3 : 52 (16.2%)	IIIII II II IIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII	322 (8.55%)	3443 (91.45%)
186	strngXTC_NormMTC_xtcFriends [numeric]	mean (sd) : 0.56 (1.79) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (3.16)	-3 : 31 (10.1%) -2 : 19 ( 6.2%) -1 : 21 ( 6.8%) 0 : 59 (19.2%) 1 : 70 (22.7%) 2 : 68 (22.1%) 3 : 40 (13.0%)	IIIIIII IIII IIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIII	308 (8.18%)	3457 (91.82%)
187	strngXTC_NormMTC_otherFriends [numeric]	mean (sd) : -0.4 (1.57) min < med < max : -3 < 0 < 3 IQR (CV) : 2.25 (-3.92)	-3 : 52 (16.7%) -2 : 26 ( 8.3%) -1 : 45 (14.4%) 0 : 94 (30.1%) 1 : 65 (20.8%) 2 : 27 ( 8.6%) 3 : 3 ( 1.0%)	IIIIIIII IIII IIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIII	312 (8.29%)	3453 (91.71%)
188	strngXTC_NormMTC_partyPeople [numeric]	mean (sd) : -1.48 (1.59) min < med < max : -3 < -2 < 3 IQR (CV) : 3 (-1.07)	-3 : 134 (41.2%) -2 : 47 (14.5%) -1 : 43 (13.2%) 0 : 60 (18.5%) 1 : 27 ( 8.3%) 2 : 12 ( 3.7%) 3 : 2 ( 0.6%)	IIIIIIIIIIIIIIII IIIII IIIII IIIIIII III I	325 (8.63%)	3440 (91.37%)
189	strngXTC_NormMTC_parents [numeric]	mean (sd) : -0.38 (1.83) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-4.84)	-3 : 61 (21.2%) -2 : 25 ( 8.7%) -1 : 32 (11.1%) 0 : 79 (27.4%) 1 : 44 (15.3%) 2 : 29 (10.1%) 3 : 18 ( 6.2%)	IIIIIIIIIIII IIIII IIIIII IIIIIIIIIIIIIIII IIIIIIII IIIII III	288 (7.65%)	3477 (92.35%)
190	strngXTC_NormMTC_siblings [numeric]	mean (sd) : -0.18 (1.91) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-10.37)	-3 : 55 (20.3%) -2 : 17 ( 6.3%) -1 : 34 (12.6%) 0 : 65 (24.0%) 1 : 43 (15.9%) 2 : 31 (11.4%) 3 : 26 ( 9.6%)	IIIIIIIIIIIII IIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII IIIIIII IIIIII	271 (7.2%)	3494 (92.8%)
191	strngXTC_DescrNorm_partner [numeric]	mean (sd) : 4.3 (2.12) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.49)	1 : 32 (21.9%) 2 : 4 ( 2.7%) 3 : 11 ( 7.5%) 4 : 11 ( 7.5%) 5 : 40 (27.4%) 6 : 25 (17.1%) 7 : 23 (15.8%)	IIIIIIIIIIII I IIII IIII IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIIII	146 (3.88%)	3619 (96.12%)
192	strngXTC_DescrNorm_bestFriends [numeric]	mean (sd) : 4.74 (1.71) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.36)	1 : 34 (10.6%) 2 : 10 ( 3.1%) 3 : 10 ( 3.1%) 4 : 54 (16.8%) 5 : 97 (30.1%) 6 : 79 (24.5%) 7 : 38 (11.8%)	IIIII I I IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIII	322 (8.55%)	3443 (91.45%)
193	strngXTC_DescrNorm_xtcFriends [numeric]	mean (sd) : 5.59 (1.2) min < med < max : 1 < 6 < 7 IQR (CV) : 1 (0.21)	1 : 3 ( 1.0%) 2 : 4 ( 1.3%) 3 : 11 ( 3.6%) 4 : 27 ( 8.8%) 5 : 78 (25.3%) 6 : 116 (37.7%) 7 : 69 (22.4%)	I III IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII	308 (8.18%)	3457 (91.82%)
194	strngXTC_DescrNorm_otherFriends [numeric]	mean (sd) : 3.59 (1.85) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.51)	1 : 71 (22.8%) 2 : 26 ( 8.3%) 3 : 32 (10.3%) 4 : 82 (26.3%) 5 : 49 (15.7%) 6 : 36 (11.5%) 7 : 16 ( 5.1%)	IIIIIIIIIIIII IIIII IIIIII IIIIIIIIIIIIIIII IIIIIIIII IIIIIII III	312 (8.29%)	3453 (91.71%)
195	strngXTC_DescrNorm_partyPeople [numeric]	mean (sd) : 5.35 (1.19) min < med < max : 1 < 6 < 7 IQR (CV) : 1 (0.22)	1 : 6 ( 1.8%) 2 : 2 ( 0.6%) 3 : 7 ( 2.1%) 4 : 57 (17.5%) 5 : 83 (25.5%) 6 : 126 (38.8%) 7 : 44 (13.5%)	IIIIIII IIIIIIIIII IIIIIIIIIIIIIIII IIIII	325 (8.63%)	3440 (91.37%)
196	strngXTC_DescrNorm_parents [numeric]	mean (sd) : 1.29 (0.91) min < med < max : 1 < 1 < 6 IQR (CV) : 0 (0.71)	1 : 258 (89.6%) 2 : 5 ( 1.7%) 3 : 2 ( 0.7%) 4 : 18 ( 6.2%) 5 : 4 ( 1.4%) 6 : 1 ( 0.4%)	IIIIIIIIIIIIIIII I	288 (7.65%)	3477 (92.35%)
197	strngXTC_DescrNorm_siblings [numeric]	mean (sd) : 2.63 (1.99) min < med < max : 1 < 1 < 7 IQR (CV) : 3 (0.76)	1 : 143 (52.8%) 2 : 17 ( 6.3%) 3 : 13 ( 4.8%) 4 : 32 (11.8%) 5 : 40 (14.8%) 6 : 13 ( 4.8%) 7 : 13 ( 4.8%)	IIIIIIIIIIIIIIII I I III IIII I I	271 (7.2%)	3494 (92.8%)
198	strngXTC_ContrBeliefs_sayNo [numeric]	mean (sd) : 5.69 (1.64) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.29)	1 : 7 ( 2.2%) 2 : 10 ( 3.1%) 3 : 19 ( 5.9%) 4 : 52 (16.1%) 5 : 22 ( 6.8%) 6 : 55 (17.0%) 7 : 159 (49.1%)	I I IIIII II IIIII IIIIIIIIIIIIIIII	324 (8.61%)	3441 (91.39%)
199	strngXTC_ContrBeliefs_highDoseEasy [numeric]	mean (sd) : 5.31 (1.59) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.3)	1 : 8 ( 2.5%) 2 : 14 ( 4.3%) 3 : 16 ( 5.0%) 4 : 58 (18.0%) 5 : 64 (19.8%) 6 : 62 (19.2%) 7 : 101 (31.3%)	I II II IIIIIIIII IIIIIIIIII IIIIIIIII IIIIIIIIIIIIIIII	323 (8.58%)	3442 (91.42%)
200	strngXTC_ContrBeliefs_normalDoseEasy [numeric]	mean (sd) : 5.36 (1.71) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.32)	1 : 7 ( 2.2%) 2 : 20 ( 6.2%) 3 : 19 ( 5.9%) 4 : 60 (18.6%) 5 : 40 (12.4%) 6 : 52 (16.1%) 7 : 125 (38.7%)	II II IIIIIII IIIII IIIIII IIIIIIIIIIIIIIII	323 (8.58%)	3442 (91.42%)
201	strngXTC_ContrBeliefs_easyHighDoseWhenHigh [numeric]	mean (sd) : 4.79 (1.78) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.37)	1 : 21 ( 6.5%) 2 : 20 ( 6.2%) 3 : 24 ( 7.4%) 4 : 77 (23.8%) 5 : 52 (16.1%) 6 : 57 (17.6%) 7 : 72 (22.3%)	IIII IIII IIII IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIIIIII IIIIIIIIIIIIII	323 (8.58%)	3442 (91.42%)
202	strngXTC_ContrBeliefs_easyNormalDoWhenHigh [numeric]	mean (sd) : 4.7 (1.83) min < med < max : 1 < 5 < 7 IQR (CV) : 4 (0.39)	1 : 10 ( 3.1%) 2 : 30 ( 9.3%) 3 : 58 (18.0%) 4 : 63 (19.5%) 5 : 38 (11.8%) 6 : 37 (11.5%) 7 : 87 (26.9%)	I IIIII IIIIIIIIII IIIIIIIIIII IIIIII IIIIII IIIIIIIIIIIIIIII	323 (8.58%)	3442 (91.42%)
203	highDose_IntentionRAA_intention [numeric]	mean (sd) : 3.8 (2.02) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.53)	1 : 64 (20.7%) 2 : 37 (12.0%) 3 : 31 (10.0%) 4 : 54 (17.5%) 5 : 44 (14.2%) 6 : 47 (15.2%) 7 : 32 (10.4%)	IIIIIIIIIIIIIIII IIIIIIIII IIIIIII IIIIIIIIIIIII IIIIIIIIIII IIIIIIIIIII IIIIIIII	309 (8.21%)	3456 (91.79%)
204	highDose_IntentionRAA_want [numeric]	mean (sd) : 3.58 (1.95) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.54)	1 : 71 (23.0%) 2 : 41 (13.3%) 3 : 28 ( 9.1%) 4 : 55 (17.8%) 5 : 58 (18.8%) 6 : 34 (11.0%) 7 : 22 ( 7.1%)	IIIIIIIIIIIIIIII IIIIIIIII IIIIII IIIIIIIIIIII IIIIIIIIIIIII IIIIIII IIII	309 (8.21%)	3456 (91.79%)
205	highDose_IntentionRAA_expectation [numeric]	mean (sd) : 3.97 (2.1) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.53)	1 : 58 (18.8%) 2 : 37 (12.0%) 3 : 38 (12.3%) 4 : 42 (13.6%) 5 : 40 (12.9%) 6 : 46 (14.9%) 7 : 48 (15.5%)	IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIIIII IIIIIIIIIII IIIIIIIIIII IIIIIIIIIIII IIIIIIIIIIIII	309 (8.21%)	3456 (91.79%)
206	highDose_IntentionFrq_freq.0 [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 1/2 8. 6 9. - 10. 0,5 [ 5 others ]	122 (39.6%) 74 (24.0%) 57 (18.5%) 25 ( 8.1%) 14 ( 4.5%) 4 ( 1.3%) 3 ( 1.0%) 2 ( 0.6%) 1 ( 0.3%) 1 ( 0.3%) 5 ( 1.6%)	IIIIIIIIIIIIIIII IIIIIIIII IIIIIII III I	308 (8.18%)	3457 (91.82%)
207	highDose_IntentionFrq_freq.1 [numeric]	mean (sd) : 1.24 (1.08) min < med < max : 1 < 1 < 6 IQR (CV) : 0 (0.87)	1 : 293 (95.1%) 6 : 15 ( 4.9%)	IIIIIIIIIIIIIIII	308 (8.18%)	3457 (91.82%)
208	highDose_AttGeneral_good [numeric]	mean (sd) : 3.7 (1.71) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.46)	1 : 43 (14.1%) 2 : 34 (11.2%) 3 : 62 (20.3%) 4 : 66 (21.6%) 5 : 49 (16.1%) 6 : 36 (11.8%) 7 : 15 ( 4.9%)	IIIIIIIIII IIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIIIII III	305 (8.1%)	3460 (91.9%)
209	highDose_AttGeneral_prettig [numeric]	mean (sd) : 4.15 (1.84) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.44)	1 : 38 (12.5%) 2 : 31 (10.2%) 3 : 37 (12.1%) 4 : 52 (17.1%) 5 : 61 (20.0%) 6 : 60 (19.7%) 7 : 26 ( 8.5%)	IIIIIIIII IIIIIIII IIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIII	305 (8.1%)	3460 (91.9%)
210	highDose_AttGeneral_slim [numeric]	mean (sd) : 2.94 (1.23) min < med < max : 1 < 3 < 7 IQR (CV) : 2 (0.42)	1 : 52 (17.1%) 2 : 49 (16.1%) 3 : 96 (31.6%) 4 : 84 (27.6%) 5 : 19 ( 6.2%) 6 : 3 ( 1.0%) 7 : 1 ( 0.3%)	IIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII III	304 (8.07%)	3461 (91.93%)
211	highDose_AttGeneral_gezond [numeric]	mean (sd) : 2.51 (1.13) min < med < max : 1 < 2 < 6 IQR (CV) : 1 (0.45)	1 : 68 (22.4%) 2 : 87 (28.6%) 3 : 84 (27.6%) 4 : 57 (18.8%) 5 : 6 ( 2.0%) 6 : 2 ( 0.7%)	IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIII I	304 (8.07%)	3461 (91.93%)
212	highDose_AttGeneral_spannend [numeric]	mean (sd) : 4.87 (1.31) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.27)	1 : 11 ( 3.6%) 2 : 3 ( 1.0%) 3 : 13 ( 4.3%) 4 : 89 (29.3%) 5 : 86 (28.3%) 6 : 76 (25.0%) 7 : 26 ( 8.6%)	I II IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIII IIII	304 (8.07%)	3461 (91.93%)
213	highDose_NormGeneral_in1 [numeric]	mean (sd) : 1.96 (1.41) min < med < max : 1 < 1 < 6 IQR (CV) : 2 (0.72)	1 : 177 (59.4%) 2 : 42 (14.1%) 3 : 24 ( 8.1%) 4 : 34 (11.4%) 5 : 12 ( 4.0%) 6 : 9 ( 3.0%)	IIIIIIIIIIIIIIII III II III I	298 (7.92%)	3467 (92.08%)
214	highDose_NormGeneral_in2 [numeric]	mean (sd) : 3.32 (1.97) min < med < max : 1 < 3 < 7 IQR (CV) : 4 (0.6)	1 : 85 (28.5%) 2 : 38 (12.8%) 3 : 34 (11.4%) 4 : 52 (17.4%) 5 : 37 (12.4%) 6 : 32 (10.7%) 7 : 20 ( 6.7%)	IIIIIIIIIIIIIIII IIIIIII IIIIII IIIIIIIII IIIIII IIIIII III	298 (7.92%)	3467 (92.08%)
215	highDose_NormGeneral_dn1 [numeric]	mean (sd) : 3.18 (1.76) min < med < max : 1 < 3 < 7 IQR (CV) : 3 (0.55)	1 : 83 (28.0%) 2 : 34 (11.5%) 3 : 39 (13.1%) 4 : 67 (22.6%) 5 : 42 (14.1%) 6 : 27 ( 9.1%) 7 : 5 ( 1.7%)	IIIIIIIIIIIIIIII IIIIII IIIIIII IIIIIIIIIIII IIIIIIII IIIII	297 (7.89%)	3468 (92.11%)
216	highDose_NormGeneral_dn2 [numeric]	mean (sd) : 3.89 (1.88) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.48)	1 : 50 (16.8%) 2 : 32 (10.8%) 3 : 35 (11.8%) 4 : 53 (17.8%) 5 : 59 (19.9%) 6 : 47 (15.8%) 7 : 21 ( 7.1%)	IIIIIIIIIIIII IIIIIIII IIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII IIIII	297 (7.89%)	3468 (92.11%)
217	highDose_PBCgeneral_ifwanted [numeric]	mean (sd) : 6.18 (1.26) min < med < max : 1 < 7 < 7 IQR (CV) : 1 (0.2)	1 : 4 ( 1.4%) 2 : 2 ( 0.7%) 3 : 7 ( 2.4%) 4 : 21 ( 7.1%) 5 : 29 ( 9.8%) 6 : 62 (20.9%) 7 : 172 (57.9%)	I II IIIII IIIIIIIIIIIIIIII	297 (7.89%)	3468 (92.11%)
218	highDose_PBCgeneral_easy [numeric]	mean (sd) : 5.3 (1.56) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.29)	1 : 5 ( 1.7%) 2 : 14 ( 4.7%) 3 : 22 ( 7.4%) 4 : 41 (13.8%) 5 : 65 (21.9%) 6 : 64 (21.6%) 7 : 86 (29.0%)	II IIII IIIIIII IIIIIIIIIIII IIIIIIIIIII IIIIIIIIIIIIIIII	297 (7.89%)	3468 (92.11%)
219	highDose_PBCgeneral_control [numeric]	mean (sd) : 5.89 (1.47) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.25)	1 : 6 ( 2.0%) 2 : 5 ( 1.7%) 3 : 15 ( 5.1%) 4 : 24 ( 8.1%) 5 : 36 (12.1%) 6 : 64 (21.6%) 7 : 147 (49.5%)	I II III IIIIII IIIIIIIIIIIIIIII	297 (7.89%)	3468 (92.11%)
220	highDose_PBCgeneral_externalFactors [numeric]	mean (sd) : 3.03 (1.76) min < med < max : 1 < 3 < 7 IQR (CV) : 4 (0.58)	1 : 78 (26.3%) 2 : 69 (23.2%) 3 : 29 ( 9.8%) 4 : 38 (12.8%) 5 : 59 (19.9%) 6 : 18 ( 6.1%) 7 : 6 ( 2.0%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIII IIIII IIIIIII IIIIIIIIIIII III I	297 (7.89%)	3468 (92.11%)
221	highDose_PBCgeneral_notOnlyMe [numeric]	mean (sd) : 5.98 (1.25) min < med < max : 2 < 6 < 7 IQR (CV) : 2 (0.21)	2 : 4 ( 1.4%) 3 : 10 ( 3.4%) 4 : 37 (12.5%) 5 : 24 ( 8.1%) 6 : 84 (28.3%) 7 : 138 (46.5%)	I IIII II IIIIIIIII IIIIIIIIIIIIIIII	297 (7.89%)	3468 (92.11%)
222	highDose_OpenWhy [character]	1. Hard gaan 2. - Gebrek aan kennis - Des 3. Als ze vinden dat het het 4. Andere mensen gebruiken h 5. Beetje stom om de zelfde 6. Beschikbaarheid, denken d 7. Beter gevoel, vager zijn 8. Bewijsdrang of verslaving 9. Bij een hogere dosis ga j 10. Bij mijzelf gaat het voor [ 171 others ]	2 ( 1.1%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 171 (94.0%)	IIIIIIIIIIIIIIII	182 (4.83%)	3583 (95.17%)
223	highDose_OpenWhyNot [character]	1. Gevaarlijk 2. Gevaarlijker 3. - Op de hoogte zijn van d 4. Ala je weet dat je maar w 5. als ik het gewenste effec 6. als je er niet goed op re 7. Als je even een rustig av 8. Als je iets anders op heb 9. Als je teveel neemt voel 10. Als je uitdeelt heb je ka [ 163 others ]	2 ( 1.1%) 2 ( 1.1%) 1 ( 0.6%) 1 ( 0.6%) 1 ( 0.6%) 1 ( 0.6%) 1 ( 0.6%) 1 ( 0.6%) 1 ( 0.6%) 1 ( 0.6%) 163 (92.9%)	IIIIIIIIIIIIIIII	175 (4.65%)	3590 (95.35%)
224	highDose_AttBeliefs_long [numeric]	mean (sd) : 1.26 (1.25) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (0.99)	-3 : 3 ( 1.4%) -2 : 3 ( 1.4%) -1 : 3 ( 1.4%) 0 : 54 (24.9%) 1 : 54 (24.9%) 2 : 62 (28.6%) 3 : 38 (17.5%)	IIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII	217 (5.76%)	3548 (94.24%)
225	highDose_AttBeliefs_intensity [numeric]	mean (sd) : 2.03 (1.03) min < med < max : -1 < 2 < 3 IQR (CV) : 1 (0.51)	-1 : 2 ( 0.9%) 0 : 24 (11.1%) 1 : 26 (12.0%) 2 : 77 (35.6%) 3 : 87 (40.3%)	IIII IIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII	216 (5.74%)	3549 (94.26%)
226	highDose_AttBeliefs_intoxicated [numeric]	mean (sd) : 2.14 (1.03) min < med < max : -1 < 2 < 3 IQR (CV) : 1 (0.48)	-1 : 2 ( 0.9%) 0 : 22 (10.3%) 1 : 22 (10.3%) 2 : 67 (31.3%) 3 : 101 (47.2%)	III III IIIIIIIIII IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
227	highDose_AttBeliefs_energy [numeric]	mean (sd) : 0.72 (1.55) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (2.16)	-3 : 7 ( 3.3%) -2 : 14 ( 6.5%) -1 : 21 ( 9.8%) 0 : 50 (23.4%) 1 : 48 (22.4%) 2 : 46 (21.5%) 3 : 28 (13.1%)	II IIII IIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIII	214 (5.68%)	3551 (94.32%)
228	highDose_AttBeliefs_euphoria [numeric]	mean (sd) : 0.84 (1.48) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.77)	-3 : 3 ( 1.4%) -2 : 13 ( 6.1%) -1 : 20 ( 9.4%) 0 : 53 (24.9%) 1 : 45 (21.1%) 2 : 49 (23.0%) 3 : 30 (14.1%)	III IIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIII	213 (5.66%)	3552 (94.34%)
229	highDose_AttBeliefs_insight [numeric]	mean (sd) : -0.15 (1.32) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (-8.81)	-3 : 15 ( 7.0%) -2 : 19 ( 8.9%) -1 : 24 (11.3%) 0 : 109 (51.2%) 1 : 21 ( 9.9%) 2 : 21 ( 9.9%) 3 : 4 ( 1.9%)	II II III IIIIIIIIIIIIIIII III III	213 (5.66%)	3552 (94.34%)
230	highDose_AttBeliefs_connection [numeric]	mean (sd) : 0.36 (1.56) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (4.37)	-3 : 8 ( 3.8%) -2 : 20 ( 9.4%) -1 : 34 (16.0%) 0 : 51 (23.9%) 1 : 43 (20.2%) 2 : 40 (18.8%) 3 : 17 ( 8.0%)	II IIIIII IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIII IIIII	213 (5.66%)	3552 (94.34%)
231	highDose_AttBeliefs_contact [numeric]	mean (sd) : 0.34 (1.66) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (4.91)	-3 : 13 ( 6.1%) -2 : 21 ( 9.9%) -1 : 27 (12.7%) 0 : 53 (24.9%) 1 : 37 (17.4%) 2 : 43 (20.2%) 3 : 19 ( 8.9%)	III IIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIIIIIIIII IIIII	213 (5.66%)	3552 (94.34%)
232	highDose_AttBeliefs_sex [numeric]	mean (sd) : -0.25 (1.58) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (-6.25)	-3 : 23 (10.8%) -2 : 28 (13.2%) -1 : 24 (11.3%) 0 : 83 (39.0%) 1 : 29 (13.6%) 2 : 12 ( 5.6%) 3 : 14 ( 6.6%)	IIII IIIII IIII IIIIIIIIIIIIIIII IIIII II II	213 (5.66%)	3552 (94.34%)
233	highDose_AttBeliefs_coping [numeric]	mean (sd) : 0.9 (1.3) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.44)	-3 : 1 ( 0.5%) -2 : 7 ( 3.3%) -1 : 6 ( 2.8%) 0 : 89 (41.8%) 1 : 36 (16.9%) 2 : 43 (20.2%) 3 : 31 (14.5%)	I I IIIIIIIIIIIIIIII IIIIII IIIIIII IIIII	213 (5.66%)	3552 (94.34%)
234	highDose_AttBeliefs_isolated [numeric]	mean (sd) : 0.57 (1.53) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (2.67)	-3 : 9 ( 4.2%) -2 : 12 ( 5.6%) -1 : 19 ( 8.9%) 0 : 67 (31.5%) 1 : 46 (21.6%) 2 : 34 (16.0%) 3 : 26 (12.2%)	II II IIII IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIII IIIIII	213 (5.66%)	3552 (94.34%)
235	highDose_AttBeliefs_boundaries [numeric]	mean (sd) : -0.06 (1.3) min < med < max : -3 < 0 < 2 IQR (CV) : 2 (-21.13)	-3 : 12 ( 5.7%) -2 : 22 (10.4%) -1 : 20 ( 9.4%) 0 : 97 (45.8%) 1 : 35 (16.5%) 2 : 26 (12.3%)	I III III IIIIIIIIIIIIIIII IIIII IIII	212 (5.63%)	3553 (94.37%)
236	highDose_AttBeliefs_music [numeric]	mean (sd) : 1.12 (1.3) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.16)	-3 : 1 ( 0.5%) -2 : 3 ( 1.4%) -1 : 10 ( 4.7%) 0 : 69 (32.6%) 1 : 42 (19.8%) 2 : 47 (22.2%) 3 : 40 (18.9%)	II IIIIIIIIIIIIIIII IIIIIIIII IIIIIIIIII IIIIIIIII	212 (5.63%)	3553 (94.37%)
237	highDose_AttBeliefs_hallucinate [numeric]	mean (sd) : 1.38 (1.22) min < med < max : -2 < 1 < 3 IQR (CV) : 2 (0.88)	-2 : 2 ( 0.9%) -1 : 3 ( 1.4%) 0 : 58 (27.4%) 1 : 50 (23.6%) 2 : 47 (22.2%) 3 : 52 (24.5%)	IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIII	212 (5.63%)	3553 (94.37%)
238	highDose_AttBeliefs_timeAwareness [numeric]	mean (sd) : 1.66 (1.31) min < med < max : -2 < 2 < 3 IQR (CV) : 2 (0.79)	-2 : 5 ( 2.4%) -1 : 5 ( 2.4%) 0 : 41 (19.3%) 1 : 26 (12.3%) 2 : 64 (30.2%) 3 : 71 (33.5%)	I I IIIIIIIII IIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII	212 (5.63%)	3553 (94.37%)
239	highDose_AttBeliefs_memory [numeric]	mean (sd) : -1.06 (1.38) min < med < max : -3 < -1 < 3 IQR (CV) : 2 (-1.3)	-3 : 45 (21.2%) -2 : 37 (17.4%) -1 : 41 (19.3%) 0 : 75 (35.4%) 1 : 4 ( 1.9%) 2 : 9 ( 4.2%) 3 : 1 ( 0.5%)	IIIIIIIII IIIIIII IIIIIIII IIIIIIIIIIIIIIII I	212 (5.63%)	3553 (94.37%)
240	highDose_AttBeliefs_health [numeric]	mean (sd) : -1.84 (1.16) min < med < max : -3 < -2 < 2 IQR (CV) : 2 (-0.63)	-3 : 82 (38.7%) -2 : 54 (25.5%) -1 : 42 (19.8%) 0 : 30 (14.1%) 1 : 3 ( 1.4%) 2 : 1 ( 0.5%)	IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIII IIIII	212 (5.63%)	3553 (94.37%)
241	highDose_AttBeliefs_better [numeric]	mean (sd) : -0.09 (1.59) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (-16.8)	-3 : 22 (10.4%) -2 : 19 ( 9.0%) -1 : 33 (15.6%) 0 : 66 (31.1%) 1 : 36 (17.0%) 2 : 27 (12.7%) 3 : 9 ( 4.2%)	IIIII IIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIII IIIIII II	212 (5.63%)	3553 (94.37%)
242	highDose_AttBeliefs_physicalSideEffects [numeric]	mean (sd) : 1.2 (1.14) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (0.95)	-3 : 1 ( 0.5%) -2 : 1 ( 0.5%) -1 : 4 ( 1.9%) 0 : 60 (28.3%) 1 : 62 (29.2%) 2 : 51 (24.1%) 3 : 33 (15.6%)	I IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIII	212 (5.63%)	3553 (94.37%)
243	highDose_AttBeliefs_psychicSideEffects [numeric]	mean (sd) : 1.09 (1.23) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.13)	-3 : 1 ( 0.5%) -2 : 3 ( 1.4%) -1 : 7 ( 3.3%) 0 : 68 (32.1%) 1 : 52 (24.5%) 2 : 48 (22.6%) 3 : 33 (15.6%)	I IIIIIIIIIIIIIIII IIIIIIIIIIII IIIIIIIIIII IIIIIII	212 (5.63%)	3553 (94.37%)
244	highDose_AttBeliefs_regret [numeric]	mean (sd) : 0.64 (1.13) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (1.78)	-3 : 2 ( 0.9%) -2 : 2 ( 0.9%) -1 : 9 ( 4.2%) 0 : 111 (52.4%) 1 : 40 (18.9%) 2 : 30 (14.1%) 3 : 18 ( 8.5%)	I IIIIIIIIIIIIIIII IIIII IIII II	212 (5.63%)	3553 (94.37%)
245	highDose_AttDesirable_long [numeric]	mean (sd) : 1.85 (1.1) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (0.6)	-3 : 1 ( 0.5%) -1 : 4 ( 1.9%) 0 : 22 (10.5%) 1 : 40 (19.1%) 2 : 74 (35.2%) 3 : 69 (32.9%)	IIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
246	highDose_AttDesirable_intens [numeric]	mean (sd) : 1.39 (1.39) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (1)	-3 : 1 ( 0.5%) -2 : 6 ( 2.9%) -1 : 19 ( 9.0%) 0 : 20 ( 9.5%) 1 : 57 (27.1%) 2 : 52 (24.8%) 3 : 55 (26.2%)	I IIIII IIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
247	highDose_AttDesirable_intoxicated [numeric]	mean (sd) : 0.59 (1.5) min < med < max : -3 < 1 < 3 IQR (CV) : 3 (2.56)	-3 : 3 ( 1.4%) -2 : 13 ( 6.2%) -1 : 38 (18.1%) 0 : 46 (21.9%) 1 : 52 (24.8%) 2 : 30 (14.3%) 3 : 28 (13.3%)	IIII IIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII IIIIIIII	210 (5.58%)	3555 (94.42%)
248	highDose_AttDesirable_energy [numeric]	mean (sd) : 1.78 (1.01) min < med < max : -1 < 2 < 3 IQR (CV) : 2 (0.57)	-1 : 3 ( 1.4%) 0 : 22 (10.5%) 1 : 50 (23.8%) 2 : 78 (37.1%) 3 : 57 (27.1%)	IIII IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII	210 (5.58%)	3555 (94.42%)
249	highDose_AttDesirable_euphoria [numeric]	mean (sd) : 2.38 (0.84) min < med < max : 0 < 3 < 3 IQR (CV) : 1 (0.35)	0 : 9 ( 4.3%) 1 : 22 (10.5%) 2 : 60 (28.6%) 3 : 119 (56.7%)	I II IIIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
250	highDose_AttDesirable_insight [numeric]	mean (sd) : 0.99 (1.29) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (1.31)	-3 : 1 ( 0.5%) -2 : 4 ( 1.9%) -1 : 8 ( 3.8%) 0 : 82 (39.1%) 1 : 40 (19.1%) 2 : 39 (18.6%) 3 : 36 (17.1%)	I IIIIIIIIIIIIIIII IIIIIII IIIIIII IIIIIII	210 (5.58%)	3555 (94.42%)
251	highDose_AttDesirable_connection [numeric]	mean (sd) : 2 (1.02) min < med < max : 0 < 2 < 3 IQR (CV) : 2 (0.51)	0 : 24 (11.4%) 1 : 37 (17.6%) 2 : 64 (30.5%) 3 : 85 (40.5%)	IIII IIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
252	highDose_AttDesirable_contact [numeric]	mean (sd) : 1.93 (1.04) min < med < max : 0 < 2 < 3 IQR (CV) : 2 (0.54)	0 : 29 (13.8%) 1 : 33 (15.7%) 2 : 72 (34.3%) 3 : 76 (36.2%)	IIIIII IIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
253	highDose_AttDesirable_sex [numeric]	mean (sd) : 0.7 (1.35) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (1.93)	-3 : 4 ( 1.9%) -2 : 5 ( 2.4%) -1 : 13 ( 6.2%) 0 : 93 (44.3%) 1 : 38 (18.1%) 2 : 27 (12.9%) 3 : 30 (14.3%)	II IIIIIIIIIIIIIIII IIIIII IIII IIIII	210 (5.58%)	3555 (94.42%)
254	highDose_AttDesirable_coping [numeric]	mean (sd) : 0.5 (1.42) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (2.82)	-3 : 9 ( 4.3%) -2 : 7 ( 3.3%) -1 : 14 ( 6.7%) 0 : 91 (43.3%) 1 : 41 (19.5%) 2 : 24 (11.4%) 3 : 24 (11.4%)	I I II IIIIIIIIIIIIIIII IIIIIII IIII IIII	210 (5.58%)	3555 (94.42%)
255	highDose_AttDesirable_isolated [numeric]	mean (sd) : -1.27 (1.36) min < med < max : -3 < -1 < 3 IQR (CV) : 2 (-1.07)	-3 : 48 (22.9%) -2 : 52 (24.8%) -1 : 43 (20.5%) 0 : 51 (24.3%) 1 : 10 ( 4.8%) 2 : 4 ( 1.9%) 3 : 2 ( 0.9%)	IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIII III I	210 (5.58%)	3555 (94.42%)
256	highDose_AttDesirable_boundaries [numeric]	mean (sd) : -0.21 (1.61) min < med < max : -3 < 0 < 3 IQR (CV) : 2 (-7.69)	-3 : 25 (11.9%) -2 : 26 (12.4%) -1 : 22 (10.5%) 0 : 71 (33.8%) 1 : 36 (17.1%) 2 : 21 (10.0%) 3 : 9 ( 4.3%)	IIIII IIIII IIII IIIIIIIIIIIIIIII IIIIIIII IIII II	210 (5.58%)	3555 (94.42%)
257	highDose_AttDesirable_purity [numeric]	mean (sd) : 2.35 (0.95) min < med < max : 0 < 3 < 3 IQR (CV) : 1 (0.4)	0 : 17 ( 8.1%) 1 : 19 ( 9.0%) 2 : 48 (22.9%) 3 : 126 (60.0%)	II II IIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
258	highDose_AttDesirable_music [numeric]	mean (sd) : 2.28 (0.96) min < med < max : 0 < 3 < 3 IQR (CV) : 1 (0.42)	0 : 18 ( 8.6%) 1 : 22 (10.5%) 2 : 54 (25.7%) 3 : 116 (55.2%)	II III IIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
259	highDose_AttDesirable_hallucinate [numeric]	mean (sd) : -0.48 (1.8) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-3.75)	-3 : 46 (21.9%) -2 : 22 (10.5%) -1 : 25 (11.9%) 0 : 50 (23.8%) 1 : 37 (17.6%) 2 : 21 (10.0%) 3 : 9 ( 4.3%)	IIIIIIIIIIIIII IIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIII II	210 (5.58%)	3555 (94.42%)
260	highDose_AttDesirable_timeAwareness [numeric]	mean (sd) : -1.07 (1.54) min < med < max : -3 < -1 < 3 IQR (CV) : 3 (-1.44)	-3 : 57 (27.1%) -2 : 28 (13.3%) -1 : 38 (18.1%) 0 : 61 (29.0%) 1 : 16 ( 7.6%) 2 : 6 ( 2.9%) 3 : 4 ( 1.9%)	IIIIIIIIIIIIII IIIIIII IIIIIIIII IIIIIIIIIIIIIIII IIII I I	210 (5.58%)	3555 (94.42%)
261	highDose_AttDesirable_memory [numeric]	mean (sd) : 2.05 (1.16) min < med < max : -2 < 2 < 3 IQR (CV) : 2 (0.57)	-2 : 1 ( 0.5%) -1 : 1 ( 0.5%) 0 : 33 (15.7%) 1 : 21 (10.0%) 2 : 50 (23.8%) 3 : 104 (49.5%)	IIIII III IIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
262	highDose_NormBeliefs_partner [numeric]	mean (sd) : 4.67 (1.7) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.36)	1 : 5 ( 5.1%) 2 : 6 ( 6.1%) 3 : 15 (15.2%) 4 : 18 (18.2%) 5 : 17 (17.2%) 6 : 23 (23.2%) 7 : 15 (15.2%)	III IIII IIIIIIIIII IIIIIIIIIIII IIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII	99 (2.63%)	3666 (97.37%)
263	highDose_NormBeliefs_bestFriends [numeric]	mean (sd) : 4.33 (1.57) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.36)	1 : 10 ( 4.8%) 2 : 16 ( 7.8%) 3 : 34 (16.5%) 4 : 52 (25.2%) 5 : 41 (19.9%) 6 : 36 (17.5%) 7 : 17 ( 8.2%)	III IIII IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII IIIIIIIIIII IIIII	206 (5.47%)	3559 (94.53%)
264	highDose_NormBeliefs_xtcFriends [numeric]	mean (sd) : 5.23 (1.48) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.28)	1 : 2 ( 1.1%) 2 : 8 ( 4.2%) 3 : 16 ( 8.5%) 4 : 33 (17.5%) 5 : 31 (16.4%) 6 : 58 (30.7%) 7 : 41 (21.7%)	II IIII IIIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII	189 (5.02%)	3576 (94.98%)
265	highDose_NormBeliefs_otherFriends [numeric]	mean (sd) : 3.68 (1.44) min < med < max : 1 < 4 < 7 IQR (CV) : 2 (0.39)	1 : 21 (10.5%) 2 : 20 (10.1%) 3 : 35 (17.6%) 4 : 71 (35.7%) 5 : 34 (17.1%) 6 : 14 ( 7.0%) 7 : 4 ( 2.0%)	IIII IIII IIIIIII IIIIIIIIIIIIIIII IIIIIII III	199 (5.29%)	3566 (94.71%)
266	highDose_NormBeliefs_partyPeople [numeric]	mean (sd) : 5.02 (1.34) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.27)	1 : 2 ( 0.9%) 2 : 5 ( 2.4%) 3 : 14 ( 6.7%) 4 : 62 (29.5%) 5 : 39 (18.6%) 6 : 58 (27.6%) 7 : 30 (14.3%)	I III IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIIIIIIIII IIIIIII	210 (5.58%)	3555 (94.42%)
267	highDose_NormBeliefs_parents [numeric]	mean (sd) : 1.97 (1.3) min < med < max : 1 < 1 < 6 IQR (CV) : 2 (0.66)	1 : 98 (55.1%) 2 : 29 (16.3%) 3 : 20 (11.2%) 4 : 21 (11.8%) 5 : 9 ( 5.1%) 6 : 1 ( 0.6%)	IIIIIIIIIIIIIIII IIII III III I	178 (4.73%)	3587 (95.27%)
268	highDose_NormBeliefs_siblings [numeric]	mean (sd) : 3.25 (1.6) min < med < max : 1 < 3 < 7 IQR (CV) : 2 (0.49)	1 : 34 (19.5%) 2 : 30 (17.2%) 3 : 24 (13.8%) 4 : 48 (27.6%) 5 : 23 (13.2%) 6 : 13 ( 7.5%) 7 : 2 ( 1.1%)	IIIIIIIIIII IIIIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIII IIII	174 (4.62%)	3591 (95.38%)
269	highDose_NormMTC_partner [numeric]	mean (sd) : 1.56 (1.67) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (1.08)	-3 : 5 ( 5.1%) -2 : 3 ( 3.0%) -1 : 3 ( 3.0%) 0 : 11 (11.1%) 1 : 13 (13.1%) 2 : 27 (27.3%) 3 : 37 (37.4%)	II I I IIII IIIII IIIIIIIIIII IIIIIIIIIIIIIIII	99 (2.63%)	3666 (97.37%)
270	highDose_NormMTC_bestFriends [numeric]	mean (sd) : 0.73 (1.75) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (2.38)	-3 : 19 ( 9.2%) -2 : 7 ( 3.4%) -1 : 15 ( 7.3%) 0 : 39 (18.9%) 1 : 46 (22.3%) 2 : 49 (23.8%) 3 : 31 (15.0%)	IIIIII II IIII IIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII	206 (5.47%)	3559 (94.53%)
271	highDose_NormMTC_xtcFriends [numeric]	mean (sd) : 0.52 (1.7) min < med < max : -3 < 1 < 3 IQR (CV) : 2 (3.27)	-3 : 19 (10.1%) -2 : 9 ( 4.8%) -1 : 10 ( 5.3%) 0 : 44 (23.3%) 1 : 51 (27.0%) 2 : 36 (19.1%) 3 : 20 (10.6%)	IIIII II III IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIII	189 (5.02%)	3576 (94.98%)
272	highDose_NormMTC_otherFriends [numeric]	mean (sd) : -0.48 (1.6) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-3.32)	-3 : 37 (18.6%) -2 : 18 ( 9.0%) -1 : 26 (13.1%) 0 : 60 (30.1%) 1 : 43 (21.6%) 2 : 11 ( 5.5%) 3 : 4 ( 2.0%)	IIIIIIIII IIII IIIIII IIIIIIIIIIIIIIII IIIIIIIIIII II I	199 (5.29%)	3566 (94.71%)
273	highDose_NormMTC_partyPeople [numeric]	mean (sd) : -1.45 (1.6) min < med < max : -3 < -2 < 3 IQR (CV) : 3 (-1.1)	-3 : 89 (42.4%) -2 : 26 (12.4%) -1 : 20 ( 9.5%) 0 : 48 (22.9%) 1 : 21 (10.0%) 2 : 5 ( 2.4%) 3 : 1 ( 0.5%)	IIIIIIIIIIIIIIII IIII III IIIIIIII III	210 (5.58%)	3555 (94.42%)
274	highDose_NormMTC_parents [numeric]	mean (sd) : -0.75 (1.7) min < med < max : -3 < -0.5 < 3 IQR (CV) : 2 (-2.26)	-3 : 43 (24.2%) -2 : 23 (12.9%) -1 : 23 (12.9%) 0 : 45 (25.3%) 1 : 27 (15.2%) 2 : 14 ( 7.9%) 3 : 3 ( 1.7%)	IIIIIIIIIIIIIII IIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIIIII IIII I	178 (4.73%)	3587 (95.27%)
275	highDose_NormMTC_siblings [numeric]	mean (sd) : -0.36 (1.89) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-5.23)	-3 : 38 (21.8%) -2 : 17 ( 9.8%) -1 : 19 (10.9%) 0 : 39 (22.4%) 1 : 30 (17.2%) 2 : 19 (10.9%) 3 : 12 ( 6.9%)	IIIIIIIIIIIIIII IIIIII IIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIII IIIIIII IIII	174 (4.62%)	3591 (95.38%)
276	highDose_DescrNorm_partner [numeric]	mean (sd) : 3.97 (2.12) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.53)	1 : 21 (21.2%) 2 : 11 (11.1%) 3 : 7 ( 7.1%) 4 : 13 (13.1%) 5 : 18 (18.2%) 6 : 16 (16.2%) 7 : 13 (13.1%)	IIIIIIIIIIIIIIII IIIIIIII IIIII IIIIIIIII IIIIIIIIIIIII IIIIIIIIIIII IIIIIIIII	99 (2.63%)	3666 (97.37%)
277	highDose_DescrNorm_bestFriends [numeric]	mean (sd) : 4.01 (1.73) min < med < max : 1 < 4 < 7 IQR (CV) : 2 (0.43)	1 : 24 (11.6%) 2 : 21 (10.2%) 3 : 30 (14.6%) 4 : 39 (18.9%) 5 : 49 (23.8%) 6 : 31 (15.0%) 7 : 12 ( 5.8%)	IIIIIII IIIIII IIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII III	206 (5.47%)	3559 (94.53%)
278	highDose_DescrNorm_xtcFriends [numeric]	mean (sd) : 5.14 (1.38) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.27)	1 : 3 ( 1.6%) 2 : 7 ( 3.7%) 3 : 14 ( 7.4%) 4 : 24 (12.7%) 5 : 59 (31.2%) 6 : 53 (28.0%) 7 : 29 (15.3%)	I III IIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIII	189 (5.02%)	3576 (94.98%)
279	highDose_DescrNorm_otherFriends [numeric]	mean (sd) : 3.25 (1.7) min < med < max : 1 < 3 < 7 IQR (CV) : 2 (0.52)	1 : 47 (23.6%) 2 : 25 (12.6%) 3 : 28 (14.1%) 4 : 55 (27.6%) 5 : 26 (13.1%) 6 : 11 ( 5.5%) 7 : 7 ( 3.5%)	IIIIIIIIIIIII IIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIIII III II	199 (5.29%)	3566 (94.71%)
280	highDose_DescrNorm_partyPeople [numeric]	mean (sd) : 4.92 (1.36) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.28)	1 : 7 ( 3.3%) 2 : 6 ( 2.9%) 3 : 10 ( 4.8%) 4 : 50 (23.8%) 5 : 54 (25.7%) 6 : 67 (31.9%) 7 : 16 ( 7.6%)	I I II IIIIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII III	210 (5.58%)	3555 (94.42%)
281	highDose_DescrNorm_parents [numeric]	mean (sd) : 1.23 (0.77) min < med < max : 1 < 1 < 5 IQR (CV) : 0 (0.63)	1 : 161 (90.5%) 2 : 5 ( 2.8%) 3 : 1 ( 0.6%) 4 : 10 ( 5.6%) 5 : 1 ( 0.6%)	IIIIIIIIIIIIIIII	178 (4.73%)	3587 (95.27%)
282	highDose_DescrNorm_siblings [numeric]	mean (sd) : 2.56 (1.87) min < med < max : 1 < 1 < 7 IQR (CV) : 3 (0.73)	1 : 88 (50.6%) 2 : 15 ( 8.6%) 3 : 11 ( 6.3%) 4 : 27 (15.5%) 5 : 16 ( 9.2%) 6 : 13 ( 7.5%) 7 : 4 ( 2.3%)	IIIIIIIIIIIIIIII II II IIII II II	174 (4.62%)	3591 (95.38%)
283	highDose_ContrBeliefs_sayNo [numeric]	mean (sd) : 5.96 (1.48) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.25)	1 : 1 ( 0.5%) 2 : 7 ( 3.3%) 3 : 13 ( 6.2%) 4 : 17 ( 8.1%) 5 : 19 ( 9.0%) 6 : 37 (17.6%) 7 : 116 (55.2%)	I II II IIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
284	highDose_ContrBeliefs_highDoseEasy [numeric]	mean (sd) : 5.14 (1.65) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.32)	1 : 9 ( 4.3%) 2 : 7 ( 3.3%) 3 : 16 ( 7.6%) 4 : 38 (18.1%) 5 : 39 (18.6%) 6 : 46 (21.9%) 7 : 55 (26.2%)	II II IIII IIIIIIIIIII IIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
285	highDose_ContrBeliefs_normalDoseEasy [numeric]	mean (sd) : 5.69 (1.5) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.26)	1 : 1 ( 0.5%) 2 : 4 ( 1.9%) 3 : 21 (10.0%) 4 : 24 (11.4%) 5 : 26 (12.4%) 6 : 42 (20.0%) 7 : 92 (43.8%)	III IIII IIII IIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
286	highDose_ContrBeliefs_easyHighDoseWhenHigh [numeric]	mean (sd) : 4.69 (1.7) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.36)	1 : 9 ( 4.3%) 2 : 15 ( 7.1%) 3 : 25 (11.9%) 4 : 51 (24.3%) 5 : 31 (14.8%) 6 : 41 (19.5%) 7 : 38 (18.1%)	II IIII IIIIIII IIIIIIIIIIIIIIII IIIIIIIII IIIIIIIIIIII IIIIIIIIIII	210 (5.58%)	3555 (94.42%)
287	highDose_ContrBeliefs_easyNormalDoWhenHigh [numeric]	mean (sd) : 4.97 (1.76) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.35)	1 : 6 ( 2.9%) 2 : 12 ( 5.7%) 3 : 32 (15.2%) 4 : 40 (19.1%) 5 : 21 (10.0%) 6 : 40 (19.1%) 7 : 59 (28.1%)	I III IIIIIIII IIIIIIIIII IIIII IIIIIIIIII IIIIIIIIIIIIIIII	210 (5.58%)	3555 (94.42%)
288	testing_AttGeneral_good [numeric]	mean (sd) : 6.56 (0.93) min < med < max : 1 < 7 < 7 IQR (CV) : 0 (0.14)	1 : 1 ( 0.4%) 4 : 16 ( 6.7%) 5 : 11 ( 4.6%) 6 : 29 (12.2%) 7 : 181 (76.0%)	I II IIIIIIIIIIIIIIII	238 (6.32%)	3527 (93.68%)
289	testing_AttGeneral_prettig [numeric]	mean (sd) : 6.02 (1.47) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.24)	1 : 4 ( 1.7%) 2 : 3 ( 1.3%) 3 : 9 ( 3.8%) 4 : 30 (12.6%) 5 : 21 ( 8.8%) 6 : 27 (11.3%) 7 : 144 (60.5%)	I III II III IIIIIIIIIIIIIIII	238 (6.32%)	3527 (93.68%)
290	testing_AttGeneral_slim [numeric]	mean (sd) : 6.7 (0.84) min < med < max : 1 < 7 < 7 IQR (CV) : 0 (0.13)	1 : 2 ( 0.8%) 4 : 8 ( 3.4%) 5 : 5 ( 2.1%) 6 : 25 (10.5%) 7 : 197 (83.1%)	II IIIIIIIIIIIIIIII	237 (6.29%)	3528 (93.71%)
291	testing_AttGeneral_gezond [numeric]	mean (sd) : 6.22 (1.18) min < med < max : 1 < 7 < 7 IQR (CV) : 1 (0.19)	1 : 1 ( 0.4%) 4 : 37 (15.6%) 5 : 19 ( 8.0%) 6 : 30 (12.7%) 7 : 150 (63.3%)	III II III IIIIIIIIIIIIIIII	237 (6.29%)	3528 (93.71%)
292	testing_AttGeneral_spannend [numeric]	mean (sd) : 4.39 (1.47) min < med < max : 1 < 4 < 7 IQR (CV) : 1 (0.33)	1 : 15 ( 6.3%) 2 : 9 ( 3.8%) 3 : 11 ( 4.6%) 4 : 110 (46.4%) 5 : 40 (16.9%) 6 : 29 (12.2%) 7 : 23 ( 9.7%)	II I I IIIIIIIIIIIIIIII IIIII IIII III	237 (6.29%)	3528 (93.71%)
293	testing_NormGeneral_in1 [numeric]	mean (sd) : 4.79 (2.01) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.42)	1 : 26 (11.0%) 2 : 16 ( 6.8%) 3 : 15 ( 6.4%) 4 : 37 (15.7%) 5 : 39 (16.5%) 6 : 37 (15.7%) 7 : 66 (28.0%)	IIIIII III III IIIIIIII IIIIIIIII IIIIIIII IIIIIIIIIIIIIIII	236 (6.27%)	3529 (93.73%)
294	testing_NormGeneral_in2 [numeric]	mean (sd) : 6.09 (1.37) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.22)	1 : 6 ( 2.5%) 2 : 2 ( 0.8%) 3 : 2 ( 0.8%) 4 : 18 ( 7.7%) 5 : 34 (14.5%) 6 : 38 (16.2%) 7 : 135 (57.5%)	II IIII IIII IIIIIIIIIIIIIIII	235 (6.24%)	3530 (93.76%)
295	testing_NormGeneral_dn1 [numeric]	mean (sd) : 3.99 (2.03) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.51)	1 : 45 (19.1%) 2 : 19 ( 8.1%) 3 : 22 ( 9.4%) 4 : 56 (23.8%) 5 : 29 (12.3%) 6 : 28 (11.9%) 7 : 36 (15.3%)	IIIIIIIIIIII IIIII IIIIII IIIIIIIIIIIIIIII IIIIIIII IIIIIIII IIIIIIIIII	235 (6.24%)	3530 (93.76%)
296	testing_NormGeneral_dn2 [numeric]	mean (sd) : 3.53 (2.08) min < med < max : 1 < 3 < 7 IQR (CV) : 3 (0.59)	1 : 55 (23.4%) 2 : 38 (16.2%) 3 : 31 (13.2%) 4 : 32 (13.6%) 5 : 28 (11.9%) 6 : 20 ( 8.5%) 7 : 31 (13.2%)	IIIIIIIIIIIIIIII IIIIIIIIIII IIIIIIIII IIIIIIIII IIIIIIII IIIII IIIIIIIII	235 (6.24%)	3530 (93.76%)
297	testing_PBCgeneral_ifwanted [numeric]	mean (sd) : 6.2 (1.4) min < med < max : 1 < 7 < 7 IQR (CV) : 1 (0.23)	1 : 4 ( 1.7%) 2 : 8 ( 3.4%) 3 : 3 ( 1.3%) 4 : 10 ( 4.3%) 5 : 24 (10.2%) 6 : 34 (14.5%) 7 : 152 (64.7%)	I II III IIIIIIIIIIIIIIII	235 (6.24%)	3530 (93.76%)
298	testing_PBCgeneral_easy [numeric]	mean (sd) : 5.09 (1.88) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.37)	1 : 8 ( 3.4%) 2 : 19 ( 8.1%) 3 : 28 (11.9%) 4 : 37 (15.7%) 5 : 28 (11.9%) 6 : 27 (11.5%) 7 : 88 (37.5%)	I III IIIII IIIIII IIIII IIII IIIIIIIIIIIIIIII	235 (6.24%)	3530 (93.76%)
299	testing_PBCgeneral_control [numeric]	mean (sd) : 6.03 (1.43) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.24)	1 : 4 ( 1.7%) 2 : 3 ( 1.3%) 3 : 9 ( 3.8%) 4 : 24 (10.2%) 5 : 21 ( 8.9%) 6 : 38 (16.2%) 7 : 136 (57.9%)	I II II IIII IIIIIIIIIIIIIIII	235 (6.24%)	3530 (93.76%)
300	testing_PBCgeneral_externalFactors [numeric]	mean (sd) : 3.51 (2.05) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.58)	1 : 62 (26.4%) 2 : 35 (14.9%) 3 : 17 ( 7.2%) 4 : 30 (12.8%) 5 : 42 (17.9%) 6 : 32 (13.6%) 7 : 17 ( 7.2%)	IIIIIIIIIIIIIIII IIIIIIIII IIII IIIIIII IIIIIIIIII IIIIIIII IIII	235 (6.24%)	3530 (93.76%)
301	testing_PBCgeneral_notOnlyMe [numeric]	mean (sd) : 5.63 (1.59) min < med < max : 1 < 6 < 7 IQR (CV) : 2.5 (0.28)	1 : 5 ( 2.1%) 2 : 5 ( 2.1%) 3 : 18 ( 7.7%) 4 : 31 (13.2%) 5 : 29 (12.3%) 6 : 43 (18.3%) 7 : 104 (44.3%)	II IIII IIII IIIIII IIIIIIIIIIIIIIII	235 (6.24%)	3530 (93.76%)
302	testing_OpenWhy [character]	1. veiligheid 2. Veiligheid 3. - Om zeker te weten wat e 4. - Verantwoorde gebruikers 5. -Weten of er daadwerkelij 6. -zekerheid over de hoevee 7. Aangezien er veel ’foute 8. Allereerst werk ik de tes 9. Als het onbekende pillen 10. Als ik geen zekerheid heb [ 175 others ]	2 ( 1.1%) 2 ( 1.1%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 175 (92.8%)	IIIIIIIIIIIIIIII	187 (4.97%)	3578 (95.03%)
303	testing_OpenWhyNot [character]	1. Geen 2. - Niet op de hoogte van b 3. -dan moet je weer dat hel 4. -Vrienden hebben dezelfde 5. Als de pil online te vind 6. Als het al getest is of a 7. Als het gewoon in de smar 8. Als ie al bekent is op in 9. Als ik XTC pas vlak voor 10. Als je altijd dezelfde pi [ 169 others ]	4 ( 2.2%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 1 ( 0.5%) 169 (93.0%)	IIIIIIIIIIIIIIII	182 (4.83%)	3583 (95.17%)
304	testing_AttBeliefs_dealerKnows [numeric]	mean (sd) : 1.38 (1.5) min < med < max : -3 < 2 < 3 IQR (CV) : 3 (1.09)	-3 : 1 ( 0.5%) -2 : 12 ( 5.5%) -1 : 18 ( 8.2%) 0 : 25 (11.4%) 1 : 39 (17.8%) 2 : 64 (29.2%) 3 : 60 (27.4%)	III IIII IIIIII IIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII	219 (5.82%)	3546 (94.18%)
305	testing_AttBeliefs_testingDose [numeric]	mean (sd) : 1.6 (1.43) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (0.89)	-3 : 4 ( 1.8%) -2 : 6 ( 2.8%) -1 : 11 ( 5.1%) 0 : 16 ( 7.3%) 1 : 49 (22.5%) 2 : 61 (28.0%) 3 : 71 (32.6%)	I II III IIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII	218 (5.79%)	3547 (94.21%)
306	testing_AttBeliefs_testingAdulterants [numeric]	mean (sd) : 1.44 (1.46) min < med < max : -3 < 2 < 3 IQR (CV) : 2 (1.02)	-3 : 2 ( 0.9%) -2 : 4 ( 1.8%) -1 : 25 (11.5%) 0 : 21 ( 9.6%) 1 : 44 (20.2%) 2 : 58 (26.6%) 3 : 64 (29.4%)	I IIIIII IIIII IIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII	218 (5.79%)	3547 (94.21%)
307	testing_AttBeliefs_testingPrice [numeric]	mean (sd) : -2.18 (1.26) min < med < max : -3 < -3 < 2 IQR (CV) : 1 (-0.58)	-3 : 138 (63.6%) -2 : 27 (12.4%) -1 : 14 ( 6.4%) 0 : 30 (13.8%) 1 : 7 ( 3.2%) 2 : 1 ( 0.5%)	IIIIIIIIIIIIIIII III I III	217 (5.76%)	3548 (94.24%)
308	testing_AttBeliefs_helpsToDose [numeric]	mean (sd) : 2.2 (1.04) min < med < max : -1 < 3 < 3 IQR (CV) : 1 (0.47)	-1 : 2 ( 0.9%) 0 : 20 ( 9.2%) 1 : 28 (12.9%) 2 : 50 (23.0%) 3 : 117 (53.9%)	II III IIIIII IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
309	testing_AttBeliefs_losePill [numeric]	mean (sd) : 0.68 (2.04) min < med < max : -3 < 0 < 3 IQR (CV) : 4 (2.99)	-3 : 21 ( 9.7%) -2 : 17 ( 7.8%) -1 : 20 ( 9.2%) 0 : 53 (24.4%) 1 : 18 ( 8.3%) 2 : 17 ( 7.8%) 3 : 71 (32.7%)	IIII III IIII IIIIIIIIIII IIII III IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
310	testing_AttBeliefs_anonimity [numeric]	mean (sd) : 2.21 (1.28) min < med < max : -2 < 3 < 3 IQR (CV) : 1 (0.58)	-2 : 3 ( 1.4%) -1 : 5 ( 2.3%) 0 : 28 (12.9%) 1 : 15 ( 6.9%) 2 : 23 (10.6%) 3 : 143 (65.9%)	III I II IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
311	testing_AttDesirable_knowDose [numeric]	mean (sd) : 2.51 (0.84) min < med < max : 0 < 3 < 3 IQR (CV) : 1 (0.33)	0 : 11 ( 5.1%) 1 : 16 ( 7.4%) 2 : 41 (18.9%) 3 : 149 (68.7%)	I I IIII IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
312	testing_AttDesirable_knowAdulterates [numeric]	mean (sd) : 2.52 (0.92) min < med < max : -1 < 3 < 3 IQR (CV) : 1 (0.37)	-1 : 3 ( 1.4%) 0 : 10 ( 4.6%) 1 : 16 ( 7.4%) 2 : 31 (14.3%) 3 : 157 (72.4%)	I I III IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
313	testing_AttDesirable_costs [numeric]	mean (sd) : -0.24 (1.62) min < med < max : -3 < 0 < 3 IQR (CV) : 1 (-6.65)	-3 : 21 ( 9.7%) -2 : 23 (10.6%) -1 : 44 (20.3%) 0 : 85 (39.2%) 1 : 11 ( 5.1%) 2 : 10 ( 4.6%) 3 : 23 (10.6%)	III IIII IIIIIIII IIIIIIIIIIIIIIII II I IIII	217 (5.76%)	3548 (94.24%)
314	testing_AttDesirable_anonimity [numeric]	mean (sd) : 2.43 (1.01) min < med < max : -3 < 3 < 3 IQR (CV) : 1 (0.42)	-3 : 1 ( 0.5%) -1 : 1 ( 0.5%) 0 : 17 ( 7.8%) 1 : 12 ( 5.5%) 2 : 38 (17.5%) 3 : 148 (68.2%)	I I IIII IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
315	testing_NormBeliefs_partner [numeric]	mean (sd) : 6.53 (0.91) min < med < max : 4 < 7 < 7 IQR (CV) : 0.75 (0.14)	4 : 7 ( 6.9%) 5 : 8 ( 7.8%) 6 : 11 (10.8%) 7 : 76 (74.5%)	I I II IIIIIIIIIIIIIIII	102 (2.71%)	3663 (97.29%)
316	testing_NormBeliefs_bestFriends [numeric]	mean (sd) : 6.34 (1.06) min < med < max : 2 < 7 < 7 IQR (CV) : 1 (0.17)	2 : 2 ( 0.9%) 3 : 1 ( 0.5%) 4 : 18 ( 8.4%) 5 : 16 ( 7.4%) 6 : 41 (19.1%) 7 : 137 (63.7%)	II I IIII IIIIIIIIIIIIIIII	215 (5.71%)	3550 (94.29%)
317	testing_NormBeliefs_xtcFriends [numeric]	mean (sd) : 6.24 (1.13) min < med < max : 2 < 7 < 7 IQR (CV) : 1 (0.18)	2 : 1 ( 0.5%) 3 : 2 ( 1.0%) 4 : 23 (11.5%) 5 : 18 ( 9.0%) 6 : 35 (17.5%) 7 : 121 (60.5%)	III II IIII IIIIIIIIIIIIIIII	200 (5.31%)	3565 (94.69%)
318	testing_NormBeliefs_otherFriends [numeric]	mean (sd) : 6.08 (1.23) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.2)	1 : 1 ( 0.5%) 2 : 1 ( 0.5%) 3 : 1 ( 0.5%) 4 : 33 (15.8%) 5 : 20 ( 9.6%) 6 : 39 (18.7%) 7 : 114 (54.5%)	IIII II IIIII IIIIIIIIIIIIIIII	209 (5.55%)	3556 (94.45%)
319	testing_NormBeliefs_partyPeople [numeric]	mean (sd) : 5.6 (1.33) min < med < max : 2 < 6 < 7 IQR (CV) : 3 (0.24)	2 : 1 ( 0.5%) 3 : 2 ( 0.9%) 4 : 66 (30.6%) 5 : 30 (13.9%) 6 : 32 (14.8%) 7 : 85 (39.4%)	IIIIIIIIIIII IIIII IIIIII IIIIIIIIIIIIIIII	216 (5.74%)	3549 (94.26%)
320	testing_NormBeliefs_parents [numeric]	mean (sd) : 5.78 (1.64) min < med < max : 1 < 7 < 7 IQR (CV) : 3 (0.28)	1 : 8 ( 4.3%) 3 : 1 ( 0.5%) 4 : 47 (25.0%) 5 : 8 ( 4.3%) 6 : 20 (10.6%) 7 : 104 (55.3%)	I IIIIIII I III IIIIIIIIIIIIIIII	188 (4.99%)	3577 (95.01%)
321	testing_NormBeliefs_siblings [numeric]	mean (sd) : 5.84 (1.47) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.25)	1 : 5 ( 2.7%) 4 : 39 (21.3%) 5 : 21 (11.5%) 6 : 23 (12.6%) 7 : 95 (51.9%)	IIIIII III III IIIIIIIIIIIIIIII	183 (4.86%)	3582 (95.14%)
322	testing_NormMTC_partner [numeric]	mean (sd) : 1.07 (2.02) min < med < max : -3 < 2 < 3 IQR (CV) : 3 (1.89)	-3 : 14 (13.9%) -2 : 2 ( 2.0%) 0 : 18 (17.8%) 1 : 11 (10.9%) 2 : 25 (24.8%) 3 : 31 (30.7%)	IIIIIII I IIIIIIIII IIIII IIIIIIIIIIII IIIIIIIIIIIIIIII	101 (2.68%)	3664 (97.32%)
323	testing_NormMTC_bestFriends [numeric]	mean (sd) : 0.4 (2.11) min < med < max : -3 < 1 < 3 IQR (CV) : 3 (5.22)	-3 : 42 (19.7%) -2 : 10 ( 4.7%) -1 : 5 ( 2.4%) 0 : 39 (18.3%) 1 : 35 (16.4%) 2 : 44 (20.7%) 3 : 38 (17.8%)	IIIIIIIIIIIIIII III I IIIIIIIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII	213 (5.66%)	3552 (94.34%)
324	testing_NormMTC_xtcFriends [numeric]	mean (sd) : 0.23 (2.05) min < med < max : -3 < 1 < 3 IQR (CV) : 3.75 (8.83)	-3 : 41 (20.7%) -2 : 9 ( 4.5%) -1 : 4 ( 2.0%) 0 : 42 (21.2%) 1 : 44 (22.2%) 2 : 27 (13.6%) 3 : 31 (15.7%)	IIIIIIIIIIIIII III I IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII IIIIIIIIIII	198 (5.26%)	3567 (94.74%)
325	testing_NormMTC_otherFriends [numeric]	mean (sd) : -0.4 (1.92) min < med < max : -3 < 0 < 3 IQR (CV) : 3 (-4.85)	-3 : 51 (24.6%) -2 : 17 ( 8.2%) -1 : 11 ( 5.3%) 0 : 63 (30.4%) 1 : 32 (15.5%) 2 : 15 ( 7.2%) 3 : 18 ( 8.7%)	IIIIIIIIIIII IIII II IIIIIIIIIIIIIIII IIIIIIII III IIII	207 (5.5%)	3558 (94.5%)
326	testing_NormMTC_partyPeople [numeric]	mean (sd) : -1.26 (1.81) min < med < max : -3 < -2 < 3 IQR (CV) : 3 (-1.44)	-3 : 88 (41.1%) -2 : 22 (10.3%) -1 : 19 ( 8.9%) 0 : 56 (26.2%) 1 : 12 ( 5.6%) 2 : 5 ( 2.3%) 3 : 12 ( 5.6%)	IIIIIIIIIIIIIIII IIII III IIIIIIIIII II II	214 (5.68%)	3551 (94.32%)
327	testing_NormMTC_parents [numeric]	mean (sd) : -0.22 (2.08) min < med < max : -3 < 0 < 3 IQR (CV) : 4 (-9.45)	-3 : 49 (26.3%) -2 : 10 ( 5.4%) -1 : 10 ( 5.4%) 0 : 50 (26.9%) 1 : 21 (11.3%) 2 : 23 (12.4%) 3 : 23 (12.4%)	IIIIIIIIIIIIIII III III IIIIIIIIIIIIIIII IIIIII IIIIIII IIIIIII	186 (4.94%)	3579 (95.06%)
328	testing_NormMTC_siblings [numeric]	mean (sd) : -0.2 (2.05) min < med < max : -3 < 0 < 3 IQR (CV) : 4 (-10.05)	-3 : 47 (26.0%) -2 : 9 ( 5.0%) -1 : 8 ( 4.4%) 0 : 50 (27.6%) 1 : 26 (14.4%) 2 : 19 (10.5%) 3 : 22 (12.2%)	IIIIIIIIIIIIIII II II IIIIIIIIIIIIIIII IIIIIIII IIIIII IIIIIII	181 (4.81%)	3584 (95.19%)
329	testing_DescrNorm_partner [numeric]	mean (sd) : 3.72 (2.54) min < med < max : 1 < 4 < 7 IQR (CV) : 5 (0.68)	1 : 40 (39.6%) 2 : 5 ( 5.0%) 3 : 1 ( 1.0%) 4 : 12 (11.9%) 5 : 7 ( 6.9%) 6 : 12 (11.9%) 7 : 24 (23.8%)	IIIIIIIIIIIIIIII II IIII II IIII IIIIIIIII	101 (2.68%)	3664 (97.32%)
330	testing_DescrNorm_bestFriends [numeric]	mean (sd) : 3.21 (2.07) min < med < max : 1 < 3 < 7 IQR (CV) : 4 (0.64)	1 : 72 (33.8%) 2 : 26 (12.2%) 3 : 20 ( 9.4%) 4 : 29 (13.6%) 5 : 31 (14.5%) 6 : 16 ( 7.5%) 7 : 19 ( 8.9%)	IIIIIIIIIIIIIIII IIIII IIII IIIIII IIIIII III IIII	213 (5.66%)	3552 (94.34%)
331	testing_DescrNorm_xtcFriends [numeric]	mean (sd) : 3.53 (2.01) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.57)	1 : 47 (23.7%) 2 : 30 (15.2%) 3 : 21 (10.6%) 4 : 29 (14.6%) 5 : 31 (15.7%) 6 : 23 (11.6%) 7 : 17 ( 8.6%)	IIIIIIIIIIIIIIII IIIIIIIIII IIIIIII IIIIIIIII IIIIIIIIII IIIIIII IIIII	198 (5.26%)	3567 (94.74%)
332	testing_DescrNorm_otherFriends [numeric]	mean (sd) : 2.77 (1.64) min < med < max : 1 < 3 < 7 IQR (CV) : 3 (0.59)	1 : 70 (33.8%) 2 : 32 (15.5%) 3 : 24 (11.6%) 4 : 52 (25.1%) 5 : 19 ( 9.2%) 6 : 5 ( 2.4%) 7 : 5 ( 2.4%)	IIIIIIIIIIIIIIII IIIIIII IIIII IIIIIIIIIII IIII I I	207 (5.5%)	3558 (94.5%)
333	testing_DescrNorm_partyPeople [numeric]	mean (sd) : 2.95 (1.26) min < med < max : 1 < 3 < 7 IQR (CV) : 2 (0.43)	1 : 31 (14.5%) 2 : 54 (25.2%) 3 : 45 (21.0%) 4 : 67 (31.3%) 5 : 13 ( 6.1%) 6 : 3 ( 1.4%) 7 : 1 ( 0.5%)	IIIIIII IIIIIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII III	214 (5.68%)	3551 (94.32%)
334	testing_DescrNorm_parents [numeric]	mean (sd) : 1.94 (1.49) min < med < max : 1 < 1 < 7 IQR (CV) : 3 (0.77)	1 : 130 (69.9%) 2 : 2 ( 1.1%) 3 : 1 ( 0.5%) 4 : 48 (25.8%) 5 : 1 ( 0.5%) 6 : 2 ( 1.1%) 7 : 2 ( 1.1%)	IIIIIIIIIIIIIIII IIIII	186 (4.94%)	3579 (95.06%)
335	testing_DescrNorm_siblings [numeric]	mean (sd) : 2.46 (1.87) min < med < max : 1 < 1 < 7 IQR (CV) : 3 (0.76)	1 : 100 (55.2%) 2 : 9 ( 5.0%) 3 : 9 ( 5.0%) 4 : 40 (22.1%) 5 : 6 ( 3.3%) 6 : 9 ( 5.0%) 7 : 8 ( 4.4%)	IIIIIIIIIIIIIIII I I IIIIII I I	181 (4.81%)	3584 (95.19%)
336	testing_ContrBeliefs_testCentreLocation [numeric]	mean (sd) : 5.48 (2.23) min < med < max : 1 < 7 < 7 IQR (CV) : 3 (0.41)	1 : 30 (14.0%) 2 : 10 ( 4.7%) 3 : 2 ( 0.9%) 4 : 14 ( 6.5%) 5 : 12 ( 5.6%) 6 : 21 ( 9.8%) 7 : 125 (58.4%)	III I I I II IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
337	testing_ContrBeliefs_locationTransport [numeric]	mean (sd) : 4.98 (2) min < med < max : 1 < 5 < 7 IQR (CV) : 4 (0.4)	1 : 14 ( 6.5%) 2 : 18 ( 8.4%) 3 : 23 (10.8%) 4 : 33 (15.4%) 5 : 21 ( 9.8%) 6 : 26 (12.2%) 7 : 79 (36.9%)	II III IIII IIIIII IIII IIIII IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
338	testing_ContrBeliefs_testProcedure [numeric]	mean (sd) : 4.51 (2.41) min < med < max : 1 < 5 < 7 IQR (CV) : 5 (0.53)	1 : 46 (21.5%) 2 : 19 ( 8.9%) 3 : 11 ( 5.1%) 4 : 17 ( 7.9%) 5 : 18 ( 8.4%) 6 : 31 (14.5%) 7 : 72 (33.6%)	IIIIIIIIII IIII II III IIII IIIIII IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
339	testing_ContrBeliefs_costsTime [numeric]	mean (sd) : 4.54 (1.65) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.36)	1 : 14 ( 6.5%) 2 : 13 ( 6.1%) 3 : 22 (10.3%) 4 : 50 (23.4%) 5 : 52 (24.3%) 6 : 35 (16.4%) 7 : 28 (13.1%)	IIII IIII IIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII IIIIIIII	214 (5.68%)	3551 (94.32%)
340	testing_ContrBeliefs_timelyTesting [numeric]	mean (sd) : 5.47 (1.8) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.33)	1 : 8 ( 3.7%) 2 : 12 ( 5.6%) 3 : 18 ( 8.4%) 4 : 20 ( 9.3%) 5 : 24 (11.2%) 6 : 39 (18.2%) 7 : 93 (43.5%)	I II III III IIII IIIIII IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
341	testing_ContrBeliefs_anonymousTesting [numeric]	mean (sd) : 6.07 (1.34) min < med < max : 1 < 7 < 7 IQR (CV) : 2 (0.22)	1 : 2 ( 0.9%) 2 : 1 ( 0.5%) 3 : 6 ( 2.8%) 4 : 30 (14.0%) 5 : 18 ( 8.4%) 6 : 31 (14.5%) 7 : 126 (58.9%)	III II III IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
342	testing_Trustworthy_testCentre [numeric]	mean (sd) : 6.72 (0.77) min < med < max : 2 < 7 < 7 IQR (CV) : 0 (0.11)	2 : 2 ( 0.9%) 4 : 6 ( 2.8%) 5 : 4 ( 1.9%) 6 : 24 (11.2%) 7 : 178 (83.2%)	II IIIIIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
343	testing_Trustworthy_friendTestCentre [numeric]	mean (sd) : 5.99 (1.06) min < med < max : 2 < 6 < 7 IQR (CV) : 1 (0.18)	2 : 2 ( 0.9%) 3 : 7 ( 3.3%) 4 : 10 ( 4.7%) 5 : 29 (13.6%) 6 : 91 (42.5%) 7 : 75 (35.0%)	I I IIIII IIIIIIIIIIIIIIII IIIIIIIIIIIII	214 (5.68%)	3551 (94.32%)
344	testing_Trustworthy_dealerTestCentre [numeric]	mean (sd) : 3.36 (1.62) min < med < max : 1 < 3 < 7 IQR (CV) : 3 (0.48)	1 : 32 (15.0%) 2 : 38 (17.8%) 3 : 49 (23.0%) 4 : 36 (16.9%) 5 : 38 (17.8%) 6 : 13 ( 6.1%) 7 : 7 ( 3.3%)	IIIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIIIIIIIII IIII II	213 (5.66%)	3552 (94.34%)
345	testing_Trustworthy_friendsExperience [numeric]	mean (sd) : 3.63 (1.72) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.47)	1 : 30 (14.1%) 2 : 36 (17.0%) 3 : 35 (16.5%) 4 : 30 (14.1%) 5 : 47 (22.2%) 6 : 30 (14.1%) 7 : 4 ( 1.9%)	IIIIIIIIII IIIIIIIIIIII IIIIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII I	212 (5.63%)	3553 (94.37%)
346	testing_Trustworthy_pillReports [numeric]	mean (sd) : 4.13 (1.59) min < med < max : 1 < 4.5 < 7 IQR (CV) : 2 (0.39)	1 : 18 ( 8.5%) 2 : 21 ( 9.9%) 3 : 32 (15.1%) 4 : 35 (16.5%) 5 : 61 (28.8%) 6 : 41 (19.3%) 7 : 4 ( 1.9%)	IIII IIIII IIIIIIII IIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIII I	212 (5.63%)	3553 (94.37%)
347	testing_Trustworthy_forum [numeric]	mean (sd) : 3.46 (1.62) min < med < max : 1 < 3.5 < 7 IQR (CV) : 3 (0.47)	1 : 34 (16.0%) 2 : 32 (15.1%) 3 : 40 (18.9%) 4 : 39 (18.4%) 5 : 46 (21.7%) 6 : 18 ( 8.5%) 7 : 3 ( 1.4%)	IIIIIIIIIII IIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIII I	212 (5.63%)	3553 (94.37%)
348	doseControlBeliefs_choice [numeric]	mean (sd) : 4.42 (2.02) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.46)	1 : 34 (10.9%) 2 : 37 (11.8%) 3 : 42 (13.4%) 4 : 29 ( 9.3%) 5 : 61 (19.5%) 6 : 43 (13.7%) 7 : 67 (21.4%)	IIIIIIII IIIIIIII IIIIIIIIII IIIIII IIIIIIIIIIIIII IIIIIIIIII IIIIIIIIIIIIIIII	313 (8.31%)	3452 (91.69%)
349	doseControlBeliefs_identifyDose [numeric]	mean (sd) : 5.08 (1.75) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.34)	1 : 16 ( 5.1%) 2 : 20 ( 6.4%) 3 : 26 ( 8.3%) 4 : 30 ( 9.6%) 5 : 65 (20.8%) 6 : 80 (25.6%) 7 : 76 (24.3%)	III IIII IIIII IIIIII IIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII	313 (8.31%)	3452 (91.69%)
350	doseControlBeliefs_buyOwn [numeric]	mean (sd) : 5.06 (1.99) min < med < max : 1 < 6 < 7 IQR (CV) : 3 (0.39)	1 : 29 ( 9.3%) 2 : 20 ( 6.4%) 3 : 23 ( 7.3%) 4 : 25 ( 8.0%) 5 : 56 (17.9%) 6 : 54 (17.2%) 7 : 106 (33.9%)	IIII III III III IIIIIIII IIIIIIII IIIIIIIIIIIIIIII	313 (8.31%)	3452 (91.69%)
351	doseControlBeliefs_knowDose [numeric]	mean (sd) : 5.08 (1.77) min < med < max : 1 < 5 < 7 IQR (CV) : 2 (0.35)	1 : 19 ( 6.1%) 2 : 20 ( 6.4%) 3 : 23 ( 7.3%) 4 : 22 ( 7.0%) 5 : 73 (23.3%) 6 : 82 (26.2%) 7 : 74 (23.6%)	III III IIII IIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII	313 (8.31%)	3452 (91.69%)
352	doseControlBeliefs_knowIntensity [numeric]	mean (sd) : 4.99 (1.85) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.37)	1 : 21 ( 6.7%) 2 : 20 ( 6.4%) 3 : 34 (10.9%) 4 : 23 ( 7.4%) 5 : 62 (19.9%) 6 : 73 (23.4%) 7 : 79 (25.3%)	IIII IIII IIIIII IIII IIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIIIIII	312 (8.29%)	3453 (91.71%)
353	intensityCause_availSelf [numeric]	mean (sd) : 3.98 (2.17) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.55)	1 : 70 (24.1%) 2 : 26 ( 8.9%) 3 : 17 ( 5.8%) 4 : 33 (11.3%) 5 : 58 (19.9%) 6 : 45 (15.5%) 7 : 42 (14.4%)	IIIIIIIIIIIIIIII IIIII III IIIIIII IIIIIIIIIIIII IIIIIIIIII IIIIIIIII	291 (7.73%)	3474 (92.27%)
354	intensityCause_availOther [numeric]	mean (sd) : 3.2 (1.93) min < med < max : 1 < 3 < 7 IQR (CV) : 4 (0.6)	1 : 91 (31.3%) 2 : 42 (14.4%) 3 : 23 ( 7.9%) 4 : 33 (11.3%) 5 : 65 (22.3%) 6 : 28 ( 9.6%) 7 : 9 ( 3.1%)	IIIIIIIIIIIIIIII IIIIIII IIII IIIII IIIIIIIIIII IIII I	291 (7.73%)	3474 (92.27%)
355	intensityCause_location [numeric]	mean (sd) : 5.08 (1.77) min < med < max : 1 < 5 < 7 IQR (CV) : 1 (0.35)	1 : 28 ( 9.6%) 2 : 8 ( 2.8%) 3 : 14 ( 4.8%) 4 : 16 ( 5.5%) 5 : 82 (28.2%) 6 : 83 (28.5%) 7 : 60 (20.6%)	IIIII I II III IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII	291 (7.73%)	3474 (92.27%)
356	intensityCause_setting [numeric]	mean (sd) : 5.24 (1.89) min < med < max : 1 < 6 < 7 IQR (CV) : 2.5 (0.36)	1 : 31 (10.6%) 2 : 4 ( 1.4%) 3 : 13 ( 4.5%) 4 : 25 ( 8.6%) 5 : 56 (19.2%) 6 : 67 (23.0%) 7 : 95 (32.6%)	IIIII II IIII IIIIIIIII IIIIIIIIIII IIIIIIIIIIIIIIII	291 (7.73%)	3474 (92.27%)
357	intensityCause_set [numeric]	mean (sd) : 5.55 (1.68) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.3)	1 : 16 ( 5.5%) 2 : 8 ( 2.8%) 3 : 11 ( 3.8%) 4 : 23 ( 7.9%) 5 : 47 (16.2%) 6 : 79 (27.2%) 7 : 107 (36.8%)	II I I III IIIIIII IIIIIIIIIII IIIIIIIIIIIIIIII	291 (7.73%)	3474 (92.27%)
358	intensityCause_milligram [numeric]	mean (sd) : 5.97 (1.41) min < med < max : 1 < 6 < 7 IQR (CV) : 1 (0.24)	1 : 9 ( 3.1%) 2 : 3 ( 1.0%) 3 : 10 ( 3.4%) 4 : 10 ( 3.4%) 5 : 38 (13.1%) 6 : 84 (28.9%) 7 : 137 (47.1%)	I I I IIII IIIIIIIII IIIIIIIIIIIIIIII	291 (7.73%)	3474 (92.27%)
359	intensityCause_nextDays [numeric]	mean (sd) : 5.56 (1.81) min < med < max : 1 < 6 < 7 IQR (CV) : 2 (0.33)	1 : 20 ( 6.9%) 2 : 10 ( 3.4%) 3 : 13 ( 4.5%) 4 : 18 ( 6.2%) 5 : 38 (13.1%) 6 : 68 (23.4%) 7 : 124 (42.6%)	II I I II IIII IIIIIIII IIIIIIIIIIIIIIII	291 (7.73%)	3474 (92.27%)
360	weight [character]	1. -oth- 2. noKg	305 (97.4%) 8 ( 2.6%)	IIIIIIIIIIIIIIII	313 (8.31%)	3452 (91.69%)
361	weight_other [numeric]	mean (sd) : 72.8 (13.03) min < med < max : 50 < 70 < 133 IQR (CV) : 16 (0.18)	53 distinct values		305 (8.1%)	3460 (91.9%)
362	myPillDose [numeric]	mean (sd) : 161.97 (57.13) min < med < max : 0 < 180 < 300 IQR (CV) : 60 (0.35)	29 distinct values		313 (8.31%)	3452 (91.69%)
363	xtcDoseStrategy_testService [numeric]	mean (sd) : 0.32 (0.47) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.46)	0 : 212 (68.0%) 1 : 100 (32.0%)	IIIIIIIIIIIIIIII IIIIIII	312 (8.29%)	3453 (91.71%)
364	xtcDoseStrategy_friendTests [numeric]	mean (sd) : 0.32 (0.47) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.45)	0 : 211 (67.6%) 1 : 101 (32.4%)	IIIIIIIIIIIIIIII IIIIIII	312 (8.29%)	3453 (91.71%)
365	xtcDoseStrategy_dealer [numeric]	mean (sd) : 0.36 (0.48) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.34)	0 : 200 (64.1%) 1 : 112 (35.9%)	IIIIIIIIIIIIIIII IIIIIIII	312 (8.29%)	3453 (91.71%)
366	xtcDoseStrategy_friendExperience [numeric]	mean (sd) : 0.42 (0.49) min < med < max : 0 < 0 < 1 IQR (CV) : 1 (1.19)	0 : 182 (58.3%) 1 : 130 (41.7%)	IIIIIIIIIIIIIIII IIIIIIIIIII	312 (8.29%)	3453 (91.71%)
367	xtcDoseStrategy_pillreports [numeric]	mean (sd) : 0.52 (0.5) min < med < max : 0 < 1 < 1 IQR (CV) : 1 (0.97)	0 : 151 (48.4%) 1 : 161 (51.6%)	IIIIIIIIIIIIIII IIIIIIIIIIIIIIII	312 (8.29%)	3453 (91.71%)
368	xtcDoseStrategy_onlineForum [numeric]	mean (sd) : 0.14 (0.35) min < med < max : 0 < 0 < 1 IQR (CV) : 0 (2.44)	0 : 267 (85.6%) 1 : 45 (14.4%)	IIIIIIIIIIIIIIII II	312 (8.29%)	3453 (91.71%)
369	xtcDoseStrategy_noStrategy [numeric]	mean (sd) : 0.07 (0.25) min < med < max : 0 < 0 < 1 IQR (CV) : 0 (3.73)	0 : 291 (93.3%) 1 : 21 ( 6.7%)	IIIIIIIIIIIIIIII I	312 (8.29%)	3453 (91.71%)
370	xtcDoseStrategy_other [character]	1. 200 is tegenwoordig ’stan 2. Betrouwbare dealer vragen 3. De bron kennen 4. de dealer heeft altijd de 5. De dealer vertelt dit 6. De ervaring 7. dealer heeft verteld hoev 8. Dealer vertrouwen haha 9. Dealer weet ongeveer hoev 10. Door de dealer gegevem do [ 18 others ]	1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 1 ( 3.6%) 18 (64.3%)	IIIIIIIIIIIIIIII	28 (0.74%)	3737 (99.26%)
371	highDose_Tolerance_tolerance [numeric]	mean (sd) : 3.63 (1.91) min < med < max : 1 < 4 < 7 IQR (CV) : 3 (0.52)	1 : 68 (21.8%) 2 : 46 (14.7%) 3 : 24 ( 7.7%) 4 : 30 ( 9.6%) 5 : 94 (30.1%) 6 : 38 (12.2%) 7 : 12 ( 3.8%)	IIIIIIIIIII IIIIIII IIII IIIII IIIIIIIIIIIIIIII IIIIII II	312 (8.29%)	3453 (91.71%)
372	testing_PriceWilling_findExpensive [numeric]	mean (sd) : 3.46 (2) min < med < max : 1 < 3 < 7 IQR (CV) : 3 (0.58)	1 : 77 (24.7%) 2 : 48 (15.4%) 3 : 36 (11.5%) 4 : 42 (13.5%) 5 : 45 (14.4%) 6 : 41 (13.1%) 7 : 23 ( 7.4%)	IIIIIIIIIIIIIIII IIIIIIIII IIIIIII IIIIIIII IIIIIIIII IIIIIIII IIII	312 (8.29%)	3453 (91.71%)
373	testing_PriceWilling_wouldTest [numeric]	mean (sd) : 4.99 (1.85) min < med < max : 1 < 5 < 7 IQR (CV) : 3 (0.37)	1 : 16 ( 5.1%) 2 : 26 ( 8.3%) 3 : 28 ( 9.0%) 4 : 38 (12.2%) 5 : 66 (21.1%) 6 : 43 (13.8%) 7 : 95 (30.4%)	II IIII IIII IIIIII IIIIIIIIIII IIIIIII IIIIIIIIIIIIIIII	312 (8.29%)	3453 (91.71%)
374	testing_Travelling [numeric]	mean (sd) : 14.31 (15.05) min < med < max : 1 < 10 < 125 IQR (CV) : 15 (1.05)	20 distinct values		312 (8.29%)	3453 (91.71%)
375	gender [factor]	1. Decline to answer 2. Male 3. Female 4. Other (e.g. genderqueer,	0 ( 0.0%) 245 (61.4%) 152 (38.1%) 2 ( 0.5%)	IIIIIIIIIIIIIIII IIIIIIIII	399 (10.6%)	3366 (89.4%)
376	age [numeric]	mean (sd) : 24.8 (6.92) min < med < max : 7 < 23 < 60 IQR (CV) : 8 (0.28)	35 distinct values		396 (10.52%)	3369 (89.48%)
377	hasJob [factor]	1. Ik wil deze vraag niet be 2. Ja, ik heb een baan, bijb 3. Nee, ik heb geen baan, bi	17 ( 4.2%) 302 (75.5%) 81 (20.2%)	IIIIIIIIIIIIIIII IIII	400 (10.62%)	3365 (89.38%)
378	jobHours [numeric]	mean (sd) : 27.15 (15.5) min < med < max : 0 < 30 < 99 IQR (CV) : 28 (0.57)	36 distinct values		302 (8.02%)	3463 (91.98%)
379	currentEducation [factor]	1. Ik wil deze vraag niet be 2. Nee, ik volg op dit momen 3. Ja, ik doe VMBO (vroeger 4. Ja, ik doe HAVO 5. Ja, ik doe VWO 6. Ja, ik doe MBO (ROC) 7. Ja, ik doe HBO (hogeschoo 8. Ja, ik doe WO (universite	7 ( 1.8%) 166 (41.5%) 2 ( 0.5%) 6 ( 1.5%) 8 ( 2.0%) 26 ( 6.5%) 102 (25.5%) 83 (20.8%)	IIIIIIIIIIIIIIII II IIIIIIIII IIIIIIII	400 (10.62%)	3365 (89.38%)
380	prevEducation [factor]	1. Ik wil deze vraag niet be 2. Basisschool 3. VMBO (vroeger MAVO) 4. HAVO 5. VWO 6. MBO (ROC) 7. HBO (hogeschool) 8. WO (universiteit)	6 ( 3.5%) 0 ( 0.0%) 4 ( 2.3%) 9 ( 5.2%) 8 ( 4.6%) 30 (17.3%) 59 (34.1%) 57 (33.0%)	I I II II IIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIII	173 (4.59%)	3592 (95.41%)
381	country [factor]	1. Wil ik niet zeggen 2. Nederland 3. Belgie	1 ( 0.2%) 387 (97.2%) 10 ( 2.5%)	IIIIIIIIIIIIIIII	398 (10.57%)	3367 (89.43%)
382	country_other [character]	1. Duitsland 2. Zweden	1 (50.0%) 1 (50.0%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIIII	2 (0.05%)	3763 (99.95%)
383	postcode [numeric]	mean (sd) : 40.26 (29.05) min < med < max : 0 < 35 < 99 IQR (CV) : 50.75 (0.72)	80 distinct values		382 (10.15%)	3383 (89.85%)
384	partyPanelCode [character]	1. 1062KG 2. 109410 3. 19fe08 4. 22SN03 5. 251077 6. 26ac85 7. 300555 8. 79HX41 9. AB02AB 10. af19ca [ 213 others ]	1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 1 ( 0.4%) 213 (95.8%)	IIIIIIIIIIIIIIII	223 (5.92%)	3542 (94.08%)
385	suggestions [character]	1. nee 2. “Het is voor mij makkelij 3. :) 4. Aantal vragen dubbelop vo 5. Algemeen bekijken wat er 6. Alles wat ik tegen kom ov 7. Als iets gratis is zullen 8. De lijst ging niet helema 9. De vraag of een trip vers 10. De vraag: Waarom gebruik [ 51 others ]	1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 1 ( 1.6%) 51 (83.6%)	IIIIIIIIIIIIIIII	61 (1.62%)	3704 (98.38%)
386	testEntry_test [numeric]	mean (sd) : 0 (0) min < med < max : 0 < 0 < 0 IQR (CV) : 0 (NaN)	0 : 382 (100.0%)	IIIIIIIIIIIIIIII	382 (10.15%)	3383 (89.85%)
387	Totaaltijd [numeric]	mean (sd) : 560.84 (4134.82) min < med < max : 0 < 6.78 < 181786 IQR (CV) : 97.23 (7.37)	1844 distinct values		3765 (100%)	0 (0%)
388	Groep.tijd..intro [numeric]	mean (sd) : 83.74 (619.34) min < med < max : 2.2 < 27.55 < 21128.4 IQR (CV) : 29.34 (7.4)	1674 distinct values		1937 (51.45%)	1828 (48.55%)
389	Groep.tijd..noConsent [numeric]	mean (sd) : 8.75 (5.28) min < med < max : 2.98 < 7.54 < 24.47 IQR (CV) : 4.41 (0.6)	20 distinct values		20 (0.53%)	3745 (99.47%)
390	Groep.tijd..partyhabits [numeric]	mean (sd) : 376.13 (904.86) min < med < max : 4.86 < 252 < 18056.2 IQR (CV) : 175.19 (2.41)	921 distinct values		929 (24.67%)	2836 (75.33%)
391	Groep.tijd..substanceUse [numeric]	mean (sd) : 489.96 (1832.7) min < med < max : 3.24 < 299.36 < 43009.3 IQR (CV) : 186.63 (3.74)	756 distinct values		761 (20.21%)	3004 (79.79%)
392	Groep.tijd..strngXTC_general [numeric]	mean (sd) : 409.62 (1670.84) min < med < max : 7.43 < 234.32 < 32290.8 IQR (CV) : 197.34 (4.08)	389 distinct values		390 (10.36%)	3375 (89.64%)
393	Groep.tijd..strngXTC_specific [numeric]	mean (sd) : 893.68 (4380.62) min < med < max : 5.86 < 377.98 < 62145.1 IQR (CV) : 248.06 (4.9)	340 distinct values		340 (9.03%)	3425 (90.97%)
394	Groep.tijd..highDose_general [numeric]	mean (sd) : 244.43 (394.54) min < med < max : 3.97 < 176.07 < 5460.89 IQR (CV) : 152.79 (1.61)	332 distinct values		333 (8.84%)	3432 (91.16%)
395	Groep.tijd..highDose_specific [numeric]	mean (sd) : 463.02 (1509.76) min < med < max : 5.18 < 268.44 < 19672.2 IQR (CV) : 204.21 (3.26)	253 distinct values		255 (6.77%)	3510 (93.23%)
396	Groep.tijd..testing_general [numeric]	mean (sd) : 554.33 (5336.91) min < med < max : 4.16 < 146.22 < 82739.2 IQR (CV) : 114.09 (9.63)	240 distinct values		240 (6.37%)	3525 (93.63%)
397	Groep.tijd..testing_specific [numeric]	mean (sd) : 1092.95 (11994.75) min < med < max : 7.02 < 192.12 < 179646 IQR (CV) : 107.39 (10.97)	224 distinct values		224 (5.95%)	3541 (94.05%)
398	Groep.tijd..finalQuestions [numeric]	mean (sd) : 175.69 (170.75) min < med < max : 4.14 < 137.06 < 2045.36 IQR (CV) : 82.14 (0.97)	313 distinct values		316 (8.39%)	3449 (91.61%)
399	Groep.tijd..demographics [numeric]	mean (sd) : 47.59 (59.18) min < med < max : 15.34 < 39.32 < 1061.93 IQR (CV) : 19.35 (1.24)	386 distinct values		400 (10.62%)	3365 (89.38%)
400	Groep.tijd..partyPanelCode [numeric]	mean (sd) : 281.53 (3520.38) min < med < max : 6.74 < 73.22 < 68866.8 IQR (CV) : 73.29 (12.5)	379 distinct values		382 (10.15%)	3383 (89.85%)
401	Groep.tijd..ending [numeric]	mean (sd) : 10.33 (10.04) min < med < max : 2.23 < 7.76 < 86.64 IQR (CV) : 7.62 (0.97)	327 distinct values		372 (9.88%)	3393 (90.12%)
402	goingOutFreqPeriod_houseparty_preConversion [character]	1. 1 2. 2 3. 3 4. 4 5. 0 6. 10 7. 5 8. 6 9. 8 10. 15 [ 11 others ]	300 (34.2%) 219 (24.9%) 115 (13.1%) 57 ( 6.5%) 41 ( 4.7%) 36 ( 4.1%) 36 ( 4.1%) 30 ( 3.4%) 10 ( 1.1%) 8 ( 0.9%) 26 ( 2.9%)	IIIIIIIIIIIIIIII IIIIIIIIIII IIIIII III II I I I I	878 (23.32%)	2887 (76.68%)
403	goingOutFreqPeriod_cafe_preConversion [character]	1. 1 2. 2 3. 3 4. 0 5. 4 6. 5 7. 6 8. 10 9. 12 10. 20 [ 15 others ]	311 (35.9%) 201 (23.2%) 94 (10.8%) 85 ( 9.8%) 43 ( 5.0%) 31 ( 3.6%) 20 ( 2.3%) 19 ( 2.2%) 12 ( 1.4%) 10 ( 1.1%) 41 ( 4.8%)	IIIIIIIIIIIIIIII IIIIIIIIII IIII IIII II I I II	867 (23.03%)	2898 (76.97%)
404	goingOutFreqPeriod_band_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 10 8. 6 9. 8 10. 00 [ 8 others ]	463 (53.5%) 198 (22.9%) 109 (12.6%) 50 ( 5.8%) 15 ( 1.7%) 10 ( 1.2%) 4 ( 0.5%) 4 ( 0.5%) 3 ( 0.4%) 1 ( 0.1%) 8 ( 1.0%)	IIIIIIIIIIIIIIII IIIIII III I	865 (22.97%)	2900 (77.03%)
405	goingOutFreqPeriod_smallPartyInside_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 10 9. 8 10. 15 [ 8 others ]	260 (30.3%) 253 (29.5%) 168 (19.6%) 69 ( 8.0%) 43 ( 5.0%) 29 ( 3.4%) 14 ( 1.6%) 5 ( 0.6%) 4 ( 0.5%) 3 ( 0.4%) 10 ( 1.2%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIIII IIIIIIIIII IIII II I	858 (22.79%)	2907 (77.21%)
406	goingOutFreqPeriod_bigPartyInside_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 10 8. 6 9. 0 10. 0,5 [ 5 others ]	376 (43.8%) 246 (28.7%) 130 (15.2%) 52 ( 6.1%) 24 ( 2.8%) 15 ( 1.8%) 5 ( 0.6%) 3 ( 0.4%) 1 ( 0.1%) 1 ( 0.1%) 5 ( 0.6%)	IIIIIIIIIIIIIIII IIIIIIIIII IIIII II I	858 (22.79%)	2907 (77.21%)
407	substUsePastBehPeriod_alc_preConversion [character]	1. 2 2. 1 3. 3 4. 4 5. 5 6. 6 7. 0 8. 10 9. 20 10. 7 [ 15 others ]	239 (31.9%) 141 (18.9%) 140 (18.7%) 67 ( 9.0%) 52 ( 7.0%) 31 ( 4.1%) 27 ( 3.6%) 13 ( 1.7%) 10 ( 1.3%) 8 ( 1.1%) 20 ( 2.6%)	IIIIIIIIIIIIIIII IIIIIIIII IIIIIIIII IIII III II I I	748 (19.87%)	3017 (80.13%)
408	substUsePastBehPeriod_tbc_preConversion [character]	1. 0 2. 7 3. 1 4. 2 5. 3 6. 5 7. 4 8. 10 9. 6 10. 30 [ 34 others ]	242 (32.4%) 157 (21.1%) 79 (10.6%) 62 ( 8.3%) 43 ( 5.8%) 32 ( 4.3%) 26 ( 3.5%) 14 ( 1.9%) 10 ( 1.3%) 8 ( 1.1%) 73 ( 9.7%)	IIIIIIIIIIIIIIII IIIIIIIIII IIIII IIII II II I IIII	746 (19.81%)	3019 (80.19%)
409	substUsePastBehPeriod_cnb_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 7 8. 6 9. 10 10. 8 [ 10 others ]	238 (31.9%) 166 (22.3%) 121 (16.2%) 60 ( 8.1%) 47 ( 6.3%) 39 ( 5.2%) 29 ( 3.9%) 14 ( 1.9%) 9 ( 1.2%) 6 ( 0.8%) 16 ( 2.1%)	IIIIIIIIIIIIIIII IIIIIIIIIII IIIIIIII IIII III II I I	745 (19.79%)	3020 (80.21%)
410	substUsePastBehPeriod_xtc_preConversion [character]	1. 1 2. 0 3. 2 4. 3 5. 4 6. 5 7. 6 8. 7 9. 8 10. 10 [ 9 others ]	192 (25.8%) 169 (22.7%) 159 (21.4%) 106 (14.2%) 42 ( 5.6%) 22 ( 3.0%) 18 ( 2.4%) 7 ( 0.9%) 7 ( 0.9%) 6 ( 0.8%) 16 ( 2.1%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIII IIIIIIIIIIIII IIIIIIII III I I I	744 (19.76%)	3021 (80.24%)
411	substUsePastBehPeriod_mdma_preConversion [character]	1. 1 2. 0 3. 1 4. 10 5. 2 6. 3 7. 4 8. 5 9. 7 10. 8 11. Rr	1 ( 0.1%) 463 (62.2%) 147 (19.7%) 1 ( 0.1%) 82 (11.0%) 26 ( 3.5%) 13 ( 1.7%) 7 ( 0.9%) 2 ( 0.3%) 2 ( 0.3%) 1 ( 0.1%)	IIIIIIIIIIIIIIII IIIII II	745 (19.79%)	3020 (80.21%)
412	substUsePastBehPeriod_fourfa_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 8 9. 7 10. - [ 2 others ]	439 (59.0%) 155 (20.8%) 77 (10.3%) 32 ( 4.3%) 14 ( 1.9%) 11 ( 1.5%) 8 ( 1.1%) 3 ( 0.4%) 2 ( 0.3%) 1 ( 0.1%) 2 ( 0.3%)	IIIIIIIIIIIIIIII IIIII II I	744 (19.76%)	3021 (80.24%)
413	substUsePastBehPeriod_coke_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 8 8. 6 9. 10 10. 7 [ 5 others ]	487 (65.5%) 102 (13.7%) 64 ( 8.6%) 24 ( 3.2%) 21 ( 2.8%) 12 ( 1.6%) 9 ( 1.2%) 8 ( 1.1%) 4 ( 0.5%) 4 ( 0.5%) 8 ( 1.1%)	IIIIIIIIIIIIIIII III II	743 (19.73%)	3022 (80.27%)
414	substUsePastBehPeriod_spd_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 8 9. 10 10. 15 [ 7 others ]	434 (58.4%) 101 (13.6%) 66 ( 8.9%) 51 ( 6.9%) 27 ( 3.6%) 19 ( 2.6%) 14 ( 1.9%) 8 ( 1.1%) 6 ( 0.8%) 4 ( 0.5%) 13 ( 1.7%)	IIIIIIIIIIIIIIII III II I	743 (19.73%)	3022 (80.27%)
415	substUsePastBehPeriod_gas_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 10 8. 6 9. 20 10. 8 [ 10 others ]	379 (51.0%) 145 (19.5%) 80 (10.8%) 55 ( 7.4%) 26 ( 3.5%) 18 ( 2.4%) 11 ( 1.5%) 7 ( 0.9%) 4 ( 0.5%) 4 ( 0.5%) 14 ( 1.8%)	IIIIIIIIIIIIIIII IIIIII III II I	743 (19.73%)	3022 (80.27%)
416	substUsePastBehPeriod_ghb_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 8 9. - 10. 00 [ 5 others ]	642 (86.4%) 46 ( 6.2%) 19 ( 2.6%) 11 ( 1.5%) 7 ( 0.9%) 4 ( 0.5%) 4 ( 0.5%) 3 ( 0.4%) 1 ( 0.1%) 1 ( 0.1%) 5 ( 0.6%)	IIIIIIIIIIIIIIII I	743 (19.73%)	3022 (80.27%)
417	substUsePastBehPeriod_ket_preConversion [character]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 10 8. 6 9. 8 10. 25 [ 2 others ]	557 (75.0%) 77 (10.4%) 46 ( 6.2%) 23 ( 3.1%) 15 ( 2.0%) 14 ( 1.9%) 3 ( 0.4%) 3 ( 0.4%) 2 ( 0.3%) 1 ( 0.1%) 2 ( 0.3%)	IIIIIIIIIIIIIIII II I	743 (19.73%)	3022 (80.27%)
418	otherSubstancesFreqPeriod_otherSubstance1_preConversion [character]	1. 1 2. 2 3. 3 4. 5 5. 4 6. 6 7. 8 8. 0 9. 10 10. 12 [ 5 others ]	124 (44.9%) 74 (26.8%) 42 (15.2%) 12 ( 4.3%) 8 ( 2.9%) 3 ( 1.1%) 3 ( 1.1%) 2 ( 0.7%) 2 ( 0.7%) 1 ( 0.4%) 5 ( 1.8%)	IIIIIIIIIIIIIIII IIIIIIIII IIIII I I	276 (7.33%)	3489 (92.67%)
419	otherSubstancesFreqPeriod_otherSubstance2_preConversion [character]	1. 1 2. 10 3. 2 4. 3 5. 30 6. 4 7. 5 8. 7 9. 8 10. Ee	73 (52.5%) 3 ( 2.2%) 33 (23.7%) 16 (11.5%) 1 ( 0.7%) 6 ( 4.3%) 4 ( 2.9%) 1 ( 0.7%) 1 ( 0.7%) 1 ( 0.7%)	IIIIIIIIIIIIIIII IIIIIII III I	139 (3.69%)	3626 (96.31%)
420	otherSubstancesFreqPeriod_otherSubstance4_preConversion [character]	1. 0 2. 1 3. 10 4. 2 5. 4 6. 5 7. 50 8. Www	1 ( 2.8%) 21 (58.3%) 1 ( 2.8%) 9 (25.0%) 1 ( 2.8%) 1 ( 2.8%) 1 ( 2.8%) 1 ( 2.8%)	IIIIIIIIIIIIIIII IIIIII	36 (0.96%)	3729 (99.04%)
421	education [ordered, factor]	1. Low (primary or VMBO) 2. Mid (MBO, HAVO, VWO) 3. High (HBO) 4. Highest (WO)	4 ( 1.0%) 67 (17.0%) 167 (42.4%) 156 (39.6%)	IIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIII	394 (10.46%)	3371 (89.54%)
422	startweekday [factor]	1. Monday 2. Tuesday 3. Wednesday 4. Thursday 5. Friday 6. Saturday 7. Sunday	661 (17.6%) 581 (15.4%) 465 (12.3%) 431 (11.5%) 823 (21.9%) 332 ( 8.8%) 472 (12.5%)	IIIIIIIIIIII IIIIIIIIIII IIIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIII IIIIIIIII	3765 (100%)	0 (0%)
423	submitweekday [factor]	1. Monday 2. Tuesday 3. Wednesday 4. Thursday 5. Friday 6. Saturday 7. Sunday	69 (18.4%) 86 (23.0%) 48 (12.8%) 39 (10.4%) 67 (17.9%) 30 ( 8.0%) 35 ( 9.4%)	IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIII IIIIIII IIIIIIIIIIII IIIII IIIIII	374 (9.93%)	3391 (90.07%)
424	starthour [factor]	1. 0 2. 1 3. 2 4. 3 5. 4 6. 5 7. 6 8. 7 9. 8 10. 9 [ 14 others ]	61 ( 1.6%) 66 ( 1.8%) 54 ( 1.4%) 51 ( 1.4%) 35 ( 0.9%) 59 ( 1.6%) 77 ( 2.0%) 102 ( 2.7%) 152 ( 4.0%) 218 ( 5.8%) 2890 (76.8%)	I IIIIIIIIIIIIIIII	3765 (100%)	0 (0%)
425	submithour [factor]	1. 0 2. 1 3. 2 4. 4 5. 6 6. 7 7. 8 8. 9 9. 10 10. 11 [ 12 others ]	5 ( 1.3%) 2 ( 0.5%) 1 ( 0.3%) 1 ( 0.3%) 4 ( 1.1%) 1 ( 0.3%) 15 ( 4.0%) 19 ( 5.1%) 31 ( 8.3%) 32 ( 8.6%) 263 (70.3%)	I I I IIIIIIIIIIIIIIII	374 (9.93%)	3391 (90.07%)
426	startday [numeric]	mean (sd) : 3.93 (1.94) min < med < max : 1 < 4 < 7 IQR (CV) : 4 (0.49)	1 : 472 (12.5%) 2 : 661 (17.6%) 3 : 581 (15.4%) 4 : 465 (12.3%) 5 : 431 (11.5%) 6 : 823 (21.9%) 7 : 332 ( 8.8%)	IIIIIIIII IIIIIIIIIIII IIIIIIIIIII IIIIIIIII IIIIIIII IIIIIIIIIIIIIIII IIIIII	3765 (100%)	0 (0%)
427	submitday [numeric]	mean (sd) : 3.82 (1.83) min < med < max : 1 < 3 < 7 IQR (CV) : 4 (0.48)	1 : 35 ( 9.4%) 2 : 69 (18.4%) 3 : 86 (23.0%) 4 : 48 (12.8%) 5 : 39 (10.4%) 6 : 67 (17.9%) 7 : 30 ( 8.0%)	IIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIII IIIIIII IIIIIIIIIIII IIIII	374 (9.93%)	3391 (90.07%)
428	goingOutFreq_houseparty [numeric]	mean (sd) : 11.87 (13.16) min < med < max : 0 < 6 < 130 IQR (CV) : 11 (1.11)	28 distinct values		868 (23.05%)	2897 (76.95%)
429	goingOutFreq_cafe [numeric]	mean (sd) : 17.27 (19.24) min < med < max : 0 < 12 < 130 IQR (CV) : 22 (1.11)	32 distinct values		859 (22.82%)	2906 (77.18%)
430	goingOutFreq_disco [numeric]	mean (sd) : 7.6 (10.32) min < med < max : 0 < 5 < 104 IQR (CV) : 9.25 (1.36)	26 distinct values		860 (22.84%)	2905 (77.16%)
431	goingOutFreq_band [numeric]	mean (sd) : 1.67 (3.8) min < med < max : 0 < 0 < 52 IQR (CV) : 2 (2.28)	19 distinct values		858 (22.79%)	2907 (77.21%)
432	goingOutFreq_smallPartyInside [numeric]	mean (sd) : 2.63 (4.24) min < med < max : 0 < 1 < 52 IQR (CV) : 3 (1.61)	19 distinct values		852 (22.63%)	2913 (77.37%)
433	goingOutFreq_bigPartyInside [numeric]	mean (sd) : 1.42 (2.27) min < med < max : 0 < 1 < 24 IQR (CV) : 2 (1.6)	15 distinct values		850 (22.58%)	2915 (77.42%)
434	goingOutFreq_smallPartyOutside [numeric]	mean (sd) : 2.03 (4.94) min < med < max : 0 < 1 < 104 IQR (CV) : 2 (2.44)	18 distinct values		847 (22.5%)	2918 (77.5%)
435	goingOutFreq_bigPartyOutside [numeric]	mean (sd) : 3.33 (7.45) min < med < max : 0 < 2 < 130 IQR (CV) : 3 (2.24)	19 distinct values		852 (22.63%)	2913 (77.37%)
436	goingOutFreq_cat_houseparty [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	40 ( 4.6%) 99 (11.4%) 109 (12.6%) 225 (25.9%) 235 (27.1%) 124 (14.3%) 30 ( 3.5%) 6 ( 0.7%)	II IIIIII IIIIIII IIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIII II	868 (23.05%)	2897 (76.95%)
437	goingOutFreq_cat_cafe [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	85 ( 9.9%) 96 (11.2%) 45 ( 5.2%) 152 (17.7%) 192 (22.3%) 192 (22.3%) 73 ( 8.5%) 25 ( 2.9%)	IIIIIII IIIIIIII III IIIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIIIIIIIIII IIIIII II	860 (22.84%)	2905 (77.16%)
438	goingOutFreq_cat_disco [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	180 (20.9%) 155 (18.0%) 93 (10.8%) 194 (22.6%) 138 (16.1%) 84 ( 9.8%) 15 ( 1.7%) 1 ( 0.1%)	IIIIIIIIIIIIII IIIIIIIIIIII IIIIIII IIIIIIIIIIIIIIII IIIIIIIIIII IIIIII I	860 (22.84%)	2905 (77.16%)
439	goingOutFreq_cat_band [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	463 (54.0%) 236 (27.5%) 63 ( 7.3%) 64 ( 7.5%) 25 ( 2.9%) 6 ( 0.7%) 1 ( 0.1%) 0 ( 0.0%)	IIIIIIIIIIIIIIII IIIIIIII II II	858 (22.79%)	2907 (77.21%)
440	goingOutFreq_cat_smallPartyInside [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	260 (30.5%) 331 (38.9%) 103 (12.1%) 105 (12.3%) 44 ( 5.2%) 8 ( 0.9%) 1 ( 0.1%) 0 ( 0.0%)	IIIIIIIIIIII IIIIIIIIIIIIIIII IIII IIIII II	852 (22.63%)	2913 (77.37%)
441	goingOutFreq_cat_bigPartyInside [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	375 (44.2%) 330 (38.9%) 74 ( 8.7%) 53 ( 6.2%) 16 ( 1.9%) 1 ( 0.1%) 0 ( 0.0%) 0 ( 0.0%)	IIIIIIIIIIIIIIII IIIIIIIIIIIIII III II	849 (22.55%)	2916 (77.45%)
442	goingOutFreq_cat_smallPartyOutside [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	311 (36.7%) 354 (41.8%) 87 (10.3%) 66 ( 7.8%) 24 ( 2.8%) 3 ( 0.4%) 1 ( 0.1%) 2 ( 0.2%)	IIIIIIIIIIIIII IIIIIIIIIIIIIIII III II I	848 (22.52%)	2917 (77.48%)
443	goingOutFreq_cat_bigPartyOutside [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	139 (16.3%) 358 (42.0%) 169 (19.8%) 133 (15.6%) 47 ( 5.5%) 3 ( 0.4%) 0 ( 0.0%) 3 ( 0.4%)	IIIIII IIIIIIIIIIIIIIII IIIIIII IIIII II	852 (22.63%)	2913 (77.37%)
444	substUsePastBeh_alc [numeric]	mean (sd) : 54.18 (40.66) min < med < max : 0 < 52 < 182 IQR (CV) : 52 (0.75)	33 distinct values		741 (19.68%)	3024 (80.32%)
445	substUsePastBeh_tbc [numeric]	mean (sd) : 59.74 (75.64) min < med < max : 0 < 10 < 186 IQR (CV) : 130 (1.27)	27 distinct values		671 (17.82%)	3094 (82.18%)
446	substUsePastBeh_cnb [numeric]	mean (sd) : 23.9 (47.02) min < med < max : 0 < 3 < 182 IQR (CV) : 15 (1.97)	25 distinct values		737 (19.58%)	3028 (80.42%)
447	substUsePastBeh_xtc [numeric]	mean (sd) : 3.59 (5.03) min < med < max : 0 < 2 < 60 IQR (CV) : 4 (1.4)	22 distinct values		742 (19.71%)	3023 (80.29%)
448	substUsePastBeh_mdma [numeric]	mean (sd) : 1.15 (2.54) min < med < max : 0 < 0 < 26 IQR (CV) : 1 (2.2)	13 distinct values		744 (19.76%)	3021 (80.24%)
449	substUsePastBeh_fourfa [numeric]	mean (sd) : 1.29 (2.58) min < med < max : 0 < 0 < 24 IQR (CV) : 1 (2)	13 distinct values		741 (19.68%)	3024 (80.32%)
450	substUsePastBeh_coke [numeric]	mean (sd) : 2.28 (7.11) min < med < max : 0 < 0 < 104 IQR (CV) : 1 (3.12)	18 distinct values		739 (19.63%)	3026 (80.37%)
451	substUsePastBeh_spd [numeric]	mean (sd) : 3.98 (14.11) min < med < max : 0 < 0 < 182 IQR (CV) : 3 (3.55)	27 distinct values		740 (19.65%)	3025 (80.35%)
452	substUsePastBeh_gas [numeric]	mean (sd) : 2.78 (8.23) min < med < max : 0 < 0 < 120 IQR (CV) : 2 (2.95)	27 distinct values		741 (19.68%)	3024 (80.32%)
453	substUsePastBeh_ghb [numeric]	mean (sd) : 0.88 (4.58) min < med < max : 0 < 0 < 78 IQR (CV) : 0 (5.22)	17 distinct values		740 (19.65%)	3025 (80.35%)
454	substUsePastBeh_ket [numeric]	mean (sd) : 1.13 (4.58) min < med < max : 0 < 0 < 78 IQR (CV) : 0 (4.06)	16 distinct values		742 (19.71%)	3023 (80.29%)
455	substUsePastBeh_cat_alc [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	27 ( 3.6%) 15 ( 2.0%) 5 ( 0.7%) 27 ( 3.6%) 87 (11.7%) 145 (19.5%) 196 (26.3%) 242 (32.5%)	I I IIIII IIIIIIIII IIIIIIIIIIII IIIIIIIIIIIIIIII	744 (19.76%)	3021 (80.24%)
456	substUsePastBeh_cat_tbc [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	242 (32.8%) 27 ( 3.7%) 17 ( 2.3%) 41 ( 5.6%) 38 ( 5.1%) 42 ( 5.7%) 37 ( 5.0%) 294 (39.8%)	IIIIIIIIIIIII I II II II II IIIIIIIIIIIIIIII	738 (19.6%)	3027 (80.4%)
457	substUsePastBeh_cat_cnb [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	238 (32.1%) 124 (16.7%) 53 ( 7.1%) 77 (10.4%) 77 (10.4%) 41 ( 5.5%) 27 ( 3.6%) 105 (14.1%)	IIIIIIIIIIIIIIII IIIIIIII III IIIII IIIII II I IIIIIII	742 (19.71%)	3023 (80.29%)
458	substUsePastBeh_cat_xtc [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	169 (22.8%) 238 (32.1%) 138 (18.6%) 120 (16.2%) 70 ( 9.4%) 5 ( 0.7%) 2 ( 0.3%) 0 ( 0.0%)	IIIIIIIIIII IIIIIIIIIIIIIIII IIIIIIIII IIIIIIII IIII	742 (19.71%)	3023 (80.29%)
459	substUsePastBeh_cat_mdma [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	463 (62.2%) 187 (25.1%) 36 ( 4.8%) 39 ( 5.2%) 18 ( 2.4%) 1 ( 0.1%) 0 ( 0.0%) 0 ( 0.0%)	IIIIIIIIIIIIIIII IIIIII I I	744 (19.76%)	3021 (80.24%)
460	substUsePastBeh_cat_fourfa [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	439 (59.2%) 186 (25.1%) 43 ( 5.8%) 52 ( 7.0%) 20 ( 2.7%) 1 ( 0.1%) 0 ( 0.0%) 0 ( 0.0%)	IIIIIIIIIIIIIIII IIIIII I I	741 (19.68%)	3024 (80.32%)
461	substUsePastBeh_cat_coke [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	487 (65.9%) 112 (15.2%) 37 ( 5.0%) 46 ( 6.2%) 40 ( 5.4%) 10 ( 1.4%) 6 ( 0.8%) 1 ( 0.1%)	IIIIIIIIIIIIIIII III I I I	739 (19.63%)	3026 (80.37%)
462	substUsePastBeh_cat_spd [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	434 (58.7%) 110 (14.9%) 59 ( 8.0%) 53 ( 7.2%) 58 ( 7.8%) 13 ( 1.8%) 5 ( 0.7%) 8 ( 1.1%)	IIIIIIIIIIIIIIII IIII II I II	740 (19.65%)	3025 (80.35%)
463	substUsePastBeh_cat_gas [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	380 (51.3%) 179 (24.2%) 71 ( 9.6%) 55 ( 7.4%) 36 ( 4.9%) 13 ( 1.8%) 5 ( 0.7%) 2 ( 0.3%)	IIIIIIIIIIIIIIII IIIIIII II II I	741 (19.68%)	3024 (80.32%)
464	substUsePastBeh_cat_ghb [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	643 (86.9%) 48 ( 6.5%) 13 ( 1.8%) 13 ( 1.8%) 15 ( 2.0%) 6 ( 0.8%) 1 ( 0.1%) 1 ( 0.1%)	IIIIIIIIIIIIIIII I	740 (19.65%)	3025 (80.35%)
465	substUsePastBeh_cat_ket [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	557 (75.1%) 98 (13.2%) 36 ( 4.8%) 30 ( 4.0%) 16 ( 2.2%) 2 ( 0.3%) 2 ( 0.3%) 1 ( 0.1%)	IIIIIIIIIIIIIIII II I	742 (19.71%)	3023 (80.29%)
466	otherSubstancesFreq_otherSubstance1 [numeric]	mean (sd) : 4.48 (12.45) min < med < max : 0 < 2 < 156 IQR (CV) : 2 (2.78)	20 distinct values		272 (7.22%)	3493 (92.78%)
467	otherSubstancesFreq_otherSubstance2 [numeric]	mean (sd) : 4.1 (9.03) min < med < max : 1 < 1 < 52 IQR (CV) : 2 (2.2)	13 distinct values		138 (3.67%)	3627 (96.33%)
468	otherSubstancesFreq_otherSubstance3 [numeric]	mean (sd) : 8.05 (25.39) min < med < max : 0 < 2 < 182 IQR (CV) : 2 (3.15)	13 distinct values		76 (2.02%)	3689 (97.98%)
469	otherSubstancesFreq_otherSubstance4 [numeric]	mean (sd) : 3.94 (9.18) min < med < max : 0 < 1 < 50 IQR (CV) : 1 (2.33)	0 : 1 ( 2.9%) 1 : 19 (54.3%) 2 : 9 (25.7%) 4 : 1 ( 2.9%) 5 : 1 ( 2.9%) 6 : 1 ( 2.9%) 10 : 1 ( 2.9%) 26 : 1 ( 2.9%) 50 : 1 ( 2.9%)	IIIIIIIIIIIIIIII IIIIIII	35 (0.93%)	3730 (99.07%)
470	otherSubstancesFreq_otherSubstance5 [numeric]	mean (sd) : 9 (14.16) min < med < max : 0 < 3 < 52 IQR (CV) : 9 (1.57)	11 distinct values		19 (0.5%)	3746 (99.5%)
471	otherSubstancesFreq_cat_otherSubstance1 [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	2 ( 0.7%) 172 (63.2%) 44 (16.2%) 28 (10.3%) 19 ( 7.0%) 3 ( 1.1%) 2 ( 0.7%) 2 ( 0.7%)	IIIIIIIIIIIIIIII IIII II I	272 (7.22%)	3493 (92.78%)
472	otherSubstancesFreq_cat_otherSubstance2 [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	0 ( 0.0%) 96 (69.6%) 21 (15.2%) 8 ( 5.8%) 8 ( 5.8%) 1 ( 0.7%) 4 ( 2.9%) 0 ( 0.0%)	IIIIIIIIIIIIIIII III I I	138 (3.67%)	3627 (96.33%)
473	otherSubstancesFreq_cat_otherSubstance3 [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	1 ( 1.3%) 53 (69.7%) 9 (11.8%) 6 ( 7.9%) 2 ( 2.6%) 0 ( 0.0%) 3 ( 4.0%) 2 ( 2.6%)	IIIIIIIIIIIIIIII II I	76 (2.02%)	3689 (97.98%)
474	otherSubstancesFreq_cat_otherSubstance4 [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	1 ( 2.9%) 28 (80.0%) 1 ( 2.9%) 2 ( 5.7%) 1 ( 2.9%) 1 ( 2.9%) 1 ( 2.9%) 0 ( 0.0%)	IIIIIIIIIIIIIIII I	35 (0.93%)	3730 (99.07%)
475	otherSubstancesFreq_cat_otherSubstance5 [factor]	1. Not at all 2. 1-2 times 3. 3-4 times 4. Every month 5. Every few weeks 6. Every week 7. Twice a week 8. More often	1 ( 5.3%) 8 (42.1%) 1 ( 5.3%) 3 (15.8%) 4 (21.1%) 0 ( 0.0%) 2 (10.5%) 0 ( 0.0%)	II IIIIIIIIIIIIIIII II IIIIII IIIIIIII IIII	19 (0.5%)	3746 (99.5%)
476	highDose_attProduct_boundaries [numeric]	mean (sd) : 0.59 (2.55) min < med < max : -9 < 0 < 9 IQR (CV) : 1 (4.31)	13 distinct values		210 (5.58%)	3555 (94.42%)
477	highDose_attProduct_connection [numeric]	mean (sd) : 0.79 (3.78) min < med < max : -9 < 0 < 9 IQR (CV) : 5 (4.78)	13 distinct values		210 (5.58%)	3555 (94.42%)
478	highDose_attProduct_contact [numeric]	mean (sd) : 0.81 (3.98) min < med < max : -9 < 0 < 9 IQR (CV) : 3.75 (4.89)	13 distinct values		210 (5.58%)	3555 (94.42%)
479	highDose_attProduct_coping [numeric]	mean (sd) : 0.92 (2.99) min < med < max : -9 < 0 < 9 IQR (CV) : 2 (3.23)	13 distinct values		210 (5.58%)	3555 (94.42%)
480	highDose_attProduct_energy [numeric]	mean (sd) : 1.49 (3.63) min < med < max : -9 < 1 < 9 IQR (CV) : 4 (2.43)	13 distinct values		210 (5.58%)	3555 (94.42%)
481	highDose_attProduct_euphoria [numeric]	mean (sd) : 2.14 (4.02) min < med < max : -9 < 2 < 9 IQR (CV) : 6 (1.88)	13 distinct values		210 (5.58%)	3555 (94.42%)
482	highDose_attProduct_hallucinate [numeric]	mean (sd) : -0.39 (3.55) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (-9.2)	13 distinct values		210 (5.58%)	3555 (94.42%)
483	highDose_attProduct_insight [numeric]	mean (sd) : 0.06 (2.61) min < med < max : -9 < 0 < 9 IQR (CV) : 0 (42.2)	13 distinct values		210 (5.58%)	3555 (94.42%)
484	highDose_attProduct_intoxicated [numeric]	mean (sd) : 1.28 (3.93) min < med < max : -9 < 0 < 9 IQR (CV) : 4 (3.07)	13 distinct values		210 (5.58%)	3555 (94.42%)
485	highDose_attProduct_isolated [numeric]	mean (sd) : -0.6 (3.62) min < med < max : -9 < 0 < 9 IQR (CV) : 2 (-6.03)	13 distinct values		210 (5.58%)	3555 (94.42%)
486	highDose_attProduct_long [numeric]	mean (sd) : 2.51 (3.23) min < med < max : -9 < 2 < 9 IQR (CV) : 4 (1.29)	13 distinct values		210 (5.58%)	3555 (94.42%)
487	highDose_attProduct_memory [numeric]	mean (sd) : -2.59 (3.79) min < med < max : -9 < -2 < 9 IQR (CV) : 6 (-1.46)	12 distinct values		210 (5.58%)	3555 (94.42%)
488	highDose_attProduct_music [numeric]	mean (sd) : 2.96 (3.67) min < med < max : -9 < 2.5 < 9 IQR (CV) : 6 (1.24)	12 distinct values		210 (5.58%)	3555 (94.42%)
489	highDose_attProduct_sex [numeric]	mean (sd) : 0.3 (2.91) min < med < max : -9 < 0 < 9 IQR (CV) : 0 (9.7)	13 distinct values		210 (5.58%)	3555 (94.42%)
490	highDose_attProduct_timeAwareness [numeric]	mean (sd) : -2.23 (3.94) min < med < max : -9 < 0 < 9 IQR (CV) : 5.5 (-1.77)	13 distinct values		210 (5.58%)	3555 (94.42%)
491	highDose_normProduct_bestFriends [numeric]	mean (sd) : 3.36 (8.07) min < med < max : -21 < 4 < 21 IQR (CV) : 9 (2.4)	29 distinct values		206 (5.47%)	3559 (94.53%)
492	highDose_normProduct_otherFriends [numeric]	mean (sd) : -1.71 (6.13) min < med < max : -21 < 0 < 12 IQR (CV) : 7 (-3.59)	23 distinct values		199 (5.29%)	3566 (94.71%)
493	highDose_normProduct_parents [numeric]	mean (sd) : -1.35 (4.15) min < med < max : -18 < -0.5 < 12 IQR (CV) : 3 (-3.08)	21 distinct values		178 (4.73%)	3587 (95.27%)
494	highDose_normProduct_partner [numeric]	mean (sd) : 7.75 (8.7) min < med < max : -21 < 8 < 21 IQR (CV) : 11 (1.12)	23 distinct values		99 (2.63%)	3666 (97.37%)
495	highDose_normProduct_partyPeople [numeric]	mean (sd) : -7.6 (8.93) min < med < max : -21 < -8 < 14 IQR (CV) : 15 (-1.18)	23 distinct values		210 (5.58%)	3555 (94.42%)
496	highDose_normProduct_siblings [numeric]	mean (sd) : -0.87 (6.27) min < med < max : -18 < 0 < 15 IQR (CV) : 7 (-7.18)	25 distinct values		174 (4.62%)	3591 (95.38%)
497	highDose_normProduct_xtcFriends [numeric]	mean (sd) : 2.62 (9.45) min < med < max : -21 < 4 < 21 IQR (CV) : 7 (3.6)	27 distinct values		189 (5.02%)	3576 (94.98%)
498	highDose_intention [numeric]	mean (sd) : 3.78 (1.94) min < med < max : 1 < 4 < 7 IQR (CV) : 3.33 (0.51)	19 distinct values		309 (8.21%)	3456 (91.79%)
499	highDose_attitude [numeric]	mean (sd) : 3.64 (1.08) min < med < max : 1 < 3.8 < 6.4 IQR (CV) : 1.4 (0.3)	26 distinct values		305 (8.1%)	3460 (91.9%)
500	highDose_perceivedNorm [numeric]	mean (sd) : 3.08 (1.34) min < med < max : 1 < 3.12 < 6.25 IQR (CV) : 2 (0.43)	21 distinct values		298 (7.92%)	3467 (92.08%)
501	highDose_pbc [numeric]	mean (sd) : 5.28 (0.7) min < med < max : 2.2 < 5.4 < 6.6 IQR (CV) : 1 (0.13)	20 distinct values		297 (7.89%)	3468 (92.11%)
502	strngXTC_attProduct_boundaries [numeric]	mean (sd) : 0.56 (2.37) min < med < max : -9 < 0 < 9 IQR (CV) : 1 (4.2)	13 distinct values		324 (8.61%)	3441 (91.39%)
503	strngXTC_attProduct_connection [numeric]	mean (sd) : 1.21 (3.28) min < med < max : -6 < 0 < 9 IQR (CV) : 3 (2.71)	12 distinct values		325 (8.63%)	3440 (91.37%)
504	strngXTC_attProduct_contact [numeric]	mean (sd) : 1.13 (3.26) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (2.88)	13 distinct values		324 (8.61%)	3441 (91.39%)
505	strngXTC_attProduct_coping [numeric]	mean (sd) : 0.88 (2.56) min < med < max : -9 < 0 < 9 IQR (CV) : 1 (2.9)	13 distinct values		324 (8.61%)	3441 (91.39%)
506	strngXTC_attProduct_energy [numeric]	mean (sd) : 1.38 (3.22) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (2.33)	13 distinct values		325 (8.63%)	3440 (91.37%)
507	strngXTC_attProduct_euphoria [numeric]	mean (sd) : 1.7 (3.71) min < med < max : -9 < 0 < 9 IQR (CV) : 4 (2.19)	13 distinct values		325 (8.63%)	3440 (91.37%)
508	strngXTC_attProduct_hallucinate [numeric]	mean (sd) : -0.06 (3.19) min < med < max : -9 < 0 < 9 IQR (CV) : 1 (-57.33)	13 distinct values		324 (8.61%)	3441 (91.39%)
509	strngXTC_attProduct_insight [numeric]	mean (sd) : 0.11 (2.32) min < med < max : -9 < 0 < 9 IQR (CV) : 0 (20.92)	13 distinct values		325 (8.63%)	3440 (91.37%)
510	strngXTC_attProduct_intoxicated [numeric]	mean (sd) : 1.12 (3.3) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (2.96)	13 distinct values		325 (8.63%)	3440 (91.37%)
511	strngXTC_attProduct_isolated [numeric]	mean (sd) : -0.15 (3.07) min < med < max : -9 < 0 < 9 IQR (CV) : 1 (-20.32)	13 distinct values		324 (8.61%)	3441 (91.39%)
512	strngXTC_attProduct_long [numeric]	mean (sd) : 1.62 (2.93) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (1.81)	13 distinct values		325 (8.63%)	3440 (91.37%)
513	strngXTC_attProduct_memory [numeric]	mean (sd) : -1.66 (3.12) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (-1.87)	13 distinct values		324 (8.61%)	3441 (91.39%)
514	strngXTC_attProduct_music [numeric]	mean (sd) : 2.06 (3.12) min < med < max : -6 < 0 < 9 IQR (CV) : 3.25 (1.51)	-6 : 5 ( 1.5%) -3 : 3 ( 0.9%) -2 : 1 ( 0.3%) 0 : 170 (52.5%) 1 : 5 ( 1.5%) 2 : 14 ( 4.3%) 3 : 45 (13.9%) 4 : 10 ( 3.1%) 6 : 46 (14.2%) 9 : 25 ( 7.7%)	IIIIIIIIIIIIIIII I IIII IIII II	324 (8.61%)	3441 (91.39%)
515	strngXTC_attProduct_purity [numeric]	mean (sd) : 0.54 (2.96) min < med < max : -9 < 0 < 9 IQR (CV) : 2 (5.49)	13 distinct values		324 (8.61%)	3441 (91.39%)
516	strngXTC_attProduct_risk [numeric]	mean (sd) : 0.13 (3.14) min < med < max : -9 < 0 < 9 IQR (CV) : 0 (24.21)	13 distinct values		324 (8.61%)	3441 (91.39%)
517	strngXTC_attProduct_sex [numeric]	mean (sd) : 0.8 (2.53) min < med < max : -9 < 0 < 9 IQR (CV) : 1 (3.15)	13 distinct values		324 (8.61%)	3441 (91.39%)
518	strngXTC_attProduct_timeAwareness [numeric]	mean (sd) : -1.31 (3.18) min < med < max : -9 < 0 < 9 IQR (CV) : 3 (-2.42)	13 distinct values		324 (8.61%)	3441 (91.39%)
519	strngXTC_normProduct_bestFriends [numeric]	mean (sd) : 4.82 (9.08) min < med < max : -21 < 5 < 21 IQR (CV) : 12 (1.89)	30 distinct values		322 (8.55%)	3443 (91.45%)
520	strngXTC_normProduct_otherFriends [numeric]	mean (sd) : -1.3 (6.79) min < med < max : -21 < 0 < 21 IQR (CV) : 9 (-5.23)	28 distinct values		312 (8.29%)	3453 (91.71%)
521	strngXTC_normProduct_parents [numeric]	mean (sd) : -0.4 (4.9) min < med < max : -15 < 0 < 18 IQR (CV) : 5 (-12.28)	23 distinct values		288 (7.65%)	3477 (92.35%)
522	strngXTC_normProduct_partner [numeric]	mean (sd) : 8.37 (9.2) min < med < max : -21 < 10 < 21 IQR (CV) : 12 (1.1)	24 distinct values		146 (3.88%)	3619 (96.12%)
523	strngXTC_normProduct_partyPeople [numeric]	mean (sd) : -8.31 (9.56) min < med < max : -21 < -10 < 21 IQR (CV) : 18 (-1.15)	21 distinct values		325 (8.63%)	3440 (91.37%)
524	strngXTC_normProduct_siblings [numeric]	mean (sd) : 0.39 (7.69) min < med < max : -21 < 0 < 21 IQR (CV) : 7.5 (19.48)	27 distinct values		271 (7.2%)	3494 (92.8%)
525	strngXTC_normProduct_xtcFriends [numeric]	mean (sd) : 3.44 (10.76) min < med < max : -21 < 6 < 21 IQR (CV) : 12 (3.12)	26 distinct values		308 (8.18%)	3457 (91.82%)
526	strngXTC_intention [numeric]	mean (sd) : 4.2 (1.85) min < med < max : 1 < 4.67 < 7 IQR (CV) : 3 (0.44)	19 distinct values		381 (10.12%)	3384 (89.88%)
527	strngXTC_attitude [numeric]	mean (sd) : 3.97 (0.97) min < med < max : 1 < 4 < 6.2 IQR (CV) : 1 (0.24)	27 distinct values		379 (10.07%)	3386 (89.93%)
528	strngXTC_perceivedNorm [numeric]	mean (sd) : 3.44 (1.32) min < med < max : 1 < 3.5 < 6.25 IQR (CV) : 2 (0.38)	21 distinct values		377 (10.01%)	3388 (89.99%)
529	strngXTC_pbc [numeric]	mean (sd) : 5.28 (0.67) min < med < max : 3.2 < 5.4 < 7 IQR (CV) : 1 (0.13)	21 distinct values		376 (9.99%)	3389 (90.01%)
530	testing_attProduct_anonimity [numeric]	mean (sd) : 5.53 (4.09) min < med < max : -6 < 6 < 9 IQR (CV) : 7 (0.74)	-6 : 3 ( 1.4%) -4 : 1 ( 0.5%) -3 : 5 ( 2.3%) 0 : 40 (18.4%) 1 : 3 ( 1.4%) 2 : 6 ( 2.8%) 3 : 13 ( 6.0%) 4 : 7 ( 3.2%) 6 : 32 (14.8%) 9 : 107 (49.3%)	IIIII I I IIII IIIIIIIIIIIIIIII	217 (5.76%)	3548 (94.24%)
531	testing_normProduct_bestFriends [numeric]	mean (sd) : 2.78 (14.08) min < med < max : -21 < 6 < 21 IQR (CV) : 20 (5.07)	21 distinct values		213 (5.66%)	3552 (94.34%)
532	testing_normProduct_otherFriends [numeric]	mean (sd) : -2.36 (12.43) min < med < max : -21 < 0 < 21 IQR (CV) : 19 (-5.27)	23 distinct values		207 (5.5%)	3558 (94.5%)
533	testing_normProduct_parents [numeric]	mean (sd) : -0.68 (12.82) min < med < max : -21 < 0 < 21 IQR (CV) : 19 (-18.78)	21 distinct values		186 (4.94%)	3579 (95.06%)
534	testing_normProduct_partner [numeric]	mean (sd) : 7.4 (13.68) min < med < max : -21 < 12 < 21 IQR (CV) : 21 (1.85)	15 distinct values		101 (2.68%)	3664 (97.32%)
535	testing_normProduct_partyPeople [numeric]	mean (sd) : -6.92 (11.23) min < med < max : -21 < -8 < 21 IQR (CV) : 15 (-1.62)	23 distinct values		214 (5.68%)	3551 (94.32%)
536	testing_normProduct_siblings [numeric]	mean (sd) : -0.73 (12.74) min < med < max : -21 < 0 < 21 IQR (CV) : 19 (-17.46)	22 distinct values		181 (4.81%)	3584 (95.19%)
537	testing_normProduct_xtcFriends [numeric]	mean (sd) : 1.7 (13.58) min < med < max : -21 < 4.5 < 21 IQR (CV) : 18.75 (8.01)	23 distinct values		198 (5.26%)	3567 (94.74%)
538	testing_intention [numeric]	mean (sd) : 5.11 (1.52) min < med < max : 1 < 5 < 7 IQR (CV) : 2.67 (0.3)	18 distinct values		278 (7.38%)	3487 (92.62%)
539	testing_attitude [numeric]	mean (sd) : 5.98 (0.77) min < med < max : 1 < 6.2 < 7 IQR (CV) : 0.8 (0.13)	17 distinct values		238 (6.32%)	3527 (93.68%)
540	testing_perceivedNorm [numeric]	mean (sd) : 4.6 (1.48) min < med < max : 1 < 4.5 < 7 IQR (CV) : 2.25 (0.32)	24 distinct values		236 (6.27%)	3529 (93.73%)
541	testing_pbc [numeric]	mean (sd) : 5.29 (0.89) min < med < max : 1 < 5.6 < 7 IQR (CV) : 1 (0.17)	23 distinct values		235 (6.24%)	3530 (93.76%)
542	age_validValue [logical]		1 ( 0.2%) 396 (99.8%)		397 (10.54%)	3368 (89.46%)
543	numberOfInvalidValues [integer]	mean (sd) : 0.67 (0.58) min < med < max : 0 < 1 < 1 IQR (CV) : 0.5 (0.87)	0 : 1 (33.3%) 1 : 2 (66.7%)	IIIIIIII IIIIIIIIIIIIIIII	3 (0.08%)	3762 (99.92%)
544	xtcUseIntentionFreq_freq.0_validValue [logical]		173 (29.4%) 415 (70.6%)		588 (15.62%)	3177 (84.38%)
545	xtcUseIntentionFreq_freq.1_validValue [logical]		589 (100.0%)		589 (15.64%)	3176 (84.36%)
546	testing_IntentionFreq_testBehav.0_validValue [logical]		15 ( 5.4%) 262 (94.6%)		277 (7.36%)	3488 (92.64%)
547	testing_IntentionFreq_testBehav.1_validValue [logical]		278 (100.0%)		278 (7.38%)	3487 (92.62%)
548	goingOutFreq_houseparty_validValue [logical]		868 (100.0%)		868 (23.05%)	2897 (76.95%)
549	goingOutFreq_cafe_validValue [logical]		1 ( 0.1%) 859 (99.9%)		860 (22.84%)	2905 (77.16%)
550	goingOutFreq_disco_validValue [logical]		860 (100.0%)		860 (22.84%)	2905 (77.16%)
551	goingOutFreq_band_validValue [logical]		858 (100.0%)		858 (22.79%)	2907 (77.21%)
552	goingOutFreq_smallPartyInside_validValue [logical]		852 (100.0%)		852 (22.63%)	2913 (77.37%)
553	goingOutFreq_bigPartyInside_validValue [logical]		850 (100.0%)		850 (22.58%)	2915 (77.42%)
554	goingOutFreq_smallPartyOutside_validValue [logical]		1 ( 0.1%) 847 (99.9%)		848 (22.52%)	2917 (77.48%)
555	goingOutFreq_bigPartyOutside_validValue [logical]		852 (100.0%)		852 (22.63%)	2913 (77.37%)
556	otherSubstancesFreq_otherSubstance1_validValue [logical]		272 (100.0%)		272 (7.22%)	3493 (92.78%)
557	otherSubstancesFreq_otherSubstance2_validValue [logical]		138 (100.0%)		138 (3.67%)	3627 (96.33%)
558	otherSubstancesFreq_otherSubstance3_validValue [logical]		76 (100.0%)		76 (2.02%)	3689 (97.98%)
559	otherSubstancesFreq_otherSubstance4_validValue [logical]		35 (100.0%)		35 (0.93%)	3730 (99.07%)
560	otherSubstancesFreq_otherSubstance5_validValue [logical]		19 (100.0%)		19 (0.5%)	3746 (99.5%)
561	substUsePastBeh_alc_validValue [logical]		3 ( 0.4%) 741 (99.6%)		744 (19.76%)	3021 (80.24%)
562	substUsePastBeh_tbc_validValue [logical]		67 ( 9.1%) 671 (90.9%)		738 (19.6%)	3027 (80.4%)
563	substUsePastBeh_cnb_validValue [logical]		5 ( 0.7%) 737 (99.3%)		742 (19.71%)	3023 (80.29%)
564	substUsePastBeh_xtc_validValue [logical]		742 (100.0%)		742 (19.71%)	3023 (80.29%)
565	substUsePastBeh_mdma_validValue [logical]		744 (100.0%)		744 (19.76%)	3021 (80.24%)
566	substUsePastBeh_fourfa_validValue [logical]		741 (100.0%)		741 (19.68%)	3024 (80.32%)
567	substUsePastBeh_coke_validValue [logical]		739 (100.0%)		739 (19.63%)	3026 (80.37%)
568	substUsePastBeh_spd_validValue [logical]		740 (100.0%)		740 (19.65%)	3025 (80.35%)
569	substUsePastBeh_gas_validValue [logical]		741 (100.0%)		741 (19.68%)	3024 (80.32%)
570	substUsePastBeh_ghb_validValue [logical]		740 (100.0%)		740 (19.65%)	3025 (80.35%)
571	substUsePastBeh_ket_validValue [logical]		742 (100.0%)		742 (19.71%)	3023 (80.29%)
572	exceptionalScores [numeric]	mean (sd) : 0.52 (1.33) min < med < max : 0 < 0 < 9 IQR (CV) : 0 (2.57)	0 : 2945 (78.2%) 1 : 416 (11.1%) 2 : 132 ( 3.5%) 3 : 92 ( 2.4%) 4 : 61 ( 1.6%) 5 : 44 ( 1.2%) 6 : 34 ( 0.9%) 7 : 19 ( 0.5%) 8 : 10 ( 0.3%) 9 : 12 ( 0.3%)	IIIIIIIIIIIIIIII II	3765 (100%)	0 (0%)
573	exceptionalNrOfExceptionalScores [numeric]	mean (sd) : 0 (0) min < med < max : 0 < 0 < 0 IQR (CV) : 0 (NaN)	0 : 3765 (100.0%)	IIIIIIIIIIIIIIII	3765 (100%)	0 (0%)

Recruitment

Party Panel participants were recruited primarily through social media. The Dutch Celebrate Safe campaign (see http://celebratesafe.nl), Unity (see http://unity.nl), as well as related organisations such as event organisers that were partnered with Celebrate Safe promoted Party Panel through Facebook and Twitter posts. In addition, visitors to the Unity website were shown a div pop-up.

This figure shows participant recruitment over time:

Figure 2: Participants starting the survey at different dates.

During this time, 3765 participants opened the first page containing the Informed Consent. From this point, the progression through the survey was as follows:

Figure 3: Dropout throughout the questionnaire.

frequency	percentage	page	prettyPercentage
3765	100	1	100%
1770	47.01	2	47%
829	22.02	3	22%
733	19.47	4	19%
687	18.25	5	18%
637	16.92	6	17%
550	14.61	7	15%
466	12.38	8	12%
437	11.61	9	12%
420	11.16	10	11%
407	10.81	11	11%
401	10.65	12	11%
376	9.987	13	10%
374	9.934	14	10%

Of the 1807 participants answering the Informed Consent, 22 participants answered negatively. Of these, 2 provided a reason. Specifically, the reasons provided were “20 minuten is te lang” & “duurt te lang”.

For each participant, two random numbers were set. The first was set to a value of 1, 2 or 3, and determined for which behavior determinants would be measured (participants were also provided with the opportunity to answer questions about the other behaviors, if they wanted). The second was set to an integer number between (and including) 0 and 10. This second number was used to explore how participants would respond if testing would be available in the whole of the Netherlands for different costs (i.e. 0 to 10 euros).

Participants (sample description)

Gender

	Frequencies	Perc.Total	Perc.Valid	Cumulative
Male	245	6.5	61.4	61.4
Female	152	4.0	38.1	99.5
Other (e.g. genderqueer, nonbinary)	2	0.1	0.5	100.0
Total valid	399	10.6	100.0	NA
NA (missing)	3366	89.4	NA	NA
Total	3765	100.0	NA	NA

Age

Describing the central tendency:

mean	median	mode	95% CI mean
24.8	23	20	[24.11; 25.48]

Describing the spread:

var	sd	iqr	se
47.82	6.915	8	0.3475

Describing the range:

min	q1	q3	max
7	20	28	60

Describing the distribution shape:

skewness	kurtosis	dip
1.736	4.427	0.04545

Describing the sample size:

total	NA.	valid
3765	3369	396

Figure 6: Histogram for age distribution.

goingOutFreq

Diamond and ridgeline plots

Figure 8: Ridgeline plot for goingOutFreq.

Frequencies and easybarplots

	Not at all	1-2 times	3-4 times	Every month	Every few weeks	Every week	Twice a week	More often
goingOutFreq_cat_houseparty	40	99	109	225	235	124	30	6
goingOutFreq_cat_cafe	85	96	45	152	192	192	73	25
goingOutFreq_cat_disco	180	155	93	194	138	84	15	1
goingOutFreq_cat_band	463	236	63	64	25	6	1	0
goingOutFreq_cat_smallPartyInside	260	331	103	105	44	8	1	0
goingOutFreq_cat_bigPartyInside	375	330	74	53	16	1	0	0
goingOutFreq_cat_smallPartyOutside	311	354	87	66	24	3	1	2
goingOutFreq_cat_bigPartyOutside	139	358	169	133	47	3	0	3

Raw

	0	0.5	1	2	3	4	5	6	7	8	9	10	11	12	14	15	16	18	20	22	24	25	26	28	30	31	32	33	34	36	40	42	48	50	52	60	78	90	104	130
goingOutFreq_houseparty	40	NA	36	63	68	41	29	191	5	8	1	34	NA	133	NA	8	1	45	5	NA	15	1	95	NA	7	NA	NA	NA	NA	6	NA	1	1	NA	26	2	4	NA	1	1
goingOutFreq_cafe	85	NA	48	48	26	19	18	133	1	5	1	19	NA	97	NA	8	1	51	10	1	22	7	139	NA	12	NA	2	NA	NA	9	1	2	2	1	67	NA	16	1	4	3
goingOutFreq_disco	180	NA	79	76	62	31	29	161	4	8	1	14	1	85	NA	2	1	23	3	NA	10	3	60	NA	9	NA	NA	NA	NA	2	NA	2	NA	NA	12	1	NA	NA	1	NA
goingOutFreq_band	463	NA	143	93	48	15	10	53	1	3	NA	4	NA	15	NA	1	NA	1	1	NA	NA	NA	3	NA	1	1	NA	1	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA
goingOutFreq_smallPartyInside	260	NA	188	143	62	41	29	74	2	4	2	5	NA	23	NA	3	NA	7	NA	NA	1	NA	5	1	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA
goingOutFreq_bigPartyInside	375	1	210	120	51	23	15	37	1	1	NA	5	NA	8	NA	1	NA	1	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
goingOutFreq_smallPartyOutside	311	NA	211	143	58	29	15	50	1	1	NA	1	NA	17	1	NA	NA	4	NA	NA	1	NA	1	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	1	NA	NA	NA	1	NA
goingOutFreq_bigPartyOutside	139	NA	196	162	102	67	56	66	11	6	2	9	2	18	NA	NA	NA	9	1	NA	2	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	2

Figure 10: EasyBar plot for goingOutFreq.

substUsePastBeh

Diamond and ridgeline plots

Figure 12: Ridgeline plot for substUsePastBeh.

Frequencies and easybarplots

	Not at all	1-2 times	3-4 times	Every month	Every few weeks	Every week	Twice a week	More often
substUsePastBeh_cat_alc	27	15	5	27	87	145	196	242
substUsePastBeh_cat_tbc	242	27	17	41	38	42	37	294
substUsePastBeh_cat_cnb	238	124	53	77	77	41	27	105
substUsePastBeh_cat_xtc	169	238	138	120	70	5	2	0
substUsePastBeh_cat_mdma	463	187	36	39	18	1	0	0
substUsePastBeh_cat_fourfa	439	186	43	52	20	1	0	0
substUsePastBeh_cat_coke	487	112	37	46	40	10	6	1
substUsePastBeh_cat_spd	434	110	59	53	58	13	5	8
substUsePastBeh_cat_gas	380	179	71	55	36	13	5	2
substUsePastBeh_cat_ghb	643	48	13	13	15	6	1	1
substUsePastBeh_cat_ket	557	98	36	30	16	2	2	1

Raw

	0	1	2	3	4	5	6	7	8	9	10	11	12	14	15	17	18	20	24	25	26	30	35	36	42	45	48	50	52	60	72	78	80	100	104	120	130	140	150	156	182	186
substUsePastBeh_alc	27	7	8	4	1	3	23	1	NA	1	6	NA	46	NA	1	NA	25	8	14	2	116	5	1	7	NA	1	2	3	185	5	1	111	1	NA	53	2	45	NA	NA	19	7	NA
substUsePastBeh_tbc	242	15	12	13	4	11	29	1	1	NA	9	NA	19	NA	NA	NA	6	3	5	NA	34	2	NA	1	NA	NA	1	1	32	3	NA	24	NA	NA	17	NA	20	NA	NA	9	156	1
substUsePastBeh_cnb	238	75	49	30	23	16	61	NA	5	1	8	NA	46	NA	3	NA	12	2	6	NA	32	2	NA	1	NA	NA	NA	NA	27	NA	NA	18	NA	NA	19	NA	23	NA	1	10	29	NA
substUsePastBeh_xtc	169	114	124	96	42	21	92	7	7	3	5	1	36	1	3	NA	11	3	NA	1	3	1	NA	NA	NA	NA	NA	NA	1	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
substUsePastBeh_mdma	463	117	70	23	13	7	30	2	2	NA	1	NA	12	NA	NA	NA	3	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
substUsePastBeh_fourfa	439	123	63	30	13	11	39	2	3	NA	1	NA	14	NA	NA	NA	2	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
substUsePastBeh_coke	487	72	40	20	17	12	31	3	8	NA	4	NA	22	NA	2	NA	4	NA	3	NA	7	NA	NA	NA	NA	NA	1	NA	5	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA
substUsePastBeh_spd	434	72	38	37	22	17	33	3	8	NA	5	NA	29	NA	4	1	11	NA	4	NA	7	1	NA	1	NA	NA	NA	2	2	1	NA	3	NA	NA	1	NA	1	1	NA	1	1	NA
substUsePastBeh_gas	380	113	66	51	20	18	35	2	3	NA	11	NA	13	NA	2	NA	4	3	6	2	2	1	1	1	1	NA	1	1	1	1	NA	NA	NA	1	NA	1	NA	NA	NA	NA	NA	NA
substUsePastBeh_ghb	643	38	10	8	5	4	8	1	3	NA	NA	NA	9	NA	1	NA	2	NA	2	NA	3	NA	NA	1	NA	NA	NA	1	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
substUsePastBeh_ket	557	63	35	21	15	14	16	NA	2	1	3	NA	9	NA	NA	NA	1	NA	NA	1	1	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Figure 14: EasyBar plot for substUsePastBeh.

otherSubstancesFreq

Diamond and ridgeline plots

Figure 16: Ridgeline plot for otherSubstancesFreq.

Frequencies and easybarplots

	Not at all	1-2 times	3-4 times	Every month	Every few weeks	Every week	Twice a week	More often
otherSubstancesFreq_cat_otherSubstance1	2	172	44	28	19	3	2	2
otherSubstancesFreq_cat_otherSubstance2	0	96	21	8	8	1	4	0
otherSubstancesFreq_cat_otherSubstance3	1	53	9	6	2	0	3	2
otherSubstancesFreq_cat_otherSubstance4	1	28	1	2	1	1	1	0
otherSubstancesFreq_cat_otherSubstance5	1	8	1	3	4	0	2	0

Raw

	0	1	2	3	4	5	6	7	8	10	12	15	18	20	24	26	30	42	50	52	54	104	156	182
otherSubstancesFreq_otherSubstance1	2	106	66	38	6	12	15	1	3	2	8	1	4	1	1	2	NA	NA	1	1	NA	1	1	NA
otherSubstancesFreq_otherSubstance2	NA	70	26	15	6	4	3	1	1	3	3	NA	1	NA	NA	NA	1	NA	NA	4	NA	NA	NA	NA
otherSubstancesFreq_otherSubstance3	1	35	18	8	1	4	1	1	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	2	1	1	NA	1
otherSubstancesFreq_otherSubstance4	1	19	9	NA	1	1	1	NA	NA	1	NA	NA	NA	NA	NA	1	NA	NA	1	NA	NA	NA	NA	NA
otherSubstancesFreq_otherSubstance5	1	5	3	1	NA	2	1	NA	NA	2	1	1	NA	NA	NA	NA	NA	1	NA	1	NA	NA	NA	NA

Figure 18: EasyBar plot for otherSubstancesFreq.

Behavioral determinants

This section is quite full, and is therefore again organised using tabs. The first tab (“CIBER plots and how to read them”) contains an introduction to and explanation of the data visualisation used to explore determinant importance. The second tab (“Determinant structures”) shows the theoretical determinant structure that these determinant importance analyses are based on. The third tab (“Determinant importance”), finally, shows the CIBER plots for the determinants measured in this Party Panel wave.

CIBER plots and how to read them

When thinking about which determinants and sub-determinants to target in a behavior change intervention, it is important to consider both the univariate distributions (i.e. means) and the associations to behavior and determinants of behavior (such as intention or other theoretically relevant determinants; Peters, 2012). Usually, means and correlation coefficients are used to inspect these, but it is important to realise that sample estimates are subject to random variability, and therefore, will be different in different samples. Instead of using point estimates, therefore, it is better to use confidence intervals (Crutzen, Peters & Noijen, 2017).

Confidence Interval Based Estimation of Relevance plots (CIBER plots) facilitate inspection of many data points and confidence intervals simultaneously (Crutzen, Peters & Noijen, 2017). Because CIBER plots are a relatively new development, we will briefly explain how to read them here using simulated data.

In this fictional example, we measured the determinants of doing a determinant study when developing an intervention. In this example, we measured three sub-determinants of attitude (called beliefs):

CIBER plot example

These are the results for question (or rather, variable) “CIBER plot example”.

Figure 19: A fictional example of a CIBER plot.

Explaining the plot title

The title doubles as a legend: each higher-level determinant (called a ‘target’ in CIBER plots) is designated a color that is used in the plot. In this case, attitude is red and intention is blue. These colors are used in the right-hand panel of the plot (see below).

The title also shows the confidence interval (by default the 95% confidence interval) for the proportion of explained variance (or ² for each target as explained by the (sub-) determinants in the plot (in this case, by the three beliefs).

Explaining the left-hand panel

The left-hand panel in a CIBER plot shows the univariate distributions of each (sub-)determinant, in these case the three beliefs. It shows both the individual participants’ scores as well as the confidence interval for the mean as diamonds (by default, CIBER plots show 99.99% confidence intervals). The diamons are colored as a function of the relative position of the mean:

if participants mostly score towards the bottom of the scale (a low mean), the diamonds are red;
if participants mostly score around the middle, or if they score all over the place (in both cases the mean is in the middle), the diamonds are blue; and
if participants score towards the top of the scale (a high mean), the diamonds are green.

Note that in this fictional example, it’s quite clear that the data were simulated: usually, participants don’t all score so closely to the mean.

Explaining the right-hand panel

The right-hand panel in a CIBER plot shows the associations to the higher-order determinants, in this case attitude and intention (of course, you could also plot associations to behavior here). In this panel, individual scores are not shown, only the diamonds representing the confidence intervals for the correlation coefficicients (by default, 95% confidence intervals).

The strokes (borders) of these diamonds indicate which target each diamond represents. In this example, the red diamonds represent the beliefs’ associations with attitude, and the blue diamonds represent the beliefs’ associations with intention (see the section on the plot title, above).

The fill (inside color) of these diamonds is also a function of how strong the association is:

diamonds representing very strong negative associations (correlations approaching -1) are filled with a red color;
diamonds representing no association (correlations around 0) are filled with a grey color; and
diamonds representing very strong associations (correlations approaching 1) are filled with a green color.

Interpretation of this CIBER plot

In this fictional sample, the responses to the first belief show that participants do not strongly believe that a determinant study provides a lot of insight into why people exhibit the target behavior. This belief is quite strongly related to attitude and intention, and therefore this seems a viable intervention target. If this were a real scenario, and we would want to promote the use of determinant studies, succesfully changing this belief would likely contribute to behavior change.

The second belief is held by even fewer people: these fictional participants believe that the effect of an intervention does not depend on whether the right determinants are targeted. Interestingly, the right-hand panel shows that this belief is not strongly associated to attitude and intention. It is possible that this is a consequence of the skewed distribution: almost all participants score 1 or 2, which means that there is very little variation, which means that the correlation cannot achieve a very high value. However, if we assume for the moment that the weak association of this belief to attitude and intention is not a statistical artifact, we would conclude that changing this belief would be unlikely to contribute to behavior change.

The third belief is already held by most participants: the mean is between 5 and 6 in a 7-point scale, so most people believe that interventions that are based on determinant studies are more effective because they are (this is an unrealistic contrast with the second belief; these are simulated data, after all). This belief was also quite strongly associated to attitude and behavior. Since most people already hold this belief to some degree, an intervention would focus on people who answered in the middle of the scale (i.e. who think that it doesn’t matter much for effectiveness whether an intervention is based on a determinant study).

Determinant structures

These are visualisations of the determinant structures of the behaviors in this Party Panel wave. The associations of the sub-determinants in each of these determinants with the overarching determinants and with intention will then be visualised using CIBER plots.

highDose

strngXTC

testing

Determinant importance

This section contains CIBER plots to show the determinant relevance. These are organised based on the determinant structure; the headings and each figure’s caption shows to which behavior and to which (sub)-determinants each CIBER plot pertains.

highDose

These are the results for question (or rather, variable) “highDose”.

Intention

These are the results for question (or rather, variable) “Intention” (296 participants provided data).

Attitude

These are the results for question (or rather, variable) “Attitude” (305 participants provided data).

Likelihood

These are the results for question (or rather, variable) “Likelihood” (212 participants provided data).

Evaluation

These are the results for question (or rather, variable) “Evaluation” (210 participants provided data).

attProduct

These are the results for question (or rather, variable) “attProduct” (210 participants provided data).

perceivedNorm

These are the results for question (or rather, variable) “perceivedNorm” (298 participants provided data).

Approval

These are the results for question (or rather, variable) “Approval” (71 participants provided data).

Motivation to Comply

These are the results for question (or rather, variable) “Motivation to Comply” (71 participants provided data).

normProduct

These are the results for question (or rather, variable) “normProduct” (71 participants provided data).

Pbc

These are the results for question (or rather, variable) “Pbc” (297 participants provided data).

Control Beliefs

These are the results for question (or rather, variable) “Control Beliefs” (124 participants provided data).

strngXTC

These are the results for question (or rather, variable) “strngXTC”.

Intention

These are the results for question (or rather, variable) “Intention” (376 participants provided data).

Attitude

These are the results for question (or rather, variable) “Attitude” (379 participants provided data).

Likelihood

These are the results for question (or rather, variable) “Likelihood” (326 participants provided data).

Evaluation

These are the results for question (or rather, variable) “Evaluation” (325 participants provided data).

attProduct

These are the results for question (or rather, variable) “attProduct” (324 participants provided data).

perceivedNorm

These are the results for question (or rather, variable) “perceivedNorm” (377 participants provided data).

Approval

These are the results for question (or rather, variable) “Approval” (110 participants provided data).

Motivation to Comply

These are the results for question (or rather, variable) “Motivation to Comply” (110 participants provided data).

normProduct

These are the results for question (or rather, variable) “normProduct” (110 participants provided data).

Pbc

These are the results for question (or rather, variable) “Pbc” (376 participants provided data).

Control Beliefs

These are the results for question (or rather, variable) “Control Beliefs” (323 participants provided data).

Testing

These are the results for question (or rather, variable) “Testing”.

Intention

These are the results for question (or rather, variable) “Intention” (112 participants provided data).

Attitude

These are the results for question (or rather, variable) “Attitude” (238 participants provided data).

Likelihood

These are the results for question (or rather, variable) “Likelihood” (217 participants provided data).

Evaluation

These are the results for question (or rather, variable) “Evaluation” (217 participants provided data).

attProduct

These are the results for question (or rather, variable) “attProduct” (217 participants provided data).

perceivedNorm

These are the results for question (or rather, variable) “perceivedNorm” (236 participants provided data).

Approval

These are the results for question (or rather, variable) “Approval” (77 participants provided data).

Motivation to Comply

These are the results for question (or rather, variable) “Motivation to Comply” (76 participants provided data).

normProduct

These are the results for question (or rather, variable) “normProduct” (76 participants provided data).

Pbc

These are the results for question (or rather, variable) “Pbc” (235 participants provided data).

Control Beliefs

These are the results for question (or rather, variable) “Control Beliefs” (214 participants provided data).

Wave specific analyses

awareOfTestFacilities

Whether participants know that they can get XTC tested in the Netherlands (‘testing_Awareness’)

	Frequencies	Perc.Total	Perc.Valid	Cumulative
heard	104	2.8	14.1	14.1
no	20	0.5	2.7	16.8
yes	615	16.3	83.2	100.0
Total valid	739	19.6	100.0	NA
NA (missing)	3026	80.4	NA	NA
Total	3765	100.0	NA	NA

xtcDoseStrategy

Strategies people use to determine the strength of their pills (‘xtcDoseStrategy_testService’, ‘xtcDoseStrategy_friendTests’, ‘xtcDoseStrategy_dealer’, ‘xtcDoseStrategy_friendExperience’, ‘xtcDoseStrategy_pillreports’, ‘xtcDoseStrategy_onlineForum’ & ‘xtcDoseStrategy_noStrategy’)

	0	1
Geen van deze opties: ik kom er meestal niet achter	291	21
Ik overleg over mijn pillen met vrienden op een online forum (bijvoorbeeld PartyFlock)	267	45
Ik laat mijn XTC pillen testen bij de testservice	212	100
Een vriend(in) laat onze XTC pillen testen bij de testservice	211	101
Mijn dealer laat de XTC pillen testen bij de testservice	200	112
Mijn vrienden vertellen me de dosis op basis van hun ervaring met die pillen	182	130
Ik zoek mijn pillen op de pillreports.com (of een andere website)	151	161

Figure 53: Visualisation for xtcDoseStrategy

testingTrustworthy

How trustworthy people consider different sources of information about their pill content/strength (‘testing_Trustworthy_testCentre’, ‘testing_Trustworthy_friendTestCentre’, ‘testing_Trustworthy_dealerTestCentre’, ‘testing_Trustworthy_friendsExperience’, ‘testing_Trustworthy_pillReports’ & ‘testing_Trustworthy_forum’)

	1	2	3	4	5	6	7
Een dealer heeft de XTC laten testen	32	38	49	36	38	13	7
Over de pillen overleggen op een online forum (bijvoorbeeld PartyFlock)	34	32	40	39	46	18	3
Vrienden vertellen de dosis op basis van hun ervaringen met die pillen	30	36	35	30	47	30	4
De pil opzoeken op PillReports.com (of een andere website)	18	21	32	35	61	41	4
Een vriend(in) heeft de XTC laten testen		2	7	10	29	91	75
De XTC zelf laten testen bij een testcentrum		2		6	4	24	178

Figure 54: Visualisation 1 of 3 for testingTrustworthy

Figure 55: Visualisation 2 of 3 for testingTrustworthy

Figure 56: Visualisation 3 of 3 for testingTrustworthy

doseControlBeliefs

Beliefs people have about the control over their dose (‘doseControlBeliefs_choice’, ‘doseControlBeliefs_identifyDose’, ‘doseControlBeliefs_buyOwn’, ‘doseControlBeliefs_knowDose’ & ‘doseControlBeliefs_knowIntensity’)

Figure 58: Visualisation 2 of 2 for doseControlBeliefs

Regression analysis for formula: xtcUseDosePref ~ weight_other

Significance test of the entire model (all predictors together):

Multiple R-squared: [0.02, 0.19] (point estimate = 0.08, adjusted = 0.08)

Test for significance: F[1, 133] = 12.33, p = .001

Raw regression coefficients (unstandardized beta values, called ‘B’ in SPSS):

	95% conf. int.	estimate	se	t	p
(Intercept)	[-76.57; 102.45]	12.94	45.25	0.29	.775
weight_other	[0.92; 3.3]	2.11	0.6	3.51	.001

Scaled regression coefficients (standardized beta values, called ‘Beta’ in SPSS):

	95% conf. int.	estimate	se	t	p
(Intercept)	[-0.15; 0.17]	0.01	0.08	0.1	.922
weight_other	[0.12; 0.43]	0.28	0.08	3.51	.001

De verwachting dat een hoge dosis leidt tot sociale isolatie

These are the results for question (or rather, variable) ‘highDose_AttBeliefs_isolated’.

The lead-in for this question was “Eerst een aantal vragen over hoe het gebruiken van een hoge dosis XTC voor jou verschilt van het gebruiken van een gewone dosis XTC (MDMA). Als jij alleen nog maar een gewone dosis hebt gebruikt, of alleen nog maar een hoge dosis hebt gebruikt, geef dan aan wat je denkt dat het verschil zal zijn.”.